review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1036672274 |
P356 | DOI | 10.1038/NRC1877 |
P3181 | OpenCitations bibliographic resource ID | 100268 |
P698 | PubMed publication ID | 16572188 |
P50 | author | Raghu Kalluri | Q29841277 |
P2093 | author name string | Michael Zeisberg | |
P2860 | cites work | The Hallmarks of Cancer | Q221226 |
Epithelial-mesenchymal transition and its implications for fibrosis | Q24302042 | ||
The discoidin domain receptor tyrosine kinases are activated by collagen | Q24313329 | ||
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth | Q24315369 | ||
Pituitary extracts and steroid hormones in the control of 3T3 cell growth | Q24562948 | ||
Stromal effects on mammary gland development and breast cancer | Q24645558 | ||
Inflammation and cancer | Q24649640 | ||
Prognostic significance of tenascin-C expression in superficial and invasive bladder cancer | Q24672629 | ||
Intermediate-sized filaments of human endothelial cells | Q24681997 | ||
Multistep tumorigenesis and the microenvironment | Q24794552 | ||
Distribution of vimentin and desmin filaments in smooth muscle tissue of mammalian and avian aorta | Q58439455 | ||
Occurrence of a fetal fibroblast phenotype in familial breast cancer | Q59289731 | ||
Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues | Q60305997 | ||
Collagen proline hydroxylase in wound healing, granuloma formation, scurvy, and growth | Q68713006 | ||
Characterization of human renal fibroblasts in health and disease: I. Immunophenotyping of cultured tubular epithelial cells and fibroblasts derived from kidneys with histologically proven interstitial fibrosis | Q70174120 | ||
Fibroblasts from patients with breast cancer show abnormal migratory behaviour in vitro | Q72589391 | ||
A novel model to study renal myofibroblast formation in vitro | Q73419703 | ||
Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis | Q73712026 | ||
Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial | Q73849049 | ||
Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction | Q73873891 | ||
Tumor induction of VEGF promoter activity in stromal cells | Q77349243 | ||
Elevated concentrations of serum relaxin are associated with metastatic disease in breast cancer patients | Q80586556 | ||
TGF-beta and cancer | Q81484456 | ||
Myofibroblasts in human granulation tissue | Q93754314 | ||
Transplacental carcinogenesis by stilbestrol | Q95784569 | ||
Deletion of integrin alpha 1 by homologous recombination permits normal murine development but gives rise to a specific deficit in cell adhesion. | Q52201902 | ||
Characterization of human renal fibroblasts in health and disease: II. In vitro growth, differentiation, and collagen synthesis of fibroblasts from kidneys with interstitial fibrosis. | Q52236634 | ||
Epithelial/mesenchymal interactions and branching morphogenesis of the lung. | Q52565573 | ||
Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets. | Q53364039 | ||
Differential transplantability of tumor-associated stromal cells. | Q53886677 | ||
Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas | Q57591220 | ||
Host microenvironment in breast cancer development: extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breast | Q24803379 | ||
Epithelial-mesenchymal transitions in tumour progression | Q27860487 | ||
Integrins: versatility, modulation, and signaling in cell adhesion | Q27860844 | ||
Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing | Q28131793 | ||
Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models | Q28201247 | ||
Myofibroblasts and mechano-regulation of connective tissue remodelling | Q28216468 | ||
Tumor cell interactions with the extracellular matrix during invasion and metastasis | Q28258256 | ||
Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin | Q28271413 | ||
FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressor | Q28513202 | ||
Vascular endothelial growth factor is a secreted angiogenic mitogen | Q28646475 | ||
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion | Q29547317 | ||
Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo | Q29614729 | ||
TGF-beta signaling in tumor suppression and cancer progression | Q29615427 | ||
Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer | Q29616379 | ||
Evidence that fibroblasts derive from epithelium during tissue fibrosis | Q29616581 | ||
Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid | Q29617640 | ||
Stromal fibroblasts in cancer initiation and progression | Q29618873 | ||
TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia | Q29618875 | ||
Friends or foes - bipolar effects of the tumour stroma in cancer | Q29619348 | ||
Basement membranes: structure, assembly and role in tumour angiogenesis | Q29622882 | ||
An overview of epithelio-mesenchymal transformation | Q30014826 | ||
Genetic alterations in the peritumoral stromal cells of malignant and borderline epithelial ovarian tumors as indicated by allelic imbalance on chromosome 3p. | Q33197201 | ||
Organization of fibroblasts in the heart | Q33204765 | ||
Genomic patterns of allelic imbalance in disease free tissue adjacent to primary breast carcinomas | Q33209331 | ||
The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis | Q33783677 | ||
Know thy neighbor: stromal cells can contribute oncogenic signals | Q34132830 | ||
Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation | Q34174349 | ||
Different intermediate-sized filaments distinguished by immunofluorescence microscopy | Q34187556 | ||
Diversity, topographic differentiation, and positional memory in human fibroblasts | Q34190312 | ||
Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines | Q34339034 | ||
Induction of angiogenesis during the transition from hyperplasia to neoplasia | Q34413571 | ||
Tenascin is a stromal marker for epithelial malignancy in the mammary gland | Q34636488 | ||
TGF-beta antagonists: why suppress a tumor suppressor? | Q34691800 | ||
Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks | Q34781947 | ||
Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis. | Q35083777 | ||
The myofibroblast in wound healing and fibrocontractive diseases | Q35170446 | ||
The fibroblast: sentinel cell and local immune modulator in tumor tissue | Q35593451 | ||
The tumor microenvironment: a critical determinant of neoplastic evolution | Q35619420 | ||
The role of epithelial-to-mesenchymal transition in renal fibrosis | Q35643525 | ||
Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma | Q35748940 | ||
Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB | Q36051073 | ||
A stromal address code defined by fibroblasts | Q36061032 | ||
Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels | Q36230478 | ||
Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells | Q36255048 | ||
Identification and characterization of a fibroblast marker: FSP1 | Q36382596 | ||
Overexpression of TGF-beta by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer | Q36695742 | ||
The human homolog of the JE gene encodes a monocyte secretory protein | Q36794510 | ||
Reconstruction of functionally normal and malignant human breast tissues in mice | Q37415657 | ||
Collagen biosynthesis in nonfibroblastic cell lines | Q37428169 | ||
Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression | Q37546757 | ||
Leaky vessels, fibrin deposition, and fibrosis: a sequence of events common to solid tumors and to many other types of disease | Q38208141 | ||
Specificity of desmin to avian and mammalian muscle cells | Q39496494 | ||
Genetic predisposition to cancer in man: in vitro studies. | Q40249069 | ||
Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line | Q40370679 | ||
The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway | Q40410173 | ||
Suppression of tumor development and metastasis formation in mice lacking the S100A4(mts1) gene | Q40427707 | ||
PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. | Q40459317 | ||
Measurement of macromolecular diffusion coefficients in human tumors | Q40560526 | ||
Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice | Q40633055 | ||
Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis | Q40668665 | ||
Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction | Q40964604 | ||
In vivo and in vitro invasiveness of a rat colon-cancer cell line maintaining E-cadherin expression: an enhancing role of tumor-associated myofibroblasts | Q41487536 | ||
Regulation of vimentin expression in cultured human mammary epithelial cells | Q41874497 | ||
Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells | Q42033561 | ||
Basic fibroblast growth factor expression is increased in human renal fibrogenesis and may mediate autocrine fibroblast proliferation | Q42486417 | ||
Wounding and its role in RSV-mediated tumor formation | Q43752819 | ||
Relaxin enhances in-vitro invasiveness of breast cancer cell lines by up-regulation of matrix metalloproteases | Q44117726 | ||
Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vect | Q44153756 | ||
Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-beta | Q44225473 | ||
BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury | Q44479221 | ||
Relaxin increases ubiquitin-dependent degradation of fibronectin in vitro and ameliorates renal fibrosis in vivo | Q44487248 | ||
Hyaluronan (hyaluronic acid) and hyaluronectin in the extracellular matrix of human breast carcinomas: comparison between invasive and non-invasive areas | Q44798703 | ||
Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice | Q45091472 | ||
Electroporation-mediated HGF gene transfection protected the kidney against graft injury | Q45882045 | ||
Human breast carcinoma desmoplasia is PDGF initiated. | Q46033815 | ||
De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent | Q46068963 | ||
Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis | Q46128262 | ||
Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo | Q47449181 | ||
Cre recombinase-mediated gene targeting of mesenchymal cells | Q47867267 | ||
Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts. | Q51817888 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 392-401 | |
P577 | publication date | 2006-05-01 | |
P1433 | published in | Nature Reviews Cancer | Q641657 |
P1476 | title | Fibroblasts in cancer | |
P478 | volume | 6 |
Q42594342 | "Scar-cinoma": viewing the fibrotic lung mesenchymal cell in the context of cancer biology. |
Q48234869 | 17β-estradiol and progesterone effect on human papillomavirus 16 positive cells grown as spheroid co-cultures. |
Q39385429 | 22 : 6n-3 DHA inhibits differentiation of prostate fibroblasts into myofibroblasts and tumorigenesis |
Q39076663 | 3D bioprinting: improving in vitro models of metastasis with heterogeneous tumor microenvironments. |
Q34512627 | 3D microchannel co-culture: method and biological validation |
Q35994548 | 3D tumor tissue analogs and their orthotopic implants for understanding tumor-targeting of microenvironment-responsive nanosized chemotherapy and radiation |
Q61812763 | A Barter Economy in Tumors: Exchanging Metabolites through Gap Junctions |
Q39023415 | A CCL2/ROS autoregulation loop is critical for cancer-associated fibroblasts-enhanced tumor growth of oral squamous cell carcinoma |
Q38738541 | A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets |
Q37699961 | A Conditioned Medium of Umbilical Cord Mesenchymal Stem Cells Overexpressing Wnt7a Promotes Wound Repair and Regeneration of Hair Follicles in Mice. |
Q92769536 | A DNA vaccine expressing an optimized secreted FAPα induces enhanced anti-tumor activity by altering the tumor microenvironment in a murine model of breast cancer |
Q28544872 | A FTIR imaging characterization of fibroblasts stimulated by various breast cancer cell lines |
Q42324573 | A High-Fat Diet Promotes Mammary Gland Myofibroblast Differentiation through MicroRNA 140 Downregulation |
Q47968431 | A Multiscale Mathematical Model of Tumour Invasive Growth. |
Q58698491 | A Paradoxical Correlation of Cancer-Associated Fibroblasts With Survival Outcomes in B-Cell Lymphomas and Carcinomas |
Q55289233 | A Preclinical Model for the ATLL Lymphoma Subtype With Insights Into the Role of Microenvironment in HTLV-1-Mediated Lymphomagenesis. |
Q36786090 | A Self-Folding Hydrogel In Vitro Model for Ductal Carcinoma |
Q42374110 | A Theoretical Model of the Wnt Signaling Pathway in the Epithelial Mesenchymal Transition |
Q92034936 | A ZEB1/p53 signaling axis in stromal fibroblasts promotes mammary epithelial tumours |
Q36175376 | A calixpyrrole derivative acts as an antagonist to GPER, a G-protein coupled receptor: mechanisms and models |
Q90447760 | A comparative study of the frequency of myofibroblasts and macrophages between the oral and cutaneous squamous cell carcinoma |
Q41755608 | A cross-talk network that facilitates tumor virotherapy |
Q37826352 | A digest on the role of the tumor microenvironment in gastrointestinal cancers |
Q36861021 | A fibrotic focus is a prognostic factor and a surrogate marker for hypoxia and (lymph)angiogenesis in breast cancer: review of the literature and proposal on the criteria of evaluation |
Q92932998 | A framework for advancing our understanding of cancer-associated fibroblasts |
Q35206586 | A functional in vitro model of heterotypic interactions reveals a role for interferon-positive carcinoma associated fibroblasts in breast cancer. |
Q37578778 | A gene expression profile for detection of sufficient tumour cells in breast tumour tissue: microarray diagnosis eligibility |
Q41470731 | A genetic polymorphism repurposes the G-protein coupled and membrane-associated estrogen receptor GPER to a transcription factor-like molecule promoting paracrine signaling between stroma and breast carcinoma cells |
Q28731921 | A heterogeneous in vitro three dimensional model of tumour-stroma interactions regulating sprouting angiogenesis |
Q39089853 | A high-throughput-compatible 3D microtissue co-culture system for phenotypic RNAi screening applications |
Q88488558 | A history of exploring cancer in context |
Q61795892 | A mathematical-descriptor of tumor-mesoscopic-structure from computed-tomography images annotates prognostic- and molecular-phenotypes of epithelial ovarian cancer |
Q38715630 | A mechanically active heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion |
Q27318442 | A membrane-type-1 matrix metalloproteinase (MT1-MMP)-discoidin domain receptor 1 axis regulates collagen-induced apoptosis in breast cancer cells |
Q30356080 | A microfluidic chip for screening individual cancer cells via eavesdropping on autophagy-inducing crosstalk in the stroma niche. |
Q47789820 | A microfluidic platform for modeling metastatic cancer cell matrix invasion |
Q36777149 | A multi-antigen vaccine in combination with an immunotoxin targeting tumor-associated fibroblast for treating murine melanoma |
Q35811284 | A novel 3D high-content assay identifies compounds that prevent fibroblast invasion into tissue surrogates |
Q35056258 | A novel GFP nude rat model to investigate tumor-stroma interactions |
Q36841790 | A novel eGFP-expressing immunodeficient mouse model to study tumor-host interactions. |
Q51079254 | A novel method to generate single-cell-derived cancer-associated fibroblast clones. |
Q37316568 | A novel organotypic model mimics the tumor microenvironment |
Q40437353 | A novel regulation of PD-1 ligands on mesenchymal stromal cells through MMP-mediated proteolytic cleavage. |
Q35798885 | A phenotype from tumor stroma based on the expression of metalloproteases and their inhibitors, associated with prognosis in breast cancer. |
Q47679355 | A polysaccharide from Dictyophora indusiata inhibits the immunosuppressive function of cancer-associated fibroblasts. |
Q61135012 | A positive feedback loop bi-stably activates fibroblasts |
Q36470281 | A potent immunotoxin targeting fibroblast activation protein for treatment of breast cancer in mice |
Q35763496 | A proteomic analysis of the functional effects of fatty acids in NIH 3T3 fibroblasts |
Q39013985 | A role for cancer-associated fibroblasts in inducing the epithelial-to-mesenchymal transition in human tongue squamous cell carcinoma |
Q52649935 | A shift from papillary to reticular fibroblasts enables tumour-stroma interaction and invasion. |
Q36867763 | A simple way to enhance Doxil® therapy: drug release from liposomes at the tumor site by amphiphilic block copolymer. |
Q34143251 | A strategy for integrating essential three-dimensional microphysiological systems of human organs for realistic anticancer drug screening. |
Q34579646 | A systems view of epithelial-mesenchymal transition signaling states |
Q33716526 | A three-dimensional in vitro model of tumor cell intravasation |
Q30449030 | A three-dimensional in vitro ovarian cancer coculture model using a high-throughput cell patterning platform |
Q38527867 | A top-down view of the tumor microenvironment: structure, cells and signaling |
Q91168620 | ATF3 and JDP2 deficiency in cancer associated fibroblasts promotes tumor growth via SDF-1 transcription |
Q42635937 | Aberrant DNA methylation in non-small cell lung cancer-associated fibroblasts |
Q41459813 | Aberrant low expression of p85α in stromal fibroblasts promotes breast cancer cell metastasis through exosome-mediated paracrine Wnt10b |
Q37006135 | Acidic extracellular pH of tumors induces octamer-binding transcription factor 4 expression in murine fibroblasts in vitro and in vivo |
Q36166268 | Activatable near-infrared fluorescent probe for in vivo imaging of fibroblast activation protein-alpha |
Q58555545 | Activated Tumor-infiltrating Fibroblasts Predict Worse Prognosis in Breast Cancer Patients |
Q36304689 | Activated hepatic stellate cells promote angiogenesis via interleukin-8 in hepatocellular carcinoma |
Q45819221 | Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice |
Q39553893 | Activation of Notch1 signaling in stromal fibroblasts inhibits melanoma growth by upregulating WISP-1. |
Q36243638 | Activation of Robo1 signaling of breast cancer cells by Slit2 from stromal fibroblast restrains tumorigenesis via blocking PI3K/Akt/β-catenin pathway |
Q37745603 | Activation of fibroblasts in cancer stroma |
Q45991749 | Activation of the HGF/c-Met axis in the tumor microenvironment: A multispecies model. |
Q35810840 | Active roles of tumor stroma in breast cancer metastasis |
Q40310120 | Adenovirus i-leader truncation bioselected against cancer-associated fibroblasts to overcome tumor stromal barriers |
Q36357889 | Adipocyte-derived endotrophin promotes malignant tumor progression |
Q38621456 | Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens |
Q104073598 | Advanced co-culture 3D breast cancer model for investigation of fibrosis induced by external stimuli: optimization study |
Q26828808 | Advances in the formation, use and understanding of multi-cellular spheroids |
Q97884627 | Advances in the role of exosomal non-coding RNA in the development, diagnosis, and treatment of gastric cancer (Review) |
Q37072080 | Alginate Sulfates Mitigate Binding Kinetics of Proangiogenic Growth Factors with Receptors toward Revascularization |
Q35608687 | Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10 |
Q92528551 | Alnus Sibirica Extracts Suppress the Expression of Inflammatory Cytokines Induced by Lipopolysaccharides, Tumor Necrosis Factor-α, and Interferon-γ in Human Dermal Fibroblasts |
Q35944809 | Alpha8 Integrin (Itga8) Signalling Attenuates Chronic Renal Interstitial Fibrosis by Reducing Fibroblast Activation, Not by Interfering with Regulation of Cell Turnover |
Q34712100 | Altered AIB1 or AIB1Δ3 expression impacts ERα effects on mammary gland stromal and epithelial content |
Q39595827 | Altered TGF-β signaling in a subpopulation of human stromal cells promotes prostatic carcinogenesis. |
Q37949667 | Altered angiogenesis in the tumor microenvironment |
Q36225128 | Altered expression pattern of integrin alphavbeta3 correlates with actin cytoskeleton in primary cultures of human breast cancer |
Q33686113 | Altered immunohistochemical expression of mast cell tryptase and chymase in the pathogenesis of oral submucous fibrosis and malignant transformation of the overlying epithelium |
Q34170350 | Alternative strategies for carcinogenicity assessment: an efficient and simplified approach based on in vitro mutagenicity and cell transformation assays. |
Q37987563 | Alternatives to the carcinogenicity bioassay for toxicity prediction: are we there yet? |
Q37741223 | Alternatives to the carcinogenicity bioassay: in silico methods, and the in vitro and in vivo mutagenicity assays |
Q92308114 | Amino Acid-Mediated Metabolism: A New Power to Influence Properties of Stem Cells |
Q36187733 | An "elite hacker": breast tumors exploit the normal microenvironment program to instruct their progression and biological diversity |
Q58691085 | An Approach to Visualize the Deformation of the Intermediate Filament Cytoskeleton in Response to Locally Applied Forces |
Q47953832 | An FGFR inhibitor converts the tumor promoting effect of TGF-β by the induction of fibroblast-associated genes of hepatoma cells |
Q24658358 | An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers |
Q36369411 | An analogy between the evolution of drug resistance in bacterial communities and malignant tissues |
Q52949164 | An analysis of the role of follicular lymphoma-associated fibroblasts to promote tumor cell viability following drug-induced apoptosis. |
Q90647900 | An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment |
Q34919480 | An immunocompetent, orthotopic mouse model of epithelial ovarian cancer utilizing tissue engineered tumor cell sheets |
Q38097243 | An inflammatory vicious cycle: Fibroblasts and immune cell recruitment in cancer |
Q33755480 | Analysis of Gene Expression Signatures in Cancer-Associated Stroma from Canine Mammary Tumours Reveals Molecular Homology to Human Breast Carcinomas |
Q38436627 | Analysis of gene expression changes associated with human carcinoma-associated fibroblasts in non-small cell lung carcinoma |
Q33567270 | Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection |
Q83975441 | Analysis of stromal gene expression for the identification of prognostic and predictive molecular markers in cancer therapy |
Q39559009 | Analysis of the paracrine loop between cancer cells and fibroblasts using a microfluidic chip |
Q38130312 | Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales |
Q38707625 | Angiotensin 1-7 inhibits angiotensin II-stimulated head and neck cancer progression |
Q49789215 | Angiotensin-converting enzyme inhibitor reduces scar formation by inhibiting both canonical and noncanonical TGF-β1 pathways. |
Q88556224 | Animal models for studying tumor microenvironment (TME) and resistance to lymphocytic infiltration |
Q33770680 | Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions |
Q37520300 | Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts |
Q38782807 | Anti-tumor effects of DNA vaccine targeting human fibroblast activation protein α by producing specific immune responses and altering tumor microenvironment in the 4T1 murine breast cancer model |
Q37860171 | Anticancer compounds derived from fungal endophytes: their importance and future challenges |
Q42478274 | Antifibrotic properties of c-Ski and its regulation of cardiac myofibroblast phenotype and contractility. |
Q28240977 | Are oncoantigens suitable targets for anti-tumour therapy? |
Q38276312 | Areca nut exposure increases secretion of tumor-promoting cytokines in gingival fibroblasts that trigger DNA damage in oral keratinocytes. |
Q34145927 | Arousal of cancer-associated stroma: overexpression of palladin activates fibroblasts to promote tumor invasion |
Q59332947 | Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-β signaling in breast cancer |
Q47363573 | Assembly of breast cancer heterotypic spheroids on hyaluronic acid coated surfaces. |
Q65000145 | Assessment of the Spatial Heterogeneity of Breast Cancers: Associations Between Computed Tomography and Immunohistochemistry. |
Q37708880 | Association between tumor-stroma ratio and prognosis in solid tumor patients: a systematic review and meta-analysis |
Q35168174 | Association of RB/p16-pathway perturbations with DCIS recurrence: dependence on tumor versus tissue microenvironment |
Q50883910 | Association of tumor-associated fibroblasts with progression of hepatocellular carcinoma. |
Q104478507 | Authentic Vascular and Stromal Structure in Animal Disease Model for Nanomedicine |
Q42326440 | Autocrine IL-1β-TRAF6 signalling promotes squamous cell carcinoma invasion through paracrine TNFα signalling to carcinoma-associated fibroblasts |
Q34358613 | Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts |
Q38720813 | Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma |
Q38017624 | Autophagic tumor stroma: mechanisms and roles in tumor growth and progression |
Q24611183 | Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment |
Q36585665 | Autophagy is required for IL-2-mediated fibroblast growth |
Q43602040 | Avoiding pitfalls in gene (co)expression meta-analysis |
Q34092023 | Axitinib Improves Radiotherapy in Murine Xenograft Lung Tumors |
Q37102097 | Axonal Growth Arrests After an Increased Accumulation of Schwann Cells Expressing Senescence Markers and Stromal Cells in Acellular Nerve Allografts |
Q53213846 | BMP pathway suppression is an early event in inflammation-driven colon neoplasmatogenesis of uPA-deficient mice. |
Q26824827 | BMPs and their clinical potentials |
Q35875652 | Basal Cell Carcinoma in Gorlin's Patients: a Matter of Fibroblasts-Led Protumoral Microenvironment? |
Q37082865 | Beta-catenin overexpression in Dupuytren's disease is unrelated to disease recurrence |
Q91967093 | Beyond proteases: Basement membrane mechanics and cancer invasion |
Q54993659 | Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer. |
Q28066409 | Bidirectional interconversion of stem and non-stem cancer cell populations: A reassessment of theoretical models for tumor heterogeneity |
Q49232945 | Bioinformatics analysis of gene expression alterations conferring drug resistance in tumor samples from melanoma patients with EGFR-activating BRAF mutations. |
Q39386471 | Bioinspired Hydrogels to Engineer Cancer Microenvironments |
Q34663710 | Biological characteristics and genetic heterogeneity between carcinoma-associated fibroblasts and their paired normal fibroblasts in human breast cancer |
Q91997750 | Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment |
Q33294142 | Biomarker discovery for colon cancer using a 761 gene RT-PCR assay. |
Q35414980 | Biomarker identification with ligand-targeted nucleoprotein assemblies |
Q37209254 | Biomarkers for epithelial-mesenchymal transitions |
Q92989877 | Biomaterials to model and measure epithelial cancers |
Q28246964 | Biomechanical regulation of blood vessel growth during tissue vascularization |
Q50862908 | Biomimetic Model of Tumor Microenvironment on Microfluidic Platform. |
Q28485304 | Biomimetic tumor microenvironment on a microfluidic platform |
Q48217663 | Bioprinting of biomimetic skin containing melanocytes |
Q41704441 | Biosilica from Living Diatoms: Investigations on Biocompatibility of Bare and Chemically Modified Thalassiosira weissflogii Silica Shells |
Q36229070 | Bisphenol A induces gene expression changes and proliferative effects through GPER in breast cancer cells and cancer-associated fibroblasts. |
Q34807620 | Bone Morphogenetic Proteins stimulate mammary fibroblasts to promote mammary carcinoma cell invasion |
Q36516556 | Bone marrow and tumour stroma: an intimate relationship |
Q38090230 | Bone marrow cells as precursors of the tumor stroma |
Q30415864 | Bone marrow derived "fibrocytes" contribute to tumor proliferation and fibrosis in gastric cancer |
Q46895359 | Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: in vitro and in vivo studies. |
Q35021021 | Bone marrow stromal antigen 2 expressed in cancer cells promotes mammary tumor growth and metastasis. |
Q93336018 | Bone marrow-derived fibroblasts are a functionally distinct stromal cell population in breast cancer |
Q64074414 | Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression via CCR5 |
Q36343778 | Bone marrow-derived myofibroblasts are the providers of pro-invasive matrix metalloproteinase 13 in primary tumor |
Q35909669 | Bone marrow-derived stromal cells are associated with gastric cancer progression |
Q36259458 | Bone metastasis and the metastatic niche |
Q39531184 | Bone metastasis in a novel breast cancer mouse model containing human breast and human bone |
Q36151249 | Borrelia burgdorferi Induces TLR2-Mediated Migration of Activated Dendritic Cells in an Ex Vivo Human Skin Model |
Q58734172 | Brcal Defective Breast Cancer Cells Induce in vitro Transformation of Cancer Associated Fibroblasts (CAFs) to Metastasis Associated Fibroblasts (MAF) |
Q27342933 | Breast Cancer Cell Invasion into a Three Dimensional Tumor-Stroma Microenvironment |
Q91999106 | Breast Cancer Tumor Stroma: Cellular Components, Phenotypic Heterogeneity, Intercellular Communication, Prognostic Implications and Therapeutic Opportunities |
Q26772925 | Breast Cancer-Associated Fibroblasts: Where We Are and Where We Need to Go |
Q37011741 | Breast cancer as a systemic disease: a view of metastasis |
Q39405444 | Breast cancer associated fibroblasts promote MCF-7 invasion in vitro by secretion of HGF. |
Q39823181 | Breast cancer carcinoma-associated fibroblasts differ from breast fibroblasts in immunological and extracellular matrix regulating pathways. |
Q37175709 | Breast cancer cell-derived matrix supports vascular morphogenesis |
Q28743545 | Breast cancer cells induce cancer-associated fibroblasts to secrete hepatocyte growth factor to enhance breast tumorigenesis |
Q36985012 | Breast cancer progression: insights into multifaceted matrix metalloproteinases. |
Q35501726 | Breast cancer subtype-specific interactions with the microenvironment dictate mechanisms of invasion |
Q38781885 | Breast cancer upregulating genes in stromal cells by LINE-1 hypermethylation and micrometastatic detection. |
Q33652855 | Breast cancer-associated fibroblasts confer AKT1-mediated epigenetic silencing of Cystatin M in epithelial cells |
Q38704824 | Breast cancer-associated fibroblasts: their roles in tumor initiation, progression and clinical applications |
Q36212395 | Breast cancer-derived extracellular vesicles stimulate myofibroblast differentiation and pro-angiogenic behavior of adipose stem cells |
Q34823658 | Breast stromal fibroblasts from histologically normal surgical margins are pro-carcinogenic |
Q34759911 | Breast tumor microenvironment: proteomics highlights the treatments targeting secretome |
Q37072581 | Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions |
Q38807630 | CAF cellular glycolysis: linking cancer cells with the microenvironment |
Q36839044 | CAF-like state in primary skin fibroblasts with constitutional BRCA1 epimutation sheds new light on tumor suppressor deficiency-related changes in healthy tissue |
Q36007881 | CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells |
Q43055825 | CCR1-mediated accumulation of myeloid cells in the liver microenvironment promoting mouse colon cancer metastasis |
Q34473048 | CD117 expression in fibroblasts-like stromal cells indicates unfavorable clinical outcomes in ovarian carcinoma patients |
Q35788370 | CD133+ colon cancer cells are more interactive with the tumor microenvironment than CD133- cells |
Q35485418 | CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancer |
Q33891662 | CD248 facilitates tumor growth via its cytoplasmic domain. |
Q34541032 | CD271⁺ subpopulation of pancreatic stellate cells correlates with prognosis of pancreatic cancer and is regulated by interaction with cancer cells |
Q24633702 | CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues |
Q39036931 | CD44 expressed on cancer-associated fibroblasts is a functional molecule supporting the stemness and drug resistance of malignant cancer cells in the tumor microenvironment |
Q49952398 | CD44v6 increases gastric cancer malignant phenotype by modulating adipose stromal cell-mediated ECM remodeling. |
Q92715634 | CD49b, CD87, and CD95 Are Markers for Activated Cancer-Associated Fibroblasts Whereas CD39 Marks Quiescent Normal Fibroblasts in Murine Tumor Models |
Q92738018 | COL12A1, a novel potential prognostic factor and therapeutic target in gastric cancer |
Q33703810 | COX-2 and prostaglandin EP3/EP4 signaling regulate the tumor stromal proangiogenic microenvironment via CXCL12-CXCR4 chemokine systems |
Q36715145 | COX-2 modulates mammary tumor progression in response to collagen density. |
Q38792400 | CPAM type 2-derived mesenchymal stem cells: Malignancy risk study in a 14-month-old boy. |
Q47303229 | CR6-interacting factor 1 inhibits invasiveness by suppressing TGF-β-mediated epithelial-mesenchymal transition in hepatocellular carcinoma |
Q48184506 | CXCL1 induces senescence of cancer-associated fibroblasts via autocrine loops in oral squamous cell carcinoma |
Q38743011 | CXCL1-Mediated Interaction of Cancer Cells with Tumor-Associated Macrophages and Cancer-Associated Fibroblasts Promotes Tumor Progression in Human Bladder Cancer |
Q38831871 | CXCL12/CXCR4 activation by cancer-associated fibroblasts promotes integrin β1 clustering and invasiveness in gastric cancer |
Q37344836 | CXCR4 and matrix metalloproteinase-1 are elevated in breast carcinoma-associated fibroblasts and in normal mammary fibroblasts exposed to factors secreted by breast cancer cells |
Q35111214 | Caffeine mediates sustained inactivation of breast cancer-associated myofibroblasts via up-regulation of tumor suppressor genes |
Q36234684 | Calcium channels and pumps in cancer: changes and consequences |
Q37093956 | Calreticulin mediates an invasive breast cancer phenotype through the transcriptional dysregulation of p53 and MAPK pathways |
Q34077177 | Can TIE-2 expressing monocytes represent a novel marker for hepatocellular carcinoma? |
Q38795935 | Can Targeting Stroma Pave the Way to Enhanced Antitumor Immunity and Immunotherapy of Solid Tumors? |
Q35739745 | Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers. |
Q58101680 | Cancer Associated Fibroblasts: Naughty Neighbors That Drive Ovarian Cancer Progression |
Q49561501 | Cancer Associated Fibroblasts: The Architects of Stroma Remodeling. |
Q35933910 | Cancer Exosomes as Mediators of Drug Resistance |
Q92703787 | Cancer Stem Cells and Targeting Strategies |
Q39197682 | Cancer Stem Cells and Their Microenvironment: Biology and Therapeutic Implications. |
Q33806357 | Cancer and the tumor microenvironment: a review of an essential relationship |
Q42516478 | Cancer associated fibroblasts (CAFs) are activated in cutaneous basal cell carcinoma and in the peritumoural skin |
Q34309899 | Cancer associated fibroblasts and tumor growth: focus on multiple myeloma |
Q92565907 | Cancer associated fibroblasts are distinguishable from peri-tumor fibroblasts by biological characteristics in TSCC |
Q36060343 | Cancer associated fibroblasts have phenotypic and functional characteristics similar to the fibrocytes that represent a novel MDSC subset |
Q35550041 | Cancer associated fibroblasts in hematological malignancies |
Q33517133 | Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model |
Q41614004 | Cancer associated fibroblasts: An essential role in the tumor microenvironment |
Q37943818 | Cancer associated fibroblasts: the dark side of the coin. |
Q38835031 | Cancer cell invasion driven by extracellular matrix remodeling is dependent on the properties of cancer-associated fibroblasts |
Q42250953 | Cancer cell migration in 3D tissue: negotiating space by proteolysis and nuclear deformability |
Q41636608 | Cancer cells remodel themselves and vasculature to overcome the endothelial barrier. |
Q37307037 | Cancer cells suppress p53 in adjacent fibroblasts |
Q92419533 | Cancer extracellular vesicles contribute to stromal heterogeneity by inducing chemokines in cancer-associated fibroblasts |
Q37058267 | Cancer prevention and therapy through the modulation of the tumor microenvironment |
Q35008756 | Cancer progression by breast tumors with Pit-1-overexpression is blocked by inhibition of metalloproteinase (MMP)-13. |
Q34024261 | Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology |
Q57498153 | Cancer stem cells and tumorigenesis |
Q38881450 | Cancer stem cells: progress and challenges in lung cancer |
Q38688878 | Cancer-Associated Fibroblasts Share Characteristics and Protumorigenic Activity with Mesenchymal Stromal Cells |
Q49788190 | Cancer-associated Fibroblast-derived IL-6 Promotes Head and Neck Cancer Progression via the Osteopontin-NF-kappa B Signaling Pathway. |
Q92823840 | Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms |
Q40178500 | Cancer-associated fibroblast promote transmigration through endothelial brain cells in three-dimensional in vitro models. |
Q37252683 | Cancer-associated fibroblast suppresses killing activity of natural killer cells through downregulation of poliovirus receptor (PVR/CD155), a ligand of activating NK receptor |
Q38881343 | Cancer-associated fibroblast-derived CXCL12 causes tumor progression in adenocarcinoma of the esophagogastric junction |
Q48099844 | Cancer-associated fibroblast-derived Lumican promotes gastric cancer progression via the integrin β1-FAK signaling pathway. |
Q87934636 | Cancer-associated fibroblasts affect breast cancer cell gene expression, invasion and angiogenesis |
Q39144790 | Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression |
Q34887528 | Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer |
Q33942225 | Cancer-associated fibroblasts are positively correlated with metastatic potential of human gastric cancers |
Q58709083 | Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p |
Q33939820 | Cancer-associated fibroblasts derived from EGFR-TKI-resistant tumors reverse EGFR pathway inhibition by EGFR-TKIs |
Q38048249 | Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue |
Q46763062 | Cancer-associated fibroblasts enhance metastatic potential of lung cancer cells through IL-6/STAT3 signaling pathway |
Q37722149 | Cancer-associated fibroblasts enhance pancreatic cancer cell invasion by remodeling the metabolic conversion mechanism |
Q42131374 | Cancer-associated fibroblasts from NSCLC promote the radioresistance in lung cancer cell lines |
Q34718091 | Cancer-associated fibroblasts from hepatocellular carcinoma promote malignant cell proliferation by HGF secretion |
Q35984652 | Cancer-associated fibroblasts from human NSCLC survive ablative doses of radiation but their invasive capacity is reduced |
Q35598951 | Cancer-associated fibroblasts from lung tumors maintain their immunosuppressive abilities after high-dose irradiation |
Q35556542 | Cancer-associated fibroblasts in a human HEp-2 established laryngeal xenografted tumor are not derived from cancer cells through epithelial-mesenchymal transition, phenotypically activated but karyotypically normal |
Q27022816 | Cancer-associated fibroblasts in digestive tumors |
Q91691166 | Cancer-associated fibroblasts in gastrointestinal cancer |
Q26738536 | Cancer-associated fibroblasts in hepatocellular carcinoma |
Q38568893 | Cancer-associated fibroblasts in pancreatic adenocarcinoma |
Q64236929 | Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling |
Q37559049 | Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-β signalling |
Q42377290 | Cancer-associated fibroblasts induce metalloprotease-independent cancer cell invasion of the basement membrane |
Q42697021 | Cancer-associated fibroblasts lead tumor invasion through integrin-β3-dependent fibronectin assembly |
Q51370517 | Cancer-associated fibroblasts mediated chemoresistance by a FOXO1/TGFβ1 signaling loop in esophageal squamous cell carcinoma. |
Q39137387 | Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis |
Q30358706 | Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages. |
Q38839374 | Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression |
Q64058085 | Cancer-associated fibroblasts promote cisplatin resistance in bladder cancer cells by increasing IGF-1/ERβ/Bcl-2 signalling |
Q47579071 | Cancer-associated fibroblasts promote directional cancer cell migration by aligning fibronectin. |
Q37295430 | Cancer-associated fibroblasts promote non-small cell lung cancer cell invasion by upregulation of glucose-regulated protein 78 (GRP78) expression in an integrated bionic microfluidic device |
Q38917416 | Cancer-associated fibroblasts promote renal cell carcinoma progression |
Q36553208 | Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis |
Q35763343 | Cancer-associated fibroblasts provide a suitable microenvironment for tumor development and progression in oral tongue squamous cancer |
Q43639734 | Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling. |
Q93005300 | Cancer-associated fibroblasts secrete Wnt2 to promote cancer progression in colorectal cancer |
Q60311051 | Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer coculture |
Q37476178 | Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway |
Q91754848 | Cancer-associated fibroblasts-heroes or villains? |
Q88514840 | Cancer-associated fibroblasts-stimulated interleukin-11 promotes metastasis of gastric cancer cells mediated by upregulation of MUC1 |
Q39399237 | Cancer-associated orthotopic myofibroblasts stimulates the motility of gastric carcinoma cells |
Q36844475 | Cancer-associated stromal fibroblasts promote pancreatic tumor progression |
Q41768958 | Cancer-stellate cell interactions perpetuate the hypoxia-fibrosis cycle in pancreatic ductal adenocarcinoma |
Q34268727 | Cancer-stromal cell interaction and tumor angiogenesis in gastric cancer |
Q41581107 | Cancer-stromal interactions in scirrhous gastric carcinoma |
Q43848667 | Cancer. Breaching the cancer fortress |
Q28728960 | Cancer: evolutionary, genetic and epigenetic aspects |
Q34948192 | Candidate markers that associate with chemotherapy resistance in breast cancer through the study on Taxotere-induced damage to tumor microenvironment and gene expression profiling of carcinoma-associated fibroblasts (CAFs). |
Q90483916 | Carcinoma and Sarcoma Microenvironment at a Glance: Where We Are |
Q35949286 | Carcinoma-Associated Fibroblasts Lead the Invasion of Salivary Gland Adenoid Cystic Carcinoma Cells by Creating an Invasive Track |
Q37061749 | Carcinoma-associated fibroblasts are a promising therapeutic target. |
Q37621644 | Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression. |
Q39082233 | Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis. |
Q38097963 | Carcinoma-associated fibroblasts, its implication in head and neck squamous cell carcinoma: a mini review |
Q38086460 | Carcinoma-associated fibroblasts: non-neoplastic tumour-promoting mesenchymal cells. |
Q28078667 | Carcinoma-associated fibroblasts: orchestrating the composition of malignancy |
Q43185698 | Carcinoma-derived exosomes modify microenvironment |
Q33892014 | Carcinomas contain a matrix metalloproteinase-resistant isoform of type I collagen exerting selective support to invasion |
Q38423895 | Cardiac fibroblast physiology and pathology |
Q58047168 | Cardiac fibroblast to myofibroblast differentiation in vivo and in vitro: Expression of focal adhesion components in neonatal and adult rat ventricular myofibroblasts |
Q30467800 | Cardiac fibroblast: the renaissance cell |
Q43152071 | Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling |
Q34757218 | Cathelicidin suppresses colon cancer development by inhibition of cancer associated fibroblasts |
Q33918879 | Cathepsin B is the driving force of esophageal cell invasion in a fibroblast-dependent manner |
Q37362547 | Cathepsin C is a tissue-specific regulator of squamous carcinogenesis. |
Q30525290 | Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors |
Q38164322 | Caveolin-1 expression in papillary thyroid carcinoma: correlation with clinicopathological parameters and BRAF mutation status. |
Q34634642 | Caveolin-1 expression level in cancer associated fibroblasts predicts outcome in gastric cancer |
Q35197488 | Caveolin-1 is a modulator of fibroblast activation and a potential biomarker for gastric cancer |
Q41859040 | Cdc42 regulates Cdc42EP3 function in cancer-associated fibroblasts |
Q36426917 | Cdc42EP3/BORG2 and Septin Network Enables Mechano-transduction and the Emergence of Cancer-Associated Fibroblasts |
Q36632955 | Cell Competition Drives the Growth of Intestinal Adenomas in Drosophila |
Q42829562 | Cell behavior observation and gene expression analysis of melanoma associated with stromal fibroblasts in a three-dimensional magnetic cell culture array |
Q51429442 | Cell migration in microengineered tumor environments. |
Q43185634 | Cell type specific gene expression analysis of prostate needle biopsies resolves tumor tissue heterogeneity. |
Q38134726 | Cell volume regulation in epithelial physiology and cancer |
Q90354953 | Cell-Cell Mechanical Communication in Cancer |
Q37858332 | Cell-extracellular matrix interactions in normal and diseased skin |
Q37205669 | Cell-extrinsic consequences of epithelial stress: activation of protumorigenic tissue phenotypes |
Q47113309 | Cell-to-cell communication: microRNAs as hormones |
Q27305106 | Cells activated for wound repair have the potential to direct collective invasion of an epithelium |
Q51010069 | Cellular Constituents of the Prostate Stroma: Key Contributors to Prostate Cancer Progression and Therapy Resistance. |
Q33847830 | Cellular and molecular phenotypes of proliferating stromal cells from human carcinomas |
Q82771749 | Cellular changes in the tumor microenvironment of human esophageal squamous cell carcinomas |
Q37361381 | Cellular dynamics in the muscle satellite cell niche. |
Q39026929 | Cellular localization, invasion, and turnover are differently influenced by healthy and tumor-derived extracellular matrix |
Q30443462 | Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis. |
Q38515812 | Cellular prognostic markers in hepatocellular carcinoma |
Q37045419 | Cellular sources of extracellular matrix in hepatic fibrosis |
Q64110189 | Challenges and opportunities in exosome research-Perspectives from biology, engineering, and cancer therapy |
Q39421353 | Change in the microenvironment of breast cancer studied by FTIR imaging |
Q28079969 | Changes in cellular mechanical properties during onset or progression of colorectal cancer |
Q41810070 | Changes in the Secretory Profile of NSCLC-Associated Fibroblasts after Ablative Radiotherapy: Potential Impact on Angiogenesis and Tumor Growth |
Q36376298 | Changes in the expression of MMP2, MMP9, and ColIV in stromal cells in oral squamous tongue cell carcinoma: relationships and prognostic implications |
Q35463568 | Chaperone Hsp47 Drives Malignant Growth and Invasion by Modulating an ECM Gene Network |
Q39936131 | Characterization and functional role of the stroma compartment in prostate tumors |
Q92287200 | Characterization and printability of Sodium alginate -Gelatin hydrogel for bioprinting NSCLC co-culture |
Q64064640 | Characterization of Distinct Populations of Carcinoma-Associated Fibroblasts from Non-Small Cell Lung Carcinoma Reveals a Role for ST8SIA2 in Cancer Cell Invasion |
Q52937759 | Characterization of Human Dermal Fibroblasts in Fabry Disease. |
Q40097264 | Characterization of arecoline-induced effects on cytotoxicity in normal human gingival fibroblasts by global gene expression profiling. |
Q33935224 | Characterization of cancer stem-like cells derived from mouse induced pluripotent stem cells transformed by tumor-derived extracellular vesicles |
Q50551197 | Characterization of human breast cancer tissues by infrared imaging. |
Q84100136 | Characterization of the interaction between fibroblasts and tumor cells on a microfluidic co-culture device |
Q35948210 | Characterization of various cell lines from different ampullary cancer subtypes and cancer associated fibroblast-mediated responses |
Q37816561 | Chemokines in cancer related inflammation |
Q37732119 | Chinese herbal medicine suppresses invasion-promoting capacity of cancer-associated fibroblasts in pancreatic cancer |
Q58689162 | Chronic Hypoxia Emerging as One of the Driving Forces behind Gene Expression and Prognosis of Hepatocellular Carcinoma |
Q46489977 | Chronic Inflammation in Skin Malignancies |
Q39240817 | Cigarette smoke condensate promotes pro-tumourigenic stromal-epithelial interactions by suppressing miR-145. |
Q98945336 | Cinnamaldehyde Treatment of Prostate Cancer-Associated Fibroblasts Prevents Their Inhibitory Effect on T Cells Through Toll-Like Receptor 4 |
Q52619257 | Circulating Tumor Cells: Strategies for Capture, Analyses, and Propagation. |
Q37087273 | Circulating fibrocytes prepare the lung for cancer metastasis by recruiting Ly-6C+ monocytes via CCL2. |
Q93063421 | Circulating mir-320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk |
Q89486428 | Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance |
Q35942961 | Cleavage of Type I Collagen by Fibroblast Activation Protein-α Enhances Class A Scavenger Receptor Mediated Macrophage Adhesion |
Q55516060 | Clinical Implications of Lysyl Oxidase-Like Protein 2 Expression in Pancreatic Cancer. |
Q34115941 | Clinical Implications of Marker Expression of Carcinoma-Associated Fibroblasts (CAFs) in Patients with Epithelial Ovarian Carcinoma After Treatment with Neoadjuvant Chemotherapy |
Q39367207 | Clinical and functional significance of loss of caveolin-1 expression in breast cancer-associated fibroblasts |
Q37427390 | Clinical and translational implications of the caveolin gene family: lessons from mouse models and human genetic disorders |
Q65556503 | Clinical cancer nanomedicine |
Q38184908 | Clinical relevance of circulating cell-free microRNAs in cancer |
Q45748100 | Clinical significance of integrin αvβ6 expression effects on gastric carcinoma invasiveness and progression via cancer-associated fibroblasts |
Q46281166 | Clonality of smooth muscle and fibroblast cell populations isolated from human fibroid and myometrial tissues. |
Q28552528 | Co-Culture of Tumor Spheroids and Fibroblasts in a Collagen Matrix-Incorporated Microfluidic Chip Mimics Reciprocal Activation in Solid Tumor Microenvironment |
Q41665070 | Co-culture with lung cancer A549 cells promotes the proliferation and migration of mesenchymal stem cells derived from bone marrow |
Q33716011 | Co-delivery of cisplatin and rapamycin for enhanced anticancer therapy through synergistic effects and microenvironment modulation. |
Q30485978 | Coherent anti-Stokes Raman scattering imaging of lipids in cancer metastasis |
Q92194533 | Collagen content and extracellular matrix cause cytoskeletal remodelling in pancreatic fibroblasts |
Q92239280 | Collagen fragments quantified in serum as measures of desmoplasia associate with survival outcome in patients with advanced pancreatic cancer |
Q48533249 | Collagen triple helix repeat containing 1 promotes tumor angiogenesis in gastrointestinal stromal tumors. |
Q55263775 | Collagen type 1 promotes survival of human breast cancer cells by overexpressing Kv10.1 potassium and Orai1 calcium channels through DDR1-dependent pathway. |
Q64057515 | Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology |
Q48049656 | Collateral Damage Intended-Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy. |
Q42108626 | Collective invasion of carcinoma cells: when the fibroblasts take the lead |
Q39057587 | Collective migration of cancer-associated fibroblasts is enhanced by overexpression of tight junction-associated proteins claudin-11 and occludin |
Q36143306 | Color-Coded Imaging of Breast Cancer Metastatic Niche Formation in Nude Mice |
Q38652194 | Colorectal Cancer Subtypes: Developmental Origin and Microenvironmental Regulation |
Q39585082 | Colorectal cancer cells activate adjacent fibroblasts resulting in FGF1/FGFR3 signaling and increased invasion |
Q64278846 | Colorectal cancer, radiotherapy and gut microbiota |
Q47968180 | Colorectal carcinoma-derived fibroblasts modulate natural killer cell phenotype and antitumor cytotoxicity |
Q36600567 | Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer. |
Q36545800 | Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells |
Q38556589 | Combined Secretomics and Transcriptomics Revealed Cancer-Derived GDF15 is Involved in Diffuse-Type Gastric Cancer Progression and Fibroblast Activation |
Q55066611 | Comparative assessment of HIF-1α and Akt responses in human lung and skin cells exposed to benzo[α]pyrene: Effect of conditioned medium from pre-exposed primary fibroblasts. |
Q90329840 | Comparative phenotypic profiling of the JAK2 inhibitors ruxolitinib, fedratinib, momelotinib, and pacritinib reveals distinct mechanistic signatures |
Q26851916 | Compensatory angiogenesis and tumor refractoriness |
Q54662271 | Complementary effects of ciclopirox olamine, a prolyl hydroxylase inhibitor and sphingosine 1-phosphate on fibroblasts and endothelial cells in driving capillary sprouting. |
Q57821556 | Complex formation between platelet-derived growth factor receptor β and transforming growth factor β receptor regulates the differentiation of mesenchymal stem cells into cancer-associated fibroblasts |
Q64922761 | Comprehensive functional profiling of long non-coding RNAs through a novel pan-cancer integration approach and modular analysis of their protein-coding gene association networks. |
Q36771856 | Computational selection of antibody-drug conjugate targets for breast cancer. |
Q39138664 | Concise Review: An (Im)Penetrable Shield: How the Tumor Microenvironment Protects Cancer Stem Cells. |
Q36492673 | Connective tissue growth factor is overexpressed in human hepatocellular carcinoma and promotes cell invasion and growth |
Q57790443 | Conophylline suppresses pancreatic cancer desmoplasia and cancer-promoting cytokines produced by cancer-associated fibroblasts |
Q35037058 | Contribution of bone microenvironment to leukemogenesis and leukemia progression |
Q36170766 | Control of cyclooxygenase-2 expression and tumorigenesis by endogenous 5-methoxytryptophan. |
Q33914878 | Controllable Photodynamic Therapy Implemented by Regulating Singlet Oxygen Efficiency |
Q42512025 | Convergent roles of ATF3 and CSL in chromatin control of cancer-associated fibroblast activation. |
Q93088521 | Correlation of ultra-high field MRI with histopathology for evaluation of rectal cancer heterogeneity |
Q37533025 | Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer |
Q39104480 | Cross-Talk between Cancer Cells and the Tumour Microenvironment: The Role of the 5-Lipoxygenase Pathway. |
Q37377875 | Cross-species functional analysis of cancer-associated fibroblasts identifies a critical role for CLCF1 and IL-6 in non-small cell lung cancer in vivo. |
Q36187740 | Crossroads of integrins and cadherins in epithelia and stroma remodeling |
Q37338336 | Crosstalk between bone marrow-derived myofibroblasts and gastric cancer cells regulates cancer stemness and promotes tumorigenesis |
Q60950025 | Crosstalk between the Tumor Microenvironment and Immune System in Pancreatic Ductal Adenocarcinoma: Potential Targets for New Therapeutic Approaches |
Q36334053 | Curcumin inhibits cancer-associated fibroblast-driven prostate cancer invasion through MAOA/mTOR/HIF-1α signaling |
Q28543093 | Curcumin suppresses crosstalk between colon cancer stem cells and stromal fibroblasts in the tumor microenvironment: potential role of EMT |
Q37596833 | Curcumin suppresses epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells by inhibiting cancer-associated fibroblasts |
Q36879229 | Curcumin triggers p16-dependent senescence in active breast cancer-associated fibroblasts and suppresses their paracrine procarcinogenic effects |
Q35742534 | Cyclooxygenase-2 blockade can improve efficacy of VEGF-targeting drugs |
Q48891850 | Cyclophosphamide enhances anti-tumor effects of a fibroblast activation protein α-based DNA vaccine in tumor-bearing mice with murine breast carcinoma. |
Q28080901 | Cytokines, IBD, and colitis-associated cancer |
Q38741833 | Cytoplasmic GPER translocation in cancer-associated fibroblasts mediates cAMP/PKA/CREB/glycolytic axis to confer tumor cells with multidrug resistance |
Q64108674 | Cytoskeletal alteration modulates cancer cell invasion through RhoA-YAP signaling in stromal fibroblasts |
Q37153881 | DHEA metabolism in prostate: For better or worse? |
Q35355691 | DNA damage enhanced by the attenuation of SLD5 delays cell cycle restoration in normal cells but not in cancer cells |
Q46566715 | DNA methylation signal has a major role in the response of human breast cancer cells to the microenvironment. |
Q38261602 | DNA methylome profiling beyond promoters - taking an epigenetic snapshot of the breast tumor microenvironment |
Q35843010 | Deciphering mechanisms of drug sensitivity and resistance to Selective Inhibitor of Nuclear Export (SINE) compounds |
Q42773442 | Decoding information in cell shape |
Q47292144 | Deconstruction of a metastatic tumor microenvironment reveals a common matrix response in human cancers. |
Q45350034 | Decreased expression of myosin light chain MYL9 in stroma predicts malignant progression and poor biochemical recurrence-free survival in prostate cancer |
Q64069907 | Defective Induction of COX-2 Expression by Psoriatic Fibroblasts Promotes Pro-inflammatory Activation of Macrophages |
Q55004542 | Defining the Role of Solid Stress and Matrix Stiffness in Cancer Cell Proliferation and Metastasis. |
Q92689353 | Deletion of Calcineurin Promotes a Protumorigenic Fibroblast Phenotype |
Q39560761 | Deletion of p120-catenin results in a tumor microenvironment with inflammation and cancer that establishes it as a tumor suppressor gene |
Q37268993 | Depletion of FAP+ cells reduces immunosuppressive cells and improves metabolism and functions CD8+T cells within tumors |
Q34269713 | Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival |
Q37780799 | Desmoplasia: not always a bad thing. |
Q89538302 | Desmoplastic Reaction and Tumor Budding in Cervical Squamous Cell Carcinoma are Prognostic Factors for Distant Metastasis: A Retrospective Study |
Q35320642 | Detecting high-grade squamous intraepithelial lesions in the cervix with quantitative spectroscopy and per-patient normalization |
Q30511926 | Detection of MMP-2 and MMP-9 activity in vivo with a triple-helical peptide optical probe |
Q34117482 | Development and translational imaging of a TP53 porcine tumorigenesis model |
Q39909899 | Development of tissue-engineered models of oral dysplasia and early invasive oral squamous cell carcinoma. |
Q36301365 | Diabetic angiopathy and angiogenic defects |
Q92442492 | Dietary Fucoxanthin Induces Anoikis in Colorectal Adenocarcinoma by Suppressing Integrin Signaling in a Murine Colorectal Cancer Model |
Q33498941 | Differences in the nemosis response of normal and cancer-associated fibroblasts from patients with oral squamous cell carcinoma |
Q84372258 | Different gene expression patterns in human papillary and reticular fibroblasts |
Q34796473 | Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II. |
Q35322827 | Differential expression and regulation of vitamin D hydroxylases and inflammatory genes in prostate stroma and epithelium by 1,25-dihydroxyvitamin D in men with prostate cancer and an in vitro model |
Q39041457 | Differential expression of cancer-associated fibroblast-related proteins according to molecular subtype and stromal histology in breast cancer |
Q87401555 | Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status |
Q91739093 | Differentiation and roles of bone marrow-derived cells on the tumor microenvironment of oral squamous cell carcinoma |
Q38834166 | Diffuse-type gastric cancer cells switch their driver pathways from FGFR2 signaling to SDF1/CXCR4 axis in hypoxic tumor microenvironments |
Q26782289 | Direct Interaction between Carcinoma Cells and Cancer Associated Fibroblasts for the Regulation of Cancer Invasion |
Q34636483 | Direct and indirect contribution of bone marrow-derived cells to cancer |
Q33871037 | Directing the Self-assembly of Tumour Spheroids by Bioprinting Cellular Heterogeneous Models within Alginate/Gelatin Hydrogels |
Q92854500 | Disabled Homolog 2 (DAB2) Protein in Tumor Microenvironment Correlates with Aggressive Phenotype in Human Urothelial Carcinoma of the Bladder |
Q37260920 | Discontinuation of anti-VEGF cancer therapy promotes metastasis through a liver revascularization mechanism. |
Q36804795 | Discovery of endothelium and mesenchymal properties of primo vessels in the mesentery |
Q48284400 | Dissecting Time- from Tumor-Related Gene Expression Variability in Bilateral Breast Cancer. |
Q33265960 | Dissection of a metastatic gene expression signature into distinct components |
Q36063498 | Distinct Transcriptional Changes and Epithelial-Stromal Interactions Are Altered in Early-Stage Colon Cancer Development |
Q37269185 | Distinct effects of SIRT1 in cancer and stromal cells on tumor promotion |
Q34391786 | Distinct fibroblast lineages determine dermal architecture in skin development and repair. |
Q54403267 | Distinct nuclear receptor expression in stroma adjacent to breast tumors. |
Q28069801 | Distinctive properties of metastasis-initiating cells |
Q33916413 | Distinctive responsiveness to stromal signaling accompanies histologic grade programming of cancer cells |
Q42455372 | Distribution of podoplanin-positive tumor vessels predicts disease-specific survival of node-positive breast cancer patients treated with anthracyclines and/or taxanes |
Q38181530 | Diverse effects of LPA receptors on cell motile activities of cancer cells |
Q35228622 | Diversity of biological effects induced by longwave UVA rays (UVA1) in reconstructed skin |
Q35799412 | Down-Regulation of miR-92 in Breast Epithelial Cells and in Normal but Not Tumour Fibroblasts Contributes to Breast Carcinogenesis |
Q38779085 | Down-regulation of cell adhesion via rho-associated protein kinase (ROCK) pathway promotes tumor cell migration on laminin-511. |
Q39939616 | Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma. |
Q34756307 | Down-regulation of methylthioadenosine phosphorylase (MTAP) induces progression of hepatocellular carcinoma via accumulation of 5'-deoxy-5'-methylthioadenosine (MTA). |
Q39116542 | Downregulation of activation factors of endothelia and fibroblasts via lysophosphatidic acid signaling in a mouse lung cancer LL/2 cell line |
Q37950977 | Drosophila cancer models. |
Q47169621 | Drug Resistance Driven by Cancer Stem Cells and Their Niche |
Q44482658 | Dual role of sphingosine kinase-1 in promoting the differentiation of dermal fibroblasts and the dissemination of melanoma cells |
Q90903340 | Dual role of twist1 in cancer-associated fibroblasts and tumor cells promoted epithelial-mesenchymal transition of esophageal cancer |
Q28296046 | Ductal carcinoma in situ: terminology, classification, and natural history |
Q30596963 | Dynamic and influential interaction of cancer cells with normal epithelial cells in 3D culture |
Q58577525 | Dynamism, Sensitivity, and Consequences of Mesenchymal and Stem-Like Phenotype of Cancer Cells |
Q62083308 | Dysregulation of Sphingolipid Metabolism in Melanoma: Roles in Pigmentation, Cell Survival and Tumor Progression |
Q54380363 | E-Cadherin and EpCAM expression by NSCLC tumour cells associate with normal fibroblast activation through a pathway initiated by integrin αvβ6 and maintained through TGFβ signalling. |
Q47386263 | EB1 and cytoplasmic dynein mediate protrusion dynamics for efficient 3-dimensional cell migration |
Q38834075 | EGF enhances low-invasive cancer cell invasion by promoting IMP-3 expression |
Q82566527 | EGRI and FOSB gene expressions in cancer stroma are independent prognostic indicators for epithelial ovarian cancer receiving standard therapy |
Q39233875 | EMT, CSCs, and drug resistance: the mechanistic link and clinical implications |
Q37504554 | EMT: when epithelial cells decide to become mesenchymal-like cells |
Q34248837 | ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas. |
Q36970516 | Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments |
Q33844632 | Effect of anatomy on spectroscopic detection of cervical dysplasia |
Q61447510 | Effect of fibroblast co-culture on the proliferation, viability and drug response of colon cancer cells |
Q28651675 | Effect of liver regeneration on malignant hepatic tumors |
Q34571945 | Effect of miR-122 and its target gene cationic amino acid transporter 1 on colorectal liver metastasis |
Q33840207 | Effect of non-alcoholic liver disease on recurrence rate and liver regeneration after liver resection for colorectal liver metastases |
Q36922131 | Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer |
Q52558965 | Effects of Neonicotinoid Pesticides on Promoter-Specific Aromatase (CYP19) Expression in Hs578t Breast Cancer Cells and the Role of the VEGF Pathway. |
Q41861404 | Effects of cancer-associated fibroblasts on the migration and invasion abilities of SGC-7901 gastric cancer cells |
Q41612367 | Effects of increased Kindlin-2 expression in bladder cancer stromal fibroblasts |
Q46269332 | Effects of photodynamic therapy on dermal fibroblasts from xeroderma pigmentosum and Gorlin-Goltz syndrome patients |
Q96950843 | Effects of pirfenidone targeting the tumor microenvironment and tumor-stroma interaction as a novel treatment for non-small cell lung cancer |
Q38792108 | Effects of radiation on metastasis and tumor cell migration |
Q39690173 | Effects of small interfering RNAs targeting fascin on human esophageal squamous cell carcinoma cell lines |
Q34690943 | Egr-1 activation by cancer-derived extracellular vesicles promotes endothelial cell migration via ERK1/2 and JNK signaling pathways |
Q38830344 | Elastic properties of hydrogels and decellularized tissue sections used in mechanobiology studies probed by atomic force microscopy. |
Q36820325 | Elastin-elastases and inflamm-aging |
Q28551417 | Electric Cell-Substrate Impedance Sensing (ECIS) with Microelectrode Arrays for Investigation of Cancer Cell-Fibroblasts Interaction |
Q39399018 | Elevated expression of angiomodulin (AGM/IGFBP-rP1) in tumor stroma and its roles in fibroblast activation |
Q42492498 | Elevated expression of chemokine C-C ligand 2 in stroma is associated with recurrent basal-like breast cancers. |
Q33954959 | Elevated expression of stromal palladin predicts poor clinical outcome in renal cell carcinoma |
Q39473591 | Elevated progesterone receptor membrane component 1/sigma-2 receptor levels in lung tumors and plasma from lung cancer patients |
Q37997493 | Emerging evidence of epithelial-to-mesenchymal transition in lung carcinogenesis |
Q37584296 | Emerging role of mucins in epithelial to mesenchymal transition |
Q37141168 | Emerging roles of extracellular vesicles in the adaptive response of tumour cells to microenvironmental stress. |
Q39611596 | Emerging roles of focal adhesion kinase in cancer |
Q38008496 | Emerging roles of the tumor-associated stroma in promoting tumor metastasis. |
Q37376875 | Endocrine-immune-paracrine interactions in prostate cells as targeted by phytomedicines |
Q55506580 | Endogenous Matrix-Derived Inhibitors of Angiogenesis. |
Q34988080 | Endoglin regulates cancer-stromal cell interactions in prostate tumors |
Q89631295 | Endothelial Cells in the Tumor Microenvironment |
Q64075139 | Endothelial cell-derived nidogen-1 inhibits migration of SK-BR-3 breast cancer cells |
Q34439455 | Endothelial-mesenchymal transition in normal human esophageal endothelial cells cocultured with esophageal adenocarcinoma cells: role of IL-1β and TGF-β2. |
Q37129660 | Endothelial-stromal interactions in angiogenesis |
Q92996743 | Endothelial-to-Mesenchymal Transition (EndoMT): Roles in Tumorigenesis, Metastatic Extravasation and Therapy Resistance |
Q43697611 | Endothelial-to-mesenchymal transition and renal fibrosis in ischaemia/reperfusion injury are mediated by complement anaphylatoxins and Akt pathway |
Q95936615 | Endothelial-to-mesenchymal transition in anticancer therapy and normal tissue damage |
Q54377971 | Endothelin-1 stimulates motility of head and neck squamous carcinoma cells by promoting stromal-epithelial interactions. |
Q40849132 | Energy transfer in "parasitic" cancer metabolism: mitochondria are the powerhouse and Achilles' heel of tumor cells |
Q88722501 | Engineered microfluidic bioreactor for examining the three-dimensional breast tumor microenvironment |
Q89164779 | Engineering the pre-metastatic niche |
Q34097585 | Enhanced paracrine FGF10 expression promotes formation of multifocal prostate adenocarcinoma and an increase in epithelial androgen receptor |
Q49132862 | Enhancement of fibroblast activation protein α-based vaccines and adenovirus boost immunity by cyclophosphamide through inhibiting IL-10 expression in 4T1 tumor bearing mice. |
Q39144705 | Enhancement of head and neck squamous cell carcinoma proliferation, invasion, and metastasis by tumor-associated fibroblasts in preclinical models |
Q35565766 | Enhancement of nab-paclitaxel antitumor activity through addition of multitargeting antiangiogenic agents in experimental pancreatic cancer. |
Q36744817 | Enhancing sorafenib-mediated sensitization to gemcitabine in experimental pancreatic cancer through EMAP II. |
Q38490347 | Enrichment map profiling of the cancer invasion front suggests regulation of colorectal cancer progression by the bone morphogenetic protein antagonist, gremlin-1. |
Q37786019 | Environmental control of invasiveness and metastatic dissemination of tumor cells: the role of tumor cell-host cell interactions. |
Q39295109 | EphA2-mediated mesenchymal-amoeboid transition induced by endothelial progenitor cells enhances metastatic spread due to cancer-associated fibroblasts |
Q38267753 | EphA3 biology and cancer. |
Q39279690 | Epidermal growth factor receptor activation and inhibition in 3D in vitro models of normal skin and human cutaneous squamous cell carcinoma |
Q36548726 | Epidermal β-catenin activation remodels the dermis via paracrine signalling to distinct fibroblast lineages |
Q35578981 | Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment. |
Q36379569 | Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts |
Q37422742 | Epigenomic Deconvolution of Breast Tumors Reveals Metabolic Coupling between Constituent Cell Types |
Q34047424 | Epithelial and stromal microRNA signatures of columnar cell hyperplasia linking Let-7c to precancerous and cancerous breast cancer cell proliferation |
Q92305366 | Epithelial-Mesenchymal Plasticity in Organotropism Metastasis and Tumor Immune Escape |
Q37846143 | Epithelial-mesenchymal interactions in biliary diseases |
Q37462579 | Epithelial-mesenchymal transition and migration of prostate cancer stem cells is driven by cancer-associated fibroblasts in an HIF-1α/β-catenin-dependent pathway |
Q91804158 | Epithelial-mesenchymal transition markers screened in a cell-based model and validated in lung adenocarcinoma |
Q38024791 | Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies. |
Q34502015 | Epithelial-to-mesenchymal transition in human esophageal cancer associates with tumor progression and patient's survival. |
Q37688972 | Epithelioid peritoneal mesothelioma: a hybrid phenotype within a mesenchymal-epithelial/epithelial-mesenchymal transition framework |
Q89805613 | Esophageal Cancer Development: Crucial Clues Arising from the Extracellular Matrix |
Q36187837 | Esophageal squamous cell carcinoma invasion is inhibited by Activin A in ACVRIB-positive cells |
Q26745667 | Essential role of miRNAs in orchestrating the biology of the tumor microenvironment |
Q61455117 | Establishment and Identification of a CiPSC Lineage Reprogrammed from FSP-tdTomato Mouse Embryonic Fibroblasts (MEFs) |
Q38793681 | Establishment and characterization of a new feline mammary cancer cell line, FkMTp |
Q36097586 | Establishment of 3D Co-Culture Models from Different Stages of Human Tongue Tumorigenesis: Utility in Understanding Neoplastic Progression |
Q41225849 | Establishment of a bioluminescence model for microenvironmentally induced oral carcinogenesis with implications for screening bioengineered scaffolds |
Q39177165 | Establishment of a novel dsRed NOD/Scid mouse strain to investigate the host and tumor cell compartments |
Q35099011 | Estrogen action and prostate cancer |
Q46004480 | Estrogen modulates mesenchyme-epidermis interactions in the adult nipple. |
Q36140873 | Estrogenic gper signaling regulates mir144 expression in cancer cells and cancer-associated fibroblasts (cafs) |
Q27309251 | Ets2 in tumor fibroblasts promotes angiogenesis in breast cancer |
Q34313870 | Evaluation of poly-mechanistic antiangiogenic combinations to enhance cytotoxic therapy response in pancreatic cancer |
Q33728232 | Evaluation of the circulating level of fibroblast activation protein α for diagnosis of esophageal squamous cell carcinoma |
Q93045743 | Evidence of Tumour Microenvironment and Stromal Cellular Components in Retinoblastoma |
Q38735156 | Ex vivo culture of circulating tumor cells using magnetic force-based coculture on a fibroblast feeder layer |
Q64235554 | Exercise promotes a cardioprotective gene program in resident cardiac fibroblasts |
Q34171808 | Exosomal HIF1α supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes |
Q90164290 | Exosomal MiRNAs in Pediatric Cancers |
Q41557851 | Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts |
Q36528364 | Exosomal transfer of functional small RNAs mediates cancer-stroma communication in human endometrium |
Q61812643 | Exosome-Mediated Signaling in Epithelial to Mesenchymal Transition and Tumor Progression |
Q37151539 | Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts. |
Q54959554 | Exosomes Released by Gastric Cancer Cells Induce Transition of Pericytes Into Cancer-Associated Fibroblasts. |
Q42367399 | Exosomes derived from embryonal and alveolar rhabdomyosarcoma carry differential miRNA cargo and promote invasion of recipient fibroblasts |
Q33363486 | Exosomes from the tumor microenvironment as reciprocal regulators that enhance prostate cancer progression |
Q55253817 | Exosomes in cancer: small vesicular transporters for cancer progression and metastasis, biomarkers in cancer therapeutics. |
Q38091978 | Exosomes in tumor microenvironment influence cancer progression and metastasis |
Q36028740 | Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts |
Q47273146 | Expansion of patient-derived circulating tumor cells from liquid biopsies using a CTC microfluidic culture device. |
Q35581818 | Experimental generation of carcinoma-associated fibroblasts (CAFs) from human mammary fibroblasts |
Q49859674 | Experimental models of pancreatic cancer desmoplasia. |
Q35063777 | Expression and function of methylthioadenosine phosphorylase in chronic liver disease |
Q30491596 | Expression of Estrogen and Progesterone Receptor in Tumor Stroma Predicts Favorable Prognosis of Cervical Squamous Cell Carcinoma |
Q51123368 | Expression of Stromal Caveolin- 1 May Be a Predictor for Aggressive Behaviour of Breast Cancer. |
Q83644015 | Expression of TREM-1 in hepatic stellate cells and prognostic value in hepatitis B-related hepatocellular carcinoma |
Q87774214 | Expression of basic fibroblast growth factor, CD31, and α-smooth muscle actin and esophageal cancer recurrence after definitive chemoradiation |
Q35713332 | Expression of galectin-1 in carcinoma-associated fibroblasts promotes gastric cancer cell invasion through upregulation of integrin β1. |
Q47161245 | Expression of podoplanin in stromal fibroblasts plays a pivotal role in the prognosis of patients with pancreatic cancer |
Q37415468 | Expression of the homeobox gene HOXA9 in ovarian cancer induces peritoneal macrophages to acquire an M2 tumor-promoting phenotype. |
Q34988742 | Expression, tissue distribution and function of miR-21 in esophageal squamous cell carcinoma |
Q35667722 | Extensive rewiring of epithelial-stromal co-expression networks in breast cancer |
Q28304032 | Extracellular Hsp90 mediates an NF-κB dependent inflammatory stromal program: implications for the prostate tumor microenvironment |
Q91286753 | Extracellular Microenvironmental Change by B16F10 Melanoma-derived Proteins Induces Cancer Stem-like Cell Properties from NIH3T3 Cells |
Q53541672 | Extracellular collagenases and the endocytic receptor, urokinase plasminogen activator receptor-associated protein/Endo180, cooperate in fibroblast-mediated collagen degradation. |
Q37784711 | Extracellular matrix composition reveals complex and dynamic stromal-epithelial interactions in the mammary gland |
Q45073825 | Extracellular matrix remodeling in 3D: implications in tissue homeostasis and disease progression |
Q37189687 | Extracellular matrix-induced gene expression in human breast cancer cells |
Q38632188 | Extracellular matrix-mediated cellular communication in the heart. |
Q38307717 | Extracellular vesicles as carriers of microRNA, proteins and lipids in tumor microenvironment |
Q38238011 | Extracellular vesicles as emerging intercellular communicasomes |
Q91651363 | Extracellular vesicles of carcinoma-associated fibroblasts creates a pre-metastatic niche in the lung through activating fibroblasts |
Q38933493 | Extracellular vesicles swarm the cancer microenvironment: from tumor-stroma communication to drug intervention. |
Q38617934 | Extracting Intercellular Signaling Network of Cancer Tissues using Ligand-Receptor Expression Patterns from Whole-tumor and Single-cell Transcriptomes |
Q91858448 | FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors |
Q31018027 | FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells |
Q36262850 | FGF-1/-3/FGFR4 signaling in cancer-associated fibroblasts promotes tumor progression in colon cancer through Erk and MMP-7 |
Q36785933 | FGF10/FGFR2 signal induces cell migration and invasion in pancreatic cancer |
Q51592018 | FGF2 Overrides TGFβ1-Driven Integrin ITGA11 Expression in Human Dermal Fibroblasts. |
Q38644648 | FGFR1 is critical for the anti-endothelial mesenchymal transition effect of N-acetyl-seryl-aspartyl-lysyl-proline via induction of the MAP4K4 pathway |
Q34760652 | FSP1+ fibroblasts promote skin carcinogenesis by maintaining MCP-1-mediated macrophage infiltration and chronic inflammation |
Q58799822 | FSP1-positive fibroblasts are adipogenic niche and regulate adipose homeostasis |
Q37476252 | Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles |
Q48763662 | Fatty acid binding protein 4 expression in cerebral vascular malformations: implications for vascular remodelling. |
Q46633886 | Fiber-modified hexon-chimeric oncolytic adenovirus targeting cancer associated fibroblasts inhibits tumor growth in gastric carcinoma |
Q64296038 | Fibroadhesive scarring of grafted collagen scaffolds interferes with implant-host neural tissue integration and bridging in experimental spinal cord injury |
Q98945433 | Fibroblast Activation Protein-α Expressing Fibroblasts Promote Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma |
Q28728778 | Fibroblast EXT1-levels influence tumor cell proliferation and migration in composite spheroids |
Q58697838 | Fibroblast Growth Factor 10 in Pancreas Development and Pancreatic Cancer |
Q35182174 | Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis |
Q35754294 | Fibroblast activation protein-α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations |
Q35761855 | Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma |
Q36729100 | Fibroblast differentiation in wound healing and fibrosis |
Q33964324 | Fibroblast heterogeneity in the cancer wound |
Q50424157 | Fibroblast heterogeneity: implications for human disease. |
Q37179409 | Fibroblast independency in tumors: implications in cancer therapy |
Q39771894 | Fibroblast nemosis induces angiogenic responses of endothelial cells |
Q36582035 | Fibroblast sources: Where can we get them? |
Q38771074 | Fibroblast spheroids as a model to study sustained fibroblast quiescence and their crosstalk with tumor cells |
Q35987339 | Fibroblast surface-associated FGF-2 promotes contact-dependent colorectal cancer cell migration and invasion through FGFR-SRC signaling and integrin αvβ5-mediated adhesion |
Q41151245 | Fibroblast-Extracellular Matrix Interactions in Tissue Fibrosis |
Q36917756 | Fibroblast-Mediated Collagen Remodeling Within the Tumor Microenvironment Facilitates Progression of Thyroid Cancers Driven by BrafV600E and Pten Loss |
Q92163289 | Fibroblast-Mediated Immunoregulation of Macrophage Function Is Maintained after Irradiation |
Q42475774 | Fibroblast-activation protein: a single marker that confidently differentiates morpheaform/infiltrative basal cell carcinoma from desmoplastic trichoepithelioma |
Q48102897 | Fibroblast-associated tumour microenvironment induces vascular structure-networked tumouroid |
Q35167289 | Fibroblast-endothelial partners for vascularization strategies in tissue engineering |
Q33934433 | Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion |
Q34471885 | Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver |
Q26866509 | Fibroblasts and myofibroblasts in wound healing |
Q64981236 | Fibroblasts as Modulators of Local and Systemic Cancer Metabolism. |
Q64893292 | Fibroblasts as a practical alternative to mesenchymal stem cells. |
Q37178453 | Fibroblasts as architects of cancer pathogenesis |
Q39097256 | Fibroblasts as maestros orchestrating tissue regeneration |
Q36983715 | Fibroblasts as novel therapeutic targets in chronic inflammation |
Q40994644 | Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1. |
Q26998508 | Fibroblasts in fibrosis: novel roles and mediators |
Q53279967 | Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness. |
Q89631276 | Fibroblasts in the Tumor Microenvironment |
Q55324986 | Fibroblasts in the Tumor Microenvironment: Shield or Spear? |
Q38946666 | Fibroblasts induce expression of FGF4 in ovarian cancer stem-like cells/cancer-initiating cells and upregulate their tumor initiation capacity |
Q34164261 | Fibroblasts protect melanoma cells from the cytotoxic effects of doxorubicin. |
Q51888402 | Fibroblasts share mesenchymal phenotypes with stem cells, but lack their differentiation and colony-forming potential. |
Q37543703 | Fibroblasts-a diverse population at the center of it all. |
Q26768515 | Fibronectin Mechanobiology Regulates Tumorigenesis |
Q42150675 | Fibronectin and beta-catenin act in a regulatory loop in dermal fibroblasts to modulate cutaneous healing |
Q36944869 | Fibronectin conformation regulates the proangiogenic capability of tumor-associated adipogenic stromal cells |
Q30835803 | Fibronectin-guided migration of carcinoma collectives |
Q33865082 | Fibrosis-dependent mechanisms of hepatocarcinogenesis |
Q37678004 | Fibrotic extracellular matrix activates a profibrotic positive feedback loop |
Q91599505 | Fibulin-2 is required for basement membrane integrity of mammary epithelium |
Q38579572 | Flow-induced stress on adherent cells in microfluidic devices |
Q34162432 | Focal adhesion assembly in myofibroblasts fosters a microenvironment that promotes tumor growth |
Q38958706 | Focal adhesion kinase knockdown in carcinoma-associated fibroblasts inhibits oral squamous cell carcinoma metastasis via downregulating MCP-1/CCL2 expression |
Q85886839 | Forkhead box P3 regulatory T cells coexisting with cancer associated fibroblasts are correlated with a poor outcome in lung adenocarcinoma |
Q50351390 | From Chemotherapy to Combined Targeted Therapeutics: In Vitro and in Vivo Models to Decipher Intra-tumor Heterogeneity. |
Q39252748 | From inflammation to gastric cancer - the importance of Hedgehog/GLI signaling in Helicobacter pylori-induced chronic inflammatory and neoplastic diseases |
Q38045235 | From sentinel cells to inflammatory culprits: cancer-associated fibroblasts in tumour-related inflammation |
Q46214350 | From transformation to metastasis: deconstructing the extracellular matrix in breast cancer |
Q85489649 | Functional abnormalities and changes in gene expression in fibroblasts and macrophages from the bone marrow of patients with acute myeloid leukemia |
Q39535994 | Functional characterization of cancer-associated fibroblasts of human cutaneous squamous cell carcinoma |
Q34034676 | Functional heterogeneity of breast fibroblasts is defined by a prostaglandin secretory phenotype that promotes expansion of cancer-stem like cells |
Q28486232 | Functional investigation of NCI-H460-inducible myofibroblasts on the chemoresistance to VP-16 with a microfluidic 3D co-culture device |
Q42252395 | Fusion between cancer cells and myofibroblasts is involved in osteosarcoma |
Q36481702 | G protein-coupled estrogen receptor mediates the up-regulation of fatty acid synthase induced by 17β-estradiol in cancer cells and cancer-associated fibroblasts |
Q37824814 | G protein-coupled receptors: novel targets for drug discovery in cancer |
Q38818348 | GPER Mediates Non-Genomic Effects of Estrogen |
Q39432208 | GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells. |
Q27322202 | GPER signalling in both cancer-associated fibroblasts and breast cancer cells mediates a feedforward IL1β/IL1R1 response. |
Q38762482 | GPER, IGF-IR, and EGFR transduction signaling are involved in stimulatory effects of zinc in breast cancer cells and cancer-associated fibroblasts. |
Q61804215 | GSK-3β regulates the endothelial-to-mesenchymal transition via reciprocal crosstalk between NSCLC cells and HUVECs in multicellular tumor spheroid models |
Q36885727 | GT198 Expression Defines Mutant Tumor Stroma in Human Breast Cancer. |
Q36879539 | Galectin-1 mediates TGF-β-induced transformation from normal fibroblasts into carcinoma-associated fibroblasts and promotes tumor progression in gastric cancer |
Q39039136 | Ganglioside GD3 induces convergence and synergism of adhesion and hepatocyte growth factor/Met signals in melanomas |
Q64891812 | Gastric carcinogenesis. |
Q37631370 | Gastrin, inflammation, and carcinogenesis |
Q35654127 | Gastrointestinal Fibroblasts Have Specialized, Diverse Transcriptional Phenotypes: A Comprehensive Gene Expression Analysis of Human Fibroblasts |
Q40539463 | Gene expression profile in the activation of subperitoneal fibroblasts reflects prognosis of patients with colon cancer |
Q38836952 | Gene expression profile of normal and cancer-associated fibroblasts according to intratumoral inflammatory cells phenotype from breast cancer tissue |
Q38480261 | Gene set enrichment analysis of the NF-κB/Snail/YY1/RKIP circuitry in multiple myeloma. |
Q92331139 | Gene signature characteristic of elevated stromal infiltration and activation is associated with increased risk of hematogenous and lymphatic metastasis in serous ovarian cancer |
Q33699188 | Gene targeting to the stroma of the prostate and bone |
Q37493634 | Generation of iPSC lines from archived non-cryoprotected biobanked dura mater. |
Q38115617 | Genetic regulation and potentially therapeutic application of cancer-associated fibroblasts in oral cancer. |
Q28079323 | Genetically engineered mouse models in oncology research and cancer medicine |
Q41211788 | Genomic deregulation during metastasis of renal cell carcinoma implements a myofibroblast-like program of gene expression. |
Q35684810 | Genomic differences distinguish the myofibroblast phenotype of distal lung fibroblasts from airway fibroblasts. |
Q33895270 | Genomics and proteomics approaches to the study of cancer-stroma interactions |
Q59134092 | Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier |
Q37284365 | Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2 |
Q35923493 | Glycogen synthase kinase-3 inhibition attenuates fibroblast activation and development of fibrosis following renal ischemia-reperfusion in mice |
Q38077593 | Glycosaminoglycans are functional ligands for receptor for advanced glycation end-products in tumors. |
Q57817200 | Gold nanoparticles enhance cisplatin delivery and potentiate chemotherapy by decompressing colorectal cancer vessels |
Q38605933 | Growth-induced stress enhances epithelial-mesenchymal transition induced by IL-6 in clear cell renal cell carcinoma via the Akt/GSK-3β/β-catenin signaling pathway |
Q58695521 | HGF-mediated crosstalk between cancer-associated fibroblasts and MET-unamplified gastric cancer cells activates coordinated tumorigenesis and metastasis |
Q37690722 | HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs) |
Q36290268 | HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts. |
Q22252312 | Hallmarks of Cancer: The Next Generation |
Q37704659 | Hallmarks of cancer: interactions with the tumor stroma. |
Q40408326 | Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients. |
Q37314509 | Harnessing competing endocytic pathways for overcoming the tumor-blood barrier: magnetic resonance imaging and near-infrared imaging of bifunctional contrast media |
Q60923365 | Helicobacter pylori Infection-Induced Hepatoma-Derived Growth Factor Regulates the Differentiation of Human Mesenchymal Stem Cells to Myofibroblast-Like Cells |
Q64905339 | Hematological Malignancy-Derived Small Extracellular Vesicles and Tumor Microenvironment: The Art of Turning Foes into Friends. |
Q55192426 | Hematopoietic Stem Cells as a Novel Source of Dental Tissue Cells. |
Q38826311 | Hepatic carcinoma-associated fibroblasts promote an adaptative response in colorectal cancer cells that inhibit proliferation and apoptosis: nonresistant cells die by nonapoptotic cell death |
Q53581215 | Hepatic fibrosis 2006: report of the Third AASLD Single Topic Conference. |
Q54636179 | Hepatic stellate cells accelerate the malignant behavior of cholangiocarcinoma cells. |
Q37869041 | Hepatic stellate cells: partners in crime for liver metastases? |
Q35728873 | Hepatitis C virus infection: establishment of chronicity and liver disease progression |
Q26781273 | Hepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer Challenge |
Q54484191 | Hepatocyte growth factor in the neighborhood reverses resistance to BRAF inhibitor in melanoma. |
Q38655547 | Heterocellular cadherin connections: coordinating adhesive cues in homeostasis and cancer |
Q36165598 | Heterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche |
Q33753945 | Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast |
Q38900718 | Heterogeneous tumor stromal microenvironments of oral squamous cell carcinoma cells in tongue and nodal metastatic lesions in a xenograft mouse model |
Q39496485 | Heterogenous induction of carcinoma-associated fibroblast-like differentiation in normal human prostatic fibroblasts by co-culturing with prostate cancer cells |
Q33268351 | Heterologous tissue culture expression signature predicts human breast cancer prognosis |
Q51135550 | Heterotypic 3D tumor culture in a reusable platform using pneumatic microfluidics. |
Q37559209 | Heterotypic cellular interactions in the ovarian tumor microenvironment: biological significance and therapeutic implications |
Q40453995 | Hic-5 remodeling of the stromal matrix promotes breast tumor progression. |
Q38116862 | Hidden keys in stroma: Unlocking the tumor progression. |
Q36838871 | Hierarchical paracrine interaction of breast cancer associated fibroblasts with cancer cells via hMAPK-microRNAs to drive ER-negative breast cancer phenotype |
Q38981271 | High Mobility Group Box1 (HMGB1) released from cancer cells induces the expression of pro-inflammatory cytokines in peritoneal fibroblasts |
Q39034242 | High expression of IGFBP7 in fibroblasts induced by colorectal cancer cells is co-regulated by TGF-β and Wnt signaling in a Smad2/3-Dvl2/3-dependent manner |
Q36504170 | High levels of EGFR expression in tumor stroma are associated with aggressive clinical features in epithelial ovarian cancer |
Q24569637 | High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients |
Q35830253 | High-Throughput Cancer Cell Sphere Formation for Characterizing the Efficacy of Photo Dynamic Therapy in 3D Cell Cultures |
Q42823539 | High-throughput live-cell imaging reveals differential inhibition of tumor cell proliferation by human fibroblasts |
Q36223509 | Higher heat shock factor 1 expression in tumor stroma predicts poor prognosis in esophageal squamous cell carcinoma patients |
Q33392443 | Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast |
Q84230455 | Histochemical localization of caldesmon isoforms in colon adenocarcinoma and lymph node metastases |
Q89450261 | Histone deacetylase 6 regulates the immunosuppressive properties of cancer-associated fibroblasts in breast cancer through the STAT3-COX2-dependent pathway |
Q37745937 | Histone deacetylase inhibitors provoke a tumor supportive phenotype in pancreatic cancer associated fibroblasts |
Q55401527 | Hodgkin Lymphoma-Derived Extracellular Vesicles Change the Secretome of Fibroblasts Toward a CAF Phenotype. |
Q37610824 | How cancer cells dictate their microenvironment: present roles of extracellular vesicles |
Q91973843 | How the ageing microenvironment influences tumour progression |
Q52668325 | How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive. |
Q30838920 | Hsp90 regulation of fibroblast activation in pulmonary fibrosis |
Q39599360 | HuR keeps an angiogenic switch on by stabilising mRNA of VEGF and COX-2 in tumour endothelium |
Q41082417 | Human MSCs promotes colorectal cancer epithelial-mesenchymal transition and progression via CCL5/β-catenin/Slug pathway |
Q33790023 | Human Peritoneal Mesothelial Cell Death Induced by High-Glucose Hypertonic Solution Involves Ca2+ and Na+ Ions and Oxidative Stress with the Participation of PKC/NOX2 and PI3K/Akt Pathways |
Q33665522 | Human mammary fibroblasts stimulate invasion of breast cancer cells in a three-dimensional culture and increase stroma development in mouse xenografts |
Q24642524 | Human periostin gene expression in normal tissues, tumors and melanoma: evidences for periostin production by both stromal and melanoma cells |
Q30431576 | Human prostate fibroblasts induce growth and confer castration resistance and metastatic potential in LNCaP Cells |
Q38811094 | Human proximal tubule cells form functional microtissues |
Q36394731 | Human scaphoid non-unions exhibit increased osteoclast activity compared to adjacent cancellous bone |
Q35088390 | Human subperitoneal fibroblast and cancer cell interaction creates microenvironment that enhances tumor progression and metastasis |
Q34519881 | Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice |
Q55065517 | Hyaluronan, Cancer-Associated Fibroblasts and the Tumor Microenvironment in Malignant Progression. |
Q33848539 | Hydroxytyrosol inhibits chemokine C-C motif ligand 5 mediated aged quiescent fibroblast-induced stimulation of breast cancer cell proliferation |
Q35781386 | Hyperproduction of hyaluronan in neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: possible involvement of versican/PG-M. |
Q47286024 | Hypoxia Inducible Factors Modify Collagen I Fibers in MDA-MB-231 Triple Negative Breast Cancer Xenografts |
Q49725890 | Hypoxia Pathway Proteins As Central Mediators of Metabolism in the Tumor Cells and Their Microenvironment. |
Q34820282 | Hypoxia and the extracellular matrix: drivers of tumour metastasis |
Q36001832 | Hypoxia-Induced Changes in DNA Methylation Alter RASAL1 and TGFβ1 Expression in Human Trabecular Meshwork Cells. |
Q37294778 | Hypoxia-dependent modification of collagen networks promotes sarcoma metastasis. |
Q41678975 | Hypoxia-inducible factors: a central link between inflammation and cancer |
Q63364695 | Hypoxic cancer–associated fibroblasts increase NCBP2-AS2/HIAR to promote endothelial sprouting through enhanced VEGF signaling |
Q36384120 | IKKβ in intestinal mesenchymal cells promotes initiation of colitis-associated cancer |
Q36740894 | IKKβ/NFκBp65 activated by interleukin-13 targets the autophagy-related genes LC3B and beclin 1 in fibroblasts co-cultured with breast cancer cells |
Q38982850 | IL-6 enriched lung cancer stem-like cell population by inhibition of cell cycle regulators via DNMT1 upregulation |
Q33591332 | IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway |
Q30422218 | IQGAP1 suppresses TβRII-mediated myofibroblastic activation and metastatic growth in liver |
Q39396200 | Identification of CXCL5/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer-associated fibroblasts |
Q33706243 | Identification of E-selectin as a novel target for the regulation of postnatal neovascularization: implications for diabetic wound healing |
Q92217667 | Identification of Pparγ-modulated miRNA hubs that target the fibrotic tumor microenvironment |
Q91708327 | Identification of a Tumor Microenvironment-Related Eight-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas |
Q33924416 | Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis. |
Q33446102 | Identification of multipotent mesenchymal stromal cells in the reactive stroma of a prostate cancer xenograft by side population analysis |
Q98158929 | Identification of prognosis-related genes and construction of multi-regulatory networks in pancreatic cancer microenvironment by bioinformatics analysis |
Q38836443 | Identification of tumour-reactive lymphatic endothelial cells capable of inducing progression of gastric cancer |
Q64964306 | Identification of two molecular subtypes in canine mast cell tumours through gene expression profiling. |
Q41856522 | Identifying common genes and networks in multi-organ fibrosis |
Q58214748 | Idiopathic Pulmonary Fibrosis Is Associated With Endothelial To Mesenchymal Transition |
Q36850133 | Imaging Extracellular Matrix Remodeling In Vitro by Diffusion-Sensitive Optical Coherence Tomography |
Q44680217 | Imaging the recruitment of cancer-associated fibroblasts by liver-metastatic colon cancer |
Q34339761 | Immortalized tumor derived rat fibroblasts as feeder cells facilitate the cultivation of male embryonic stem cells from the rat strain WKY/Ztm |
Q50217783 | Immune Cell Metabolism in Tumor Microenvironment. |
Q50883844 | Immunization of stromal cell targeting fibroblast activation protein providing immunotherapy to breast cancer mouse model. |
Q40009177 | Immunohistochemical evidence for Zic1 coexpression with beta-catenin in the myofibroblast of Dupuytren disease |
Q34165529 | Immunohistochemical expression of epithelial and stromal immunomodulatory signalling molecules is a prognostic indicator in breast cancer |
Q38608340 | Immunological hallmarks of stromal cells in the tumour microenvironment |
Q37974937 | Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment |
Q38407555 | Immunopathogenesis of Myocarditis: The Interplay Between Cardiac Fibroblast Cells, Dendritic Cells, Macrophages and CD4+ T Cells |
Q49592831 | Immunotherapeutic Targeting of Tumor-Associated Blood Vessels. |
Q54467130 | Immunotherapy of tumor with vaccine based on basic fibroblast growth factor-activated fibroblasts. |
Q93048666 | Impact of Cancer-Associated Fibroblast on the Radiation-Response of Solid Xenograft Tumors |
Q47714743 | Impact of Her-2 Overexpression on Survival of Patients with Metastatic Breast Cancer |
Q42281477 | Impact of the prolymphangiogenic crosstalk in the tumor microenvironment on lymphatic cancer metastasis. |
Q92030460 | Importance of the immune system in head and neck cancer |
Q30759342 | In Vivo Visualization and Characterization of Epithelial-Mesenchymal Transition in Breast Tumors |
Q33715089 | In silico and Ex vivo approaches identify a role for toll-like receptor 4 in colorectal cancer |
Q34137584 | In silico models of cancer |
Q30576475 | In vitro cell transformation assays for an integrated, alternative assessment of carcinogenicity: a data-based analysis |
Q30583218 | In vivo imaging of the systemic recruitment of fibroblasts to the angiogenic rim of ovarian carcinoma tumors |
Q39340605 | Inactivation of Rb in stromal fibroblasts promotes epithelial cell invasion. |
Q33560776 | Increased KIT inhibition enhances therapeutic efficacy in gastrointestinal stromal tumor |
Q44002372 | Increased androgen receptor and remodeling in the prostatic stroma after the inhibition of 5-alpha reductase and aromatase in gerbil ventral prostate. |
Q34050895 | Increased expression of CCN2, epithelial membrane antigen, and fibroblast activation protein in hepatocellular carcinoma with fibrous stroma showing aggressive behavior |
Q35225647 | Increased expression of chemerin in squamous esophageal cancer myofibroblasts and role in recruitment of mesenchymal stromal cells |
Q43128717 | Induction and progression of cholangiofibrosis in rat liver injured by oral administration of furan |
Q28396847 | Induction of cancer-associated fibroblast-like cells by carbon nanotubes dictates its tumorigenicity |
Q46103260 | Induction of phenotype modifying cytokines by FERMT1 mutations. |
Q30674996 | Inferring tumour purity and stromal and immune cell admixture from expression data |
Q37956599 | Inflamm-aging of the stem cell niche: breast cancer as a paradigmatic example: breakdown of the multi-shell cytokine network fuels cancer in aged people |
Q33704284 | Inflammation and Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma: Fighting Against Multiple Opponents |
Q38921024 | Inflammatory Chemokines MIP-1δ and MIP-3α Are Involved in the Migration of Multipotent Mesenchymal Stromal Cells Induced by Hepatoma Cells |
Q36352894 | Inflammatory Gene Expression Upon TGF-β1-Induced p38 Activation in Primary Dupuytren's Disease Fibroblasts. |
Q42124513 | Inflammatory alterations of the extracellular matrix in the tumor microenvironment |
Q38412911 | Inflammatory fibroblasts in cancer |
Q38238739 | Inflammatory pathways in the early steps of colorectal cancer development. |
Q51818212 | Influence of microenvironment topography and stiffness on the mechanics and motility of normal and cancer renal cells. |
Q39587564 | Influence of stromal-epithelial interactions on breast cancer in vitro and in vivo |
Q39273621 | Infrared imaging in breast cancer: automated tissue component recognition and spectral characterization of breast cancer cells as well as the tumor microenvironment |
Q35369888 | Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma |
Q41173608 | Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRβ Aptamer. |
Q42214252 | Inhibition of CXCLs/CXCR2 axis in the tumor microenvironment might be a potent therapeutics for pancreatic cancer |
Q37327720 | Inhibition of cancer cell epithelial mesenchymal transition by normal fibroblasts via production of 5-methoxytryptophan |
Q38597208 | Inhibition of discoidin domain receptor 1 reduces collagen-mediated tumorigenicity in pancreatic ductal adenocarcinoma. |
Q39816968 | Inhibition of pro-HGF activation by SRI31215, a novel approach to block oncogenic HGF/MET signaling |
Q36250217 | Inhibition of stromal CXCR4 impairs development of lung metastases. |
Q39000276 | Inhibition of transforming growth factor-β signaling potentiates tumor cell invasion into collagen matrix induced by fibroblast-derived hepatocyte growth factor. |
Q36650869 | Insight On Colorectal Carcinoma Infiltration by Studying Perilesional Extracellular Matrix |
Q28817630 | Insights into Biochemical Alteration in Cancer-Associated Fibroblasts by using Novel Correlative Spectroscopy |
Q38029555 | Insights into cancer metastasis from a clinicopathologic perspective: Epithelial-Mesenchymal Transition is not a necessary step |
Q39691733 | Insulin promotes proliferative vitality and invasive capability of pancreatic cancer cells via hypoxia-inducible factor 1alpha pathway |
Q36544603 | Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation |
Q42593140 | Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer |
Q30356846 | Integrated micro/nanoengineered functional biomaterials for cell mechanics and mechanobiology: a materials perspective. |
Q91828460 | Integrated tumor stromal features of hepatocellular carcinoma reveals two distinct subtypes with prognostic/predictive significance |
Q34335849 | Integrating macrophages into organotypic co-cultures: a 3D in vitro model to study tumor-associated macrophages |
Q48053618 | Integrating multiple microarray datasets on oral squamous cell carcinoma to reveal dysregulated networks |
Q34762113 | Integration of genotypic and phenotypic screening reveals molecular mediators of melanoma-stromal interaction. |
Q49583565 | Integrin Alpha V Beta 3 Targeted Dendrimer-Rapamycin Conjugate Reduces Fibroblast-Mediated Prostate Tumor Progression and Metastasis. |
Q24677103 | Integrin alpha 11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells |
Q39325272 | Integrin α11 is overexpressed by tumour stroma of head and neck squamous cell carcinoma and correlates positively with alpha smooth muscle actin expression. |
Q38856297 | Integrin α11β1 regulates cancer stromal stiffness and promotes tumorigenicity and metastasis in non-small cell lung cancer |
Q57790100 | Integrin αvβ6 Plays an Bi-directional Regulation Role Between Colon Cancer cells and Cancer-Associated Fibroblasts |
Q34990234 | Integrin-specific control of focal adhesion kinase and RhoA regulates membrane protrusion and invasion |
Q37730158 | Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells |
Q92349966 | Integrins, CAFs and Mechanical Forces in the Progression of Cancer |
Q44086363 | Intensity of stromal changes predicts biochemical recurrence-free survival in prostatic carcinoma |
Q39205255 | Interaction between lung cancer cell and myofibroblast influenced by cyclic tensile strain. |
Q37781426 | Interaction between the extracellular matrix and lymphatics: consequences for lymphangiogenesis and lymphatic function |
Q52550597 | Interaction of prostate carcinoma-associated fibroblasts with human epithelial cell lines in vivo. |
Q38184985 | Interaction of tumour cells with their microenvironment: ion channels and cell adhesion molecules. A focus on pancreatic cancer |
Q39233221 | Interaction with colon cancer cells hyperactivates TGF-β signaling in cancer-associated fibroblasts |
Q36484558 | Interactions between microenvironment and cancer cells in two animal models of bone metastasis |
Q38184981 | Interactions of ion transporters and channels with cancer cell metabolism and the tumour microenvironment. |
Q34610562 | Interactions with fibroblasts are distinct in Basal-like and luminal breast cancers. |
Q34428998 | Intercellular cooperation and competition in brain cancers: lessons from Drosophila and human studies. |
Q49199768 | Interferon-γ and Colorectal Cancer: an up-to date. |
Q91981799 | Interleukin-17F Has Anti-Tumor Effects in Oral Tongue Cancer |
Q36730586 | Interleukin-1β promotes ovarian tumorigenesis through a p53/NF-κB-mediated inflammatory response in stromal fibroblasts |
Q28486177 | Interleukin-6 mediates epithelial-stromal interactions and promotes gastric tumorigenesis |
Q45162655 | Interleukin-6 receptor in spindle-shaped stromal cells, a prognostic determinant of early breast cancer. |
Q37507447 | Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction |
Q28082347 | Interplay between ROS and autophagy in cancer cells, from tumor initiation to cancer therapy |
Q92382382 | Interplay of fibroblasts with anaplastic tumor cells promotes follicular thyroid cancer progression |
Q37513831 | Interplay of tumor microenvironment cell types with parenchymal cells in pancreatic cancer development and therapeutic implications |
Q60958556 | Interstitial Fluid in Gynecologic Tumors and Its Possible Application in the Clinical Practice |
Q26822264 | Interstitial fluid and lymph formation and transport: physiological regulation and roles in inflammation and cancer |
Q34060641 | Interstitial fluid: the overlooked component of the tumor microenvironment? |
Q28082707 | Intertwining of Activin A and TGFβ Signaling: Dual Roles in Cancer Progression and Cancer Cell Invasion |
Q37337701 | Intestinal GUCY2C prevents TGF-β secretion coordinating desmoplasia and hyperproliferation in colorectal cancer |
Q34289166 | Intestinal Mesenchymal Cells |
Q92809240 | Intracellular Notch1 Signaling in Cancer-Associated Fibroblasts Dictates the Plasticity and Stemness of Melanoma Stem/Initiating Cells |
Q41298234 | Intratumoral accumulation of podoplanin-expressing lymph node stromal cells promote tumor growth through elimination of CD4+ tumor-infiltrating lymphocytes |
Q64088510 | Intratumoral heterogeneity as measured using the tumor-stroma ratio and PET texture analyses in females with lung adenocarcinomas differs from that of males with lung adenocarcinomas or squamous cell carcinomas |
Q38993432 | Intratumoral phenotypic heterogeneity as an encourager of cancer invasion |
Q33653155 | Intravital imaging of stromal cell dynamics in tumors |
Q35474544 | Intravital imaging reveals how BRAF inhibition generates drug-tolerant microenvironments with high integrin β1/FAK signaling |
Q61449497 | Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors |
Q36458763 | Intrinsic genetic characteristics determine tumor-modifying capacity of fibroblasts: matrix metalloproteinase-3 5A/5A genotype enhances breast cancer cell invasion. |
Q37945305 | Intrinsic modulation of lymphocyte function by stromal cell network: advance in therapeutic targeting of cancer |
Q38352021 | Introduction to the molecular basis of cancer metabolism and the Warburg effect |
Q34359125 | Involvement of host stroma cells and tissue fibrosis in pancreatic tumor development in transgenic mice |
Q48183968 | Involvement of local renin-angiotensin system in immunosuppression of tumor microenvironment. |
Q33664889 | Involvement of stromal p53 in tumor-stroma interactions. |
Q53287029 | Ion channels and transporters in cancer. 3. Ion channels in the tumor cell-microenvironment cross talk. |
Q33600872 | Ionizing radiation abrogates the pro-tumorigenic capacity of cancer-associated fibroblasts co-implanted in xenografts |
Q37274962 | Ionizing radiation-mediated premature senescence and paracrine interactions with cancer cells enhance the expression of syndecan 1 in human breast stromal fibroblasts: the role of TGF-β. |
Q40075493 | Is cholesterol a mediator of cold-induced cancer? |
Q33570447 | Isoform-specific upregulation of palladin in human and murine pancreas tumors |
Q35130596 | Isolation and characterization of mammalian cells expressing the Arf promoter during eye development |
Q90657588 | Isolation of cancer-associated fibroblasts and its promotion to the progression of intrahepatic cholangiocarcinoma |
Q36639177 | Isolation of normal and cancer-associated fibroblasts from fresh tissues by Fluorescence Activated Cell Sorting (FACS) |
Q58738114 | Jack of many trades: Multifaceted role of neuropilins in pancreatic cancer |
Q37815128 | Jekyll and Hyde: the role of the microenvironment on the progression of cancer |
Q33858490 | KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. |
Q47316195 | Ketamine-induced bladder fibrosis involves epithelial-to-mesenchymal transition mediated by transforming growth factor-β1. |
Q26766065 | Key players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cells |
Q34135320 | Kinase domain activation of FGFR2 yields high-grade lung adenocarcinoma sensitive to a Pan-FGFR inhibitor in a mouse model of NSCLC |
Q36413000 | Knock out of the BASIGIN/CD147 chaperone of lactate/H+ symporters disproves its pro-tumour action via extracellular matrix metalloproteases (MMPs) induction |
Q21144868 | Knock-in reporter mice demonstrate that DNA repair by non-homologous end joining declines with age |
Q91692530 | Label-free molecular profiling for identification of biomarkers in carcinogenesis using multimodal multiphoton imaging |
Q38394603 | Laminin-5 gamma 2 chain expression is associated with intensity of tumor budding and density of stromal myofibroblasts in oral squamous cell carcinoma |
Q35888797 | Largescale Transcriptomics Analysis Suggests Over-Expression of BGH3, MMP9 and PDIA3 in Oral Squamous Cell Carcinoma |
Q35938703 | Laser Direct-Write Onto Live Tissues: A Novel Model for Studying Cancer Cell Migration |
Q33314416 | Laser-capture microdissection in prostate cancer research: establishment and validation of a powerful tool for the assessment of tumour-stroma interactions |
Q80146610 | Leading the charge |
Q35971435 | Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers |
Q55031925 | Let-7b inhibits cancer-promoting effects of breast cancer-associated fibroblasts through IL-8 repression. |
Q50000643 | Leukemia inhibitory factor produced by fibroblasts within tumor stroma participates in invasion of oral squamous cell carcinoma. |
Q35779386 | Leukocyte composition of human breast cancer |
Q50231558 | Licofelone abolishes survival of carcinogenic fibroblasts by inducing apoptosis. |
Q35976594 | Lipocalin produced by myelofibrosis cells affects the fate of both hematopoietic and marrow microenvironmental cells |
Q41894153 | Lipopolysaccharide induces a fibrotic-like phenotype in endothelial cells |
Q37107139 | Liquid-based three-dimensional tumor models for cancer research and drug discovery |
Q36471637 | Liver myofibroblasts regulate the phenotype and function of monocytes through soluble factors in cirrhosis |
Q37052713 | Liver regeneration and tumor stimulation--a review of cytokine and angiogenic factors. |
Q41541435 | Long Noncoding RNA JHDM1D-AS1 Promotes Tumor Growth by Regulating Angiogenesis in Response to Nutrient Starvation |
Q41617899 | Long-term changes in the properties of skin-derived fibroblasts following irradiation of the head and neck |
Q30565493 | Longitudinal confocal microscopy imaging of solid tumor destruction following adoptive T cell transfer. |
Q34477782 | Longitudinal study of mammary epithelial and fibroblast co-cultures using optical coherence tomography reveals morphological hallmarks of pre-malignancy. |
Q37725460 | Loss of MTSS1 results in increased metastatic potential in pancreatic cancer |
Q37508329 | Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions |
Q37129107 | Loss of adipocyte specification and necrosis augment tumor-associated inflammation |
Q64946165 | Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2- and CXCL8-mediated cancer cell migration. |
Q36276995 | Loss of caveolin-1 alters extracellular matrix protein expression and ductal architecture in murine mammary glands |
Q33874288 | Loss of fibroblast HIF-1α accelerates tumorigenesis. |
Q33882384 | Loss of negative feedback control of nuclear factor-kappaB2 activity in lymphocytes leads to fatal lung inflammation. |
Q36026081 | Loss of one Tgfbr2 allele in fibroblasts promotes metastasis in MMTV: polyoma middle T transgenic and transplant mouse models of mammary tumor progression |
Q53226402 | Loss of p53 in stromal fibroblasts enhances tumor cell proliferation through nitric-oxide-mediated cyclooxygenase 2 activation. |
Q38963422 | Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state |
Q89551648 | Low Dose Cyclophosphamide Modulates Tumor Microenvironment by TGF-β Signaling Pathway |
Q58777726 | Low-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial-mesenchymal transition and acts synergistically with 5-fluorouracil |
Q34806507 | Lumican Accelerates Wound Healing by Enhancing α2β1 Integrin-Mediated Fibroblast Contractility |
Q39237924 | Lung carcinogenesis and fibrosis taken together: just coincidence? |
Q50076951 | Lung fibroblasts promote metastatic colonization through upregulation of stearoyl-CoA desaturase 1 in tumor cells. |
Q36707881 | Lymphangiogenesis in Breast Cancer Correlates with Matrix Stiffness on Shear-Wave Elastography. |
Q37987842 | Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity |
Q64114248 | Lysyl Oxidase-Like Protein 2 Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer |
Q35183870 | Lysyl hydroxylase 2 induces a collagen cross-link switch in tumor stroma |
Q37437254 | MARCKS contributes to stromal cancer-associated fibroblast activation and facilitates ovarian cancer metastasis. |
Q39309649 | MEMO1, a new IRS1-interacting protein, induces epithelial-mesenchymal transition in mammary epithelial cells |
Q50317688 | MMTV-NeuT/ATTAC mice: a new model for studying the stromal tumor microenvironment. |
Q37875004 | MRI & MRS assessment of the role of the tumour microenvironment in response to therapy. |
Q80176069 | MT1-MMP is required for efficient tumor dissemination in experimental metastatic disease |
Q39517668 | MT1-MMP protects breast carcinoma cells against type I collagen-induced apoptosis. |
Q35753606 | MYC is expressed in the stromal and epithelial cells of primary breast carcinoma and paired nodal metastases. |
Q88377587 | MYC sets a tumour-stroma metabolic loop |
Q36198192 | Macrophage-mediated lymphangiogenesis: the emerging role of macrophages as lymphatic endothelial progenitors |
Q57816590 | Macrophages and Fibroblasts, Key Players in Cancer Chemoresistance |
Q37943796 | Macrophages are important mediators of either tumor- or inflammation-induced lymphangiogenesis |
Q34309316 | Malignant stroma increases luminal breast cancer cell proliferation and angiogenesis through platelet-derived growth factor signaling |
Q37003477 | Mammary fibroblasts regulate morphogenesis of normal and tumorigenic breast epithelial cells by mechanical and paracrine signals |
Q35536378 | Mammary transplantation of stromal cells and carcinoma cells in C57BL/6J mice |
Q36643000 | Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence |
Q28074177 | Mammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapies |
Q89482545 | Manipulating the tumor microenvironment by adoptive cell transfer of CAR T-cells |
Q61657666 | Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation |
Q28678685 | Mapping proteolytic processing in the secretome of gastric cancer-associated myofibroblasts reveals activation of MMP-1, MMP-2, and MMP-3 |
Q30542280 | Mapping the extracellular and membrane proteome associated with the vasculature and the stroma in the embryo |
Q34427796 | Markers of epidermal stem cell subpopulations in adult mammalian skin |
Q39356113 | Matricellular proteins in cancer: a focus on secreted Frizzled-related proteins |
Q43164806 | Matricellular proteins produced by melanocytes and melanomas: in search for functions |
Q36663581 | Matricellular proteins: priming the tumour microenvironment for cancer development and metastasis |
Q92423949 | Matrix Metalloproteinase-sensitive Multistage Nanogels Promote Drug Transport in 3D Tumor Model |
Q35107715 | Matrix metalloproteinase (MMP)-9 in cancer-associated fibroblasts (CAFs) is suppressed by omega-3 polyunsaturated fatty acids in vitro and in vivo |
Q35159014 | Matrix remodeling stimulates stromal autophagy, "fueling" cancer cell mitochondrial metabolism and metastasis |
Q37616743 | Matrix-regulated integrin αvβ5 maintains α5β1-dependent desmoplastic traits prognostic of neoplastic recurrence. |
Q39279824 | Mechanical properties of the tumor stromal microenvironment probed in vitro and ex vivo by in situ-calibrated optical trap-based active microrheology |
Q38651941 | Mechanical response of collagen networks to nonuniform microscale loads |
Q47141360 | Mechanically tuned 3 dimensional hydrogels support human mammary fibroblast growth and viability. |
Q91999628 | Mechanism for oral tumor cell lysyl oxidase like-2 in cancer development: synergy with PDGF-AB |
Q38872160 | Mechanism of irradiation-induced mammary cancer metastasis: A role for SAP-dependent Mkl1 signaling |
Q38819710 | Mechanisms of Perineural Invasion |
Q33755906 | Mechanisms of disease: epithelial-mesenchymal transition--does cellular plasticity fuel neoplastic progression? |
Q29620307 | Mechanisms of fibrosis: therapeutic translation for fibrotic disease |
Q34972161 | Mechanisms of resistance to anti-angiogenic therapy and development of third-generation anti-angiogenic drug candidates |
Q28070094 | Mechanisms of the alternative activation of macrophages and non-coding RNAs in the development of radiation-induced lung fibrosis |
Q50089395 | Mechanisms regulating T-cell infiltration and activity in solid tumors. |
Q88697944 | Mechanisms that drive inflammatory tumor microenvironment, tumor heterogeneity, and metastatic progression |
Q37766260 | Mechanistic insights into acquired drug resistance in epidermal growth factor receptor mutation-targeted lung cancer therapy |
Q35877893 | Mechanobiology of tumor invasion: engineering meets oncology |
Q37331580 | Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. |
Q36918170 | Melanoma Cells Block PEDF Production in Fibroblasts to Induce the Tumor-Promoting Phenotype of Cancer-Associated Fibroblasts |
Q39459200 | Melanoma cells control HA synthesis in peritumoral fibroblasts via PDGF-AA and PDGF-CC: impact on melanoma cell proliferation |
Q39466119 | Melanoma miRNA trafficking controls tumour primary niche formation |
Q37469815 | Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity |
Q35067933 | Melanoma-initiating cells exploit M2 macrophage TGFβ and arginase pathway for survival and proliferation. |
Q33880433 | Membrane type 1 matrix metalloproteinase-mediated stromal syndecan-1 shedding stimulates breast carcinoma cell proliferation |
Q37702090 | Membrane-bound ICAM-1 contributes to the onset of proinvasive tumor stroma by controlling acto-myosin contractility in carcinoma-associated fibroblasts |
Q28084572 | Membrane-to-Nucleus Signals and Epigenetic Mechanisms for Myofibroblastic Activation and Desmoplastic Stroma: Potential Therapeutic Targets for Liver Metastasis? |
Q28383835 | Meningeal norepinephrine produces headache behaviors in rats via actions both on dural afferents and fibroblasts |
Q37156520 | Mesenchymal CD44 expression contributes to the acquisition of an activated fibroblast phenotype via TWIST activation in the tumor microenvironment |
Q37674735 | Mesenchymal Stem Cell-Induced DDR2 Mediates Stromal-Breast Cancer Interactions and Metastasis Growth |
Q27305351 | Mesenchymal Stem Cells Induce Directional Migration of Invasive Breast Cancer Cells through TGF-β |
Q51703464 | Mesenchymal Stem Cells are Recruited and Activated into Carcinoma-Associated Fibroblasts by Prostate Cancer Microenvironment-Derived TGF-β1. |
Q93047604 | Mesenchymal Stem/Stromal Cell Engulfment Reveals Metastatic Advantage in Breast Cancer |
Q55235695 | Mesenchymal Stromal Cells: Emerging Roles in Bone Metastasis. |
Q37125569 | Mesenchymal cells of the intestinal lamina propria |
Q33753147 | Mesenchymal cells stimulate capillary morphogenesis via distinct proteolytic mechanisms. |
Q37921954 | Mesenchymal niches of bone marrow in cancer |
Q33427809 | Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression |
Q38736947 | Mesenchymal stem cells as a double-edged sword in suppression or progression of solid tumor cells |
Q26853374 | Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment |
Q60203690 | Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors |
Q49673155 | Mesenchymal stem cells in breast cancer: response to chemical and mechanical stimuli. |
Q39250469 | Mesenchymal stem cells regulate epithelial-mesenchymal transition and tumor progression of pancreatic cancer cells |
Q37358415 | Mesenchymal stem cells: the fibroblasts' new clothes? |
Q37395883 | Mesenchymal stroma: primary determinant and therapeutic target for epithelial cancer |
Q37645095 | Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response? |
Q90683248 | Mesenchymal stromal cells in cancer: a review of their immunomodulatory functions and dual effects on tumor progression |
Q39265746 | Metabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy. |
Q26786595 | Metabolic reprogramming: the emerging concept and associated therapeutic strategies |
Q44123534 | Metabolism targeting therapy of dichloroacetate-loaded electrospun mats on colorectal cancer |
Q42315708 | Metallic nanoparticles reduce the migration of human fibroblasts in vitro |
Q51416828 | Metastasis in context: modeling the tumor microenvironment with cancer-on-a-chip approaches. |
Q38776120 | Metastasized lung cancer suppression by Morinda citrifolia (Noni) leaf compared to Erlotinib via anti-inflammatory, endogenous antioxidant responses and apoptotic gene activation. |
Q35580080 | Metastatic breast cancer cells in lymph nodes increase nodal collagen density |
Q41528278 | Metastatic outgrowth encompasses COL-I, FN1, and POSTN up-regulation and assembly to fibrillar networks regulating cell adhesion, migration, and growth |
Q35019643 | Methylation determines fibroblast activation and fibrogenesis in the kidney |
Q37500307 | Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells. |
Q38721848 | MiR-124 down-regulation is critical for cancer associated fibroblasts-enhanced tumor growth of oral carcinoma |
Q47118717 | MiR-205/YAP1 in Activated Fibroblasts of Breast Tumor Promotes VEGF-independent Angiogenesis through STAT3 Signaling |
Q35155103 | MiR-21 expression in the tumor stroma of oral squamous cell carcinoma: an independent biomarker of disease free survival |
Q33907195 | MiR-302c inhibits tumor growth of hepatocellular carcinoma by suppressing the endothelial-mesenchymal transition of endothelial cells |
Q37745389 | MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2. |
Q27010255 | MicroRNA regulation in cancer-associated fibroblasts |
Q38240791 | MicroRNA regulons in tumor microenvironment. |
Q38993513 | MicroRNA-106b in cancer-associated fibroblasts from gastric cancer promotes cell migration and invasion by targeting PTEN. |
Q35051479 | MicroRNA-143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer |
Q93087093 | MicroRNA-222 reprogrammed cancer-associated fibroblasts enhance growth and metastasis of breast cancer |
Q90403264 | MicroRNA-27a (miR-27a) in Solid Tumors: A Review Based on Mechanisms and Clinical Observations |
Q38418114 | MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment |
Q39676479 | MicroRNAs as molecular classifiers for cancer |
Q36493077 | MicroRNAs play a big role in regulating ovarian cancer-associated fibroblasts and the tumor microenvironment |
Q54484920 | Microarray analysis of Dupuytren's disease cells: the profibrogenic role of the TGF-β inducible p38 MAPK pathway. |
Q35866337 | Microencapsulation of Neuroblastoma Cells and Mesenchymal Stromal Cells in Collagen Microspheres: A 3D Model for Cancer Cell Niche Study |
Q38810462 | Microengineered cancer-on-a-chip platforms to study the metastatic microenvironment |
Q37022156 | Microengineered tumor models: insights & opportunities from a physical sciences-oncology perspective |
Q30464008 | Microengineering methods for cell-based microarrays and high-throughput drug-screening applications |
Q38913083 | Microenvironment drug resistance in multiple myeloma: emerging new players |
Q39062505 | Microenvironment in determining chemo-resistance in pancreatic cancer: Neighborhood matters. |
Q38588066 | Microenvironment in metastasis: roadblocks and supportive niches |
Q36743563 | Microenvironment of the involuting mammary gland mediates mammary cancer progression |
Q33786788 | Microenvironment, oncoantigens, and antitumor vaccination: lessons learned from BALB-neuT mice |
Q37679978 | Microenvironment-dependent cues trigger miRNA-regulated feedback loop to facilitate the EMT/MET switch. |
Q52660791 | Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling. |
Q37439314 | Microenvironmental independence associated with tumor progression |
Q34444593 | Microenvironmental influences that drive progression from benign breast disease to invasive breast cancer |
Q29547660 | Microenvironmental regulation of metastasis |
Q43169264 | Microenvironmental regulation of the progression of oral potentially malignant disorders towards malignancy |
Q33654609 | Microenvironmental regulation of therapeutic response in cancer |
Q29615504 | Microenvironmental regulation of tumor progression and metastasis |
Q37100566 | Migratory neighbors and distant invaders: tumor-associated niche cells |
Q37091367 | Mimicking Metastases Including Tumor Stroma: A New Technique to Generate a Three-Dimensional Colorectal Cancer Model Based on a Biological Decellularized Intestinal Scaffold |
Q40512512 | Mitochondrial Oxidative Stress due to Complex I Dysfunction Promotes Fibroblast Activation and Melanoma Cell Invasiveness. |
Q46362794 | Model of vascular desmoplastic multispecies tumor growth |
Q53037013 | Modeling Breast Tumor Development with a Humanized Mouse Model. |
Q26800085 | Modes of cancer cell invasion and the role of the microenvironment |
Q37090422 | Modulated expression of WFDC1 during carcinogenesis and cellular senescence |
Q47315881 | Modulating secreted components of tumor microenvironment: A masterstroke in tumor therapeutics. |
Q34053962 | Modulation of TNF-induced macrophage polarization by synovial fibroblasts. |
Q39391322 | Modulation of tumor microenvironment by chemopreventive natural products |
Q57802920 | Molecular Mechanisms of Long Noncoding RNAs-medicated Cancer Metastasis |
Q38869424 | Molecular Targeting of Integrins and Integrin-Associated Signaling Networks in Radiation Oncology. |
Q38077373 | Molecular communication between tumor-associated fibroblasts and head and neck squamous cell carcinoma |
Q96952383 | Molecular dissection of CRC primary tumors and their matched liver metastases reveals critical role of immune microenvironment, EMT and angiogenesis in cancer metastasis |
Q38354860 | Molecular mechanism underlying the tumor-promoting functions of carcinoma-associated fibroblasts. |
Q37918848 | Molecular mechanisms of liver metastasis |
Q34065560 | Molecular pathogenesis of cholangiocarcinoma |
Q34775377 | Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma |
Q34770823 | Molecular profiling predicts the existence of two functionally distinct classes of ovarian cancer stroma |
Q26751709 | Molecular therapeutics in pancreas cancer |
Q34190300 | Morphometric characteristics of basal cell carcinoma peritumoral stroma varies among basal cell carcinoma subtypes |
Q36602578 | Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects |
Q41664785 | Mouse models of metastasis: progress and prospects. |
Q79988524 | Mucinous cystadenocarcinoma of the pancreas developing during hormone replacement therapy |
Q38688450 | Mueller polarimetric imaging for surgical and diagnostic applications: a review |
Q33737136 | Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1. |
Q26741948 | Multidimensional Complexity of Cancer. Simple Solutions Are Needed |
Q38045226 | Multifaceted roles of PGE2 in inflammation and cancer |
Q36284975 | Multifaceted tumor stromal fibroblasts |
Q27005678 | Multifocal epithelial tumors and field cancerization: stroma as a primary determinant |
Q36374096 | Multigenerational epigenetic adaptation of the hepatic wound-healing response |
Q33360100 | Multiple actions of lysophosphatidic acid on fibroblasts revealed by transcriptional profiling |
Q36307634 | Multistage vector (MSV) therapeutics |
Q64067726 | Muscle functions as a connective tissue and source of extracellular matrix in planarians |
Q41818426 | Myeloid-derived suppressor cells and associated events in urethane-induced lung cancer |
Q39450591 | Myofibroblast-derived PDGF-BB promotes Hedgehog survival signaling in cholangiocarcinoma cells |
Q54195617 | Myofibroblasts from salivary gland adenoid cystic carcinomas promote cancer invasion by expressing MMP2 and CXCL12. |
Q36840263 | Myofibroblasts in pulmonary and brain metastases of alveolar soft-part sarcoma: a novel target for treatment? |
Q27692541 | Myofibroblasts: trust your heart and let fate decide. |
Q98943964 | Myxoid stroma is associated with postoperative relapse in patients with stage II colon cancer |
Q37395723 | NLRC4 suppresses melanoma tumor progression independently of inflammasome activation |
Q36001853 | NOTCH3 Is Induced in Cancer-Associated Fibroblasts and Promotes Angiogenesis in Oral Squamous Cell Carcinoma |
Q36771836 | NOVA1 inhibition by miR-146b-5p in the remnant tissue microenvironment defines occult residual disease after gastric cancer removal. |
Q64098474 | Nano-Strategies to Target Breast Cancer-Associated Fibroblasts: Rearranging the Tumor Microenvironment to Achieve Antitumor Efficacy |
Q92832813 | Nano-mechanical mapping of interdependent cell and ECM mechanics by AFM force spectroscopy |
Q39380111 | Nanoformulations for combination or cascade anticancer therapy. |
Q48646732 | Nanomaterials for cancer immunotherapy. |
Q37693046 | Nanoparticles containing insoluble drug for cancer therapy |
Q33804264 | Nanotechniques Inactivate Cancer Stem Cells |
Q59807976 | Natural Products to Fight Cancer: A Focus on Juglans regia |
Q64081261 | Neddylation: a novel modulator of the tumor microenvironment |
Q37118737 | Negative control of CSL gene transcription by stress/DNA damage response and p53. |
Q41129667 | Nemosis of fibroblasts is inhibited by benign HaCaT keratinocytes but promoted by malignant HaCaT cells |
Q37418297 | Nemosis, a novel way of fibroblast activation, in inflammation and cancer |
Q35969445 | Neoangiogenesis. Assessment in Esophageal Adenocarcinomas |
Q43627381 | Neonatal human dermal fibroblasts immobilized in RGD-alginate induce angiogenesis. |
Q36618752 | Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress |
Q64891197 | Neuropilin-1 aggravates liver cirrhosis by promoting angiogenesis via VEGFR2-dependent PI3K/Akt pathway in hepatic sinusoidal endothelial cells. |
Q30495328 | Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF/TGF-beta signaling in hepatic stellate cells |
Q50042197 | New Insights into the Tumor Microenvironment Utilizing Protein Array Technology. |
Q34382914 | New advances on critical implications of tumor- and metastasis-initiating cells in cancer progression, treatment resistance and disease recurrence |
Q42239363 | New and paradoxical roles of matrix metalloproteinases in the tumor microenvironment. |
Q37860751 | Niche contributions to oncogenesis: emerging concepts and implications for the hematopoietic system |
Q35073159 | Niche-dependent gene expression profile of intratumoral heterogeneous ovarian cancer stem cell populations |
Q37099675 | Niemann-pick type C2 deficiency in human fibroblasts confers robust and selective activation of prostaglandin E2 biosynthesis. |
Q89519070 | Nintedanib inhibits intrahepatic cholangiocarcinoma aggressiveness via suppression of cytokines extracted from activated cancer-associated fibroblasts |
Q43158982 | Nintedanib selectively inhibits the activation and tumour-promoting effects of fibroblasts from lung adenocarcinoma patients. |
Q35670576 | Nintedanib, a triple angiokinase inhibitor, enhances cytotoxic therapy response in pancreatic cancer. |
Q36891506 | Nitric oxide regulates tumor cell cross-talk with stromal cells in the tumor microenvironment of the liver |
Q28581539 | Nkx2.5/Csx represses myofibroblast differentiation |
Q33507097 | Non-Linear Optical Imaging of Obesity-Related Health Risks: Review |
Q33761396 | Non-glycanated Decorin Is a Drug Target on Human Adipose Stromal Cells |
Q59327125 | Non-hematopoietic Control of Peripheral Tissue T Cell Responses: Implications for Solid Tumors |
Q51021428 | Non-small-cell lung cancer. |
Q27304413 | Noninvasive In-Vivo Quantification of Mechanical Heterogeneity of Invasive Breast Carcinomas |
Q42434242 | Norepinephrine promotes tumor microenvironment reactivity through β3-adrenoreceptors during melanoma progression |
Q37157064 | Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription |
Q30542073 | Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers |
Q90668015 | Not gene therapy, but genetic surgery-the right strategy to attack cancer |
Q41848834 | Notch1-WISP-1 axis determines the regulatory role of mesenchymal stem cell-derived stromal fibroblasts in melanoma metastasis |
Q26824909 | Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials |
Q42144287 | Novel mechanism of cardiac protection by valsartan: synergetic roles of TGF-β1 and HIF-1α in Ang II-mediated fibrosis after myocardial infarction |
Q30360377 | Novel regulatory role of neuropilin-1 in endothelial-to-mesenchymal transition and fibrosis in pancreatic ductal adenocarcinoma |
Q39456875 | Nutrient Exploitation within the Tumor-Stroma Metabolic Crosstalk |
Q28067777 | Ockham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer |
Q39642324 | Old proteins - new locations: myoglobin, haemoglobin, neuroglobin and cytoglobin in solid tumours and cancer cells. |
Q47571257 | On the mechanism of long-range orientational order of fibroblasts |
Q39016730 | Optimization of liquid overlay technique to formulate heterogenic 3D co-cultures models |
Q35210099 | Optimizing a 3D Culture System to Study the Interaction between Epithelial Breast Cancer and Its Surrounding Fibroblasts |
Q38905001 | Organ-on-a-Chip Systems: Microengineering to Biomimic Living Systems |
Q36837236 | Organotypic models of metastasis: A three-dimensional culture mimicking the human peritoneum and omentum for the study of the early steps of ovarian cancer metastasis |
Q52429973 | Organotypic three-dimensional assays based on human leiomyoma-derived matrices. |
Q37628341 | Origin of cardiac fibroblasts and the role of periostin |
Q37716879 | Origin, development, and differentiation of cardiac fibroblasts |
Q34994026 | Origins of cardiac fibroblasts |
Q26749570 | Osteopontin-A Master Regulator of Epithelial-Mesenchymal Transition |
Q49631372 | Osteopontin-integrin engagement induces HIF-1α-TCF12-mediated endothelial-mesenchymal transition to exacerbate colorectal cancer. |
Q36311002 | Osteopontin-integrin interaction as a novel molecular target for antibody-mediated immunotherapy in adult T-cell leukemia |
Q98208978 | Osterix-Cre marks distinct subsets of CD45- and CD45+ stromal populations in extra-skeletal tumors with pro-tumorigenic characteristics |
Q95840383 | Ovarian Cancer Exosomes Trigger Differential Biophysical Response in Tumor-Derived Fibroblasts |
Q37033701 | Ovarian normal and tumor-associated fibroblasts retain in vivo stromal characteristics in a 3-D matrix-dependent manner |
Q53739678 | Overcoming the tumor microenvironment: the role of nanohyperthermia. |
Q35032539 | Overexpression of COL11A1 by cancer-associated fibroblasts: clinical relevance of a stromal marker in pancreatic cancer |
Q37677701 | Overexpression of caveolin-1 in cancer-associated fibroblasts predicts good outcome in breast cancer |
Q36780735 | Overexpression of monocarboxylate anion transporter 1 and 4 in T24-induced cancer-associated fibroblasts regulates the progression of bladder cancer cells in a 3D microfluidic device |
Q80569126 | Overexpression of myocyte enhancer factor 2 and histone hyperacetylation in hepatocellular carcinoma |
Q36516942 | Overview of human primary tumorgraft models: comparisons with traditional oncology preclinical models and the clinical relevance and utility of primary tumorgrafts in basic and translational oncology research |
Q24619475 | Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells |
Q36039273 | Oxidative stress promotes myofibroblast differentiation and tumour spreading |
Q42178112 | Oxidative stress, tumor microenvironment, and metabolic reprogramming: a diabolic liaison |
Q52664220 | P-Selectin Sustains Extramedullary Hematopoiesis in the Gata1 low Model of Myelofibrosis. |
Q34746645 | P190B RhoGAP overexpression in the developing mammary epithelium induces TGFβ-dependent fibroblast activation |
Q89907649 | P53 Mutant p53N236S Regulates Cancer-Associated Fibroblasts Properties Through Stat3 Pathway |
Q52723837 | PAI1 mediates fibroblast-mast cell interactions in skin fibrosis. |
Q34778528 | PARP-1 regulates metastatic melanoma through modulation of vimentin-induced malignant transformation. |
Q35147563 | PARVA promotes metastasis by modulating ILK signalling pathway in lung adenocarcinoma |
Q92960661 | PD-L1 Induction by Cancer-Associated Fibroblast-Derived Factors in Lung Adenocarcinoma Cells |
Q39433494 | PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells |
Q58803894 | PDGF/PDGFR effects in osteosarcoma and the "add-on" strategy |
Q36003190 | PDGFRβ Is a Novel Marker of Stromal Activation in Oral Squamous Cell Carcinomas |
Q83610980 | PDGFRβ expression in tumor stroma of pancreatic adenocarcinoma as a reliable prognostic marker |
Q53263829 | PGRN promotes migration and invasion of epithelial ovarian cancer cells through an epithelial mesenchymal transition program and the activation of cancer associated fibroblasts. |
Q89991493 | PIK3Cδ expression by fibroblasts promotes triple-negative breast cancer progression |
Q39924024 | PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production |
Q33418311 | PTCH1 +/- dermal fibroblasts isolated from healthy skin of Gorlin syndrome patients exhibit features of carcinoma associated fibroblasts |
Q38629644 | PTEN and PI3K/AKT in non-small-cell lung cancer. |
Q38447860 | PTRF/cavin-1 neutralizes non-caveolar caveolin-1 microdomains in prostate cancer |
Q91284099 | PU.1 controls fibroblast polarization and tissue fibrosis |
Q38850479 | Palladin mediates stiffness-induced fibroblast activation in the tumor microenvironment |
Q40001815 | Pancreatic cancer associated fibroblasts display normal allelotypes. |
Q39781987 | Pancreatic cancer cells activate CCL5 expression in mesenchymal stromal cells through the insulin-like growth factor-I pathway |
Q64462058 | Partial reprogramming induces a steady decline in epigenetic age before loss of somatic identity |
Q34656747 | Pathogenesis, diagnosis, and management of cholangiocarcinoma |
Q36888327 | Pazopanib inhibits the activation of PDGFRβ-expressing astrocytes in the brain metastatic microenvironment of breast cancer cells |
Q38912989 | Peptide assembly integration of fibroblast-targeting and cell-penetration features for enhanced antitumor drug delivery |
Q64058113 | Peri-tumor fibroblasts promote tumorigenesis and metastasis of hepatocellular carcinoma via Interleukin6/STAT3 signaling pathway |
Q37281490 | Pericyte-fibroblast transition promotes tumor growth and metastasis. |
Q92421258 | Pericytes in Metastasis |
Q57801748 | Periostin secreted by cancer-associated fibroblasts promotes cancer stemness in head and neck cancer by activating protein tyrosine kinase 7 |
Q34519639 | Periostin suppression induces decorin secretion leading to reduced breast cancer cell motility and invasion |
Q35915338 | Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma |
Q37128159 | Perivascular fibroblasts form the fibrotic scar after contusive spinal cord injury |
Q55078362 | Persistent DNA strand breaks induce a CAF-like phenotype in normal fibroblasts. |
Q27012236 | Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma |
Q37604680 | Persistent stromal fibroblast activation is present in chronic tendinopathy. |
Q38549236 | Perspective of Targeting Cancer-Associated Fibroblasts in Melanoma |
Q30443756 | Perspective: Flicking with flow: Can microfluidics revolutionize the cancer research? |
Q90432246 | Perspective: bidirectional exosomal transport between cancer stem cells and their fibroblast-rich microenvironment during metastasis formation |
Q60951233 | Phage Ligands for Identification of Mesenchymal-Like Breast Cancer Cells and Cancer-Associated Fibroblasts |
Q92364940 | Phage display screening of therapeutic peptide for cancer targeting and therapy |
Q54346614 | Phosphatidylinositol 5-phosphate regulates invasion through binding and activation of Tiam1. |
Q37411837 | Photodynamic molecular beacon triggered by fibroblast activation protein on cancer-associated fibroblasts for diagnosis and treatment of epithelial cancers |
Q89389704 | Photosensitizer-Encapsulated Ferritins Mediate Photodynamic Therapy against Cancer-Associated Fibroblasts and Improve Tumor Accumulation of Nanoparticles |
Q37746085 | Physico-mechanical aspects of extracellular matrix influences on tumorigenic behaviors |
Q38582873 | Physiological, Tumor, and Metastatic Niches: Opportunities and Challenges for Targeting the Tumor Microenvironment |
Q37711835 | Physiologically activated mammary fibroblasts promote postpartum mammary cancer |
Q36123584 | Physiology of the Renal Interstitium |
Q35384921 | Pituitary tumor transforming gene induces epithelial to mesenchymal transition by regulation of Twist, Snail, Slug, and E-cadherin |
Q40884698 | Plasticity of fibroblasts demonstrated by tissue-specific and function-related proteome profiling |
Q38963431 | Plasticity of tumor cell invasion: governance by growth factors and cytokines. |
Q34044638 | Platelet-derived growth factor primes cancer-associated fibroblasts for apoptosis. |
Q39179249 | Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma |
Q39410987 | Pleiotropic Roles of Non-Coding RNAs in TGF-β-Mediated Epithelial-Mesenchymal Transition and Their Functions in Tumor Progression |
Q26749146 | Podoplanin - a small glycoprotein with many faces |
Q85475870 | Podoplanin expressing cancer associated fibroblasts are associated with unfavourable prognosis in adenocarcinoma of the esophagus |
Q53027845 | Podoplanin expressing cancer-associated fibroblasts in oral cancer. |
Q37562162 | Podoplanin expression in cancer-associated fibroblasts enhances tumor progression of invasive ductal carcinoma of the pancreas. |
Q88207901 | Podoplanin expression in the cyst wall correlates with the progression of intraductal papillary mucinous neoplasm |
Q64273058 | Podoplanin in Inflammation and Cancer |
Q42362588 | Podoplanin increases the migration of human fibroblasts and affects the endothelial cell network formation: A possible role for cancer-associated fibroblasts in breast cancer progression. |
Q52670614 | Podoplanin-positive cancer-associated fibroblast recruitment within cancer stroma is associated with a higher number of single nucleotide variants in cancer cells in lung adenocarcinoma. |
Q28275310 | Podoplanin: emerging functions in development, the immune system, and cancer |
Q38893743 | Polo-like kinase 3 is associated with improved overall survival in cholangiocarcinoma. |
Q64930888 | Poorly Differentiated Clusters Predict Colon Cancer Recurrence: An In-Depth Comparative Analysis of Invasive-Front Prognostic Markers. |
Q37866794 | Potential of CXCR4 antagonists for the treatment of metastatic lung cancer |
Q34786543 | Potential therapeutic effect of the secretome from human uterine cervical stem cells against both cancer and stromal cells compared with adipose tissue stem cells |
Q49196561 | Preclinical rationale for TGF-β inhibition as a therapeutic target for the treatment of myelofibrosis. |
Q52553452 | Preparation-related structural diversity and medical potential in the treatment of diabetes mellitus with ginseng pectins. |
Q35945448 | Presence of cancer-associated fibroblasts inversely correlates with Schwannian stroma in neuroblastoma tumors |
Q57144510 | Present and future of cancer immunotherapy: A tumor microenvironmental perspective |
Q42454757 | Primary breast tumor-derived cellular models: characterization of tumorigenic, metastatic, and cancer-associated fibroblasts in dissociated tumor (DT) cultures |
Q34141711 | Primary cilia are decreased in breast cancer: analysis of a collection of human breast cancer cell lines and tissues |
Q49646730 | Primed atypical ductal hyperplasia-associated fibroblasts promote cell growth and polarity changes of transformed epithelium-like breast cancer MCF-7 cells via miR-200b/c-IKKβ signaling. |
Q38232067 | Priming cancer cells for drug resistance: role of the fibroblast niche |
Q48095809 | Pro-metastatic collagen lysyl hydroxylase dimer assemblies stabilized by Fe2+-binding. |
Q38059502 | Pro-metastatic tumor-stroma interactions in breast cancer. |
Q34384216 | Probing biological nanotopology via diffusion of weakly constrained plasmonic nanorods with optical coherence tomography |
Q39365067 | Probing the role of mesenchymal stem cells in salivary gland cancer on biomimetic microdevices |
Q38785389 | Profiling lung adenocarcinoma by liquid biopsy: can one size fit all? |
Q41503155 | Prognostic Impact of Extracapsular Lymph Node Invasion and Myofibroblastic Activity in Extrahepatic Bile Duct Cancer |
Q41371061 | Prognostic Value of Metastatic Tumoral Caveolin-1 Expression in Patients with Resected Gastric Cancer |
Q41880628 | Prognostic and functional role of subtype-specific tumor-stroma interaction in breast cancer |
Q92037295 | Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma |
Q30499935 | Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer |
Q34658302 | Prognostic impact of histological categorisation of epithelial-mesenchymal transition in colorectal cancer |
Q43646189 | Prognostic impact of tumoral and/or peri-tumoral stromal SPARC expressions after surgery in patients with biliary tract cancer |
Q49178361 | Prognostic significance of E-cadherin and ZEB1 expression in intraductal papillary mucinous neoplasm. |
Q48010220 | Prognostic significance of carbonic anhydrase IX expression by cancer-associated fibroblasts in lung adenocarcinoma |
Q37257191 | Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer |
Q104795283 | Prognostic value of desmoplastic reaction characterisation in stage II colon cancer: prospective validation in a Phase 3 study (SACURA Trial) |
Q50352443 | Prognostic value of fibrosis ratio in metastatic lymph nodes of node-positive advanced gastric cancer. |
Q99551776 | Prognostic values of EDNRB in triple-negative breast cancer |
Q98771735 | Progress in Neoantigen Targeted Cancer Immunotherapies |
Q39202934 | Progression of genotype-specific oral cancer leads to senescence of cancer-associated fibroblasts and is mediated by oxidative stress and TGF-β. |
Q36257609 | Progressive Enrichment of Stemness Features and Tumor Stromal Alterations in Multistep Hepatocarcinogenesis |
Q36413420 | Prokineticin 2 (PROK2) is an important factor for angiogenesis in colorectal cancer |
Q84094346 | Proliferation of myofibroblasts in the stroma of renal oncocytoma |
Q34929340 | Pronounced cancer resistance in a subterranean rodent, the blind mole-rat, Spalax: in vivo and in vitro evidence. |
Q60960769 | Prospective Evaluation of Unprocessed Core Needle Biopsy DNA and RNA Yield from Lung, Liver, and Kidney Tumors: Implications for Cancer Genomics |
Q49401353 | Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors. |
Q50035774 | Prospects to improve chimeric antigen receptor T-cell therapy for solid tumors. |
Q38951674 | Prostanoid induces premetastatic niche in regional lymph nodes |
Q38668605 | Prostate cancer stem cells: from theory to practice. |
Q41535142 | Prostate stromal cell proteomics analysis discriminates normal from tumour reactive stromal phenotypes. |
Q37286948 | Protease-activated receptor-1 is upregulated in reactive stroma of primary prostate cancer and bone metastasis |
Q42746302 | Protein kinase c-β-dependent activation of NF-κB in stromal cells is indispensable for the survival of chronic lymphocytic leukemia B cells in vivo. |
Q54689509 | Protein pathway biomarker analysis of human cancer reveals requirement for upfront cellular-enrichment processing. |
Q37636855 | Proteoglycans: master modulators of paracrine fibroblast-carcinoma cell interactions |
Q35987073 | Proteomic signatures of the desmoplastic invasion front reveal collagen type XII as a marker of myofibroblastic differentiation during colorectal cancer metastasis |
Q52936872 | Proteomics analysis of malignant and benign prostate tissue by 2D DIGE/MS reveals new insights into proteins involved in prostate cancer. |
Q37399478 | Pten in stromal fibroblasts suppresses mammary epithelial tumours |
Q34786718 | Pten in the breast tumor microenvironment: modeling tumor-stroma coevolution. |
Q34626008 | Pulse-chase analysis of procollagen biosynthesis by azidohomoalanine labeling. |
Q34124481 | Pyruvate kinase expression (PKM1 and PKM2) in cancer-associated fibroblasts drives stromal nutrient production and tumor growth |
Q42277124 | Quantification of Mesenchymal Stem Cells (MSCs) at sites of human prostate cancer |
Q48206682 | Quantification of altered tissue turnover in a liquid biopsy: a proposed precision medicine tool to assess chronic inflammation and desmoplasia associated with a pro-cancerous niche and response to immuno-therapeutic anti-tumor modalities. |
Q30275479 | Quantitative Analysis of the Cellular Microenvironment of Glioblastoma to Develop Predictive Statistical Models of Overall Survival |
Q34145178 | Quantitative analysis of the secretome of TGF-beta signaling-deficient mammary fibroblasts |
Q44071623 | Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling |
Q61445563 | Quantitative phase imaging reveals matrix stiffness-dependent growth and migration of cancer cells |
Q55317564 | Quantitative phosphoproteomic analysis reveals reciprocal activation of receptor tyrosine kinases between cancer epithelial cells and stromal fibroblasts. |
Q59912703 | Quantitative proteomic profiling of primary cancer-associated fibroblasts in oesophageal adenocarcinoma |
Q37021841 | Quantitative spectroscopic imaging for non-invasive early cancer detection |
Q94586098 | Quantitative stain-free imaging and digital profiling of collagen structure reveal diverse survival of triple negative breast cancer patients |
Q38601575 | RETRACTED ARTICLE: Sorcin Predicts Poor Prognosis and Promotes Metastasis by Facilitating Epithelial-mesenchymal Transition in Hepatocellular Carcinoma |
Q21245504 | Rac and Rho GTPases in cancer cell motility control |
Q37382515 | Radiation promotes epithelial-to-mesenchymal transition and invasion of pancreatic cancer cell by activating carcinoma-associated fibroblasts |
Q27022685 | Radiotherapy and the tumor stroma: the importance of dose and fractionation |
Q96639861 | Radiotherapy targeting cancer stem cells "awakens" them to induce tumour relapse and metastasis in oral cancer |
Q28077930 | Reactive oxygen species and fibrosis: further evidence of a significant liaison |
Q53421985 | Reactive stroma in the prostate during late life: The role of microvasculature and antiangiogenic therapy influences. |
Q26797285 | Recapitulating the Tumor Ecosystem Along the Metastatic Cascade Using 3D Culture Models |
Q37620476 | Recent Advances in Understanding, Diagnosing, and Treating Ovarian Cancer. |
Q38111793 | Recent advances in understanding inflammation and remodeling in the airways in chronic obstructive pulmonary disease |
Q64100317 | Recent advances in understanding tumor stroma-mediated chemoresistance in breast cancer |
Q33730375 | Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies |
Q37089825 | Recent progress on tissue-resident adult stem cell biology and their therapeutic implications |
Q30300159 | Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity. |
Q34558918 | Reciprocal interaction between carcinoma-associated fibroblasts and squamous carcinoma cells through interleukin-1α induces cancer progression |
Q58092065 | Reciprocal reprogramming of cancer cells and associated Mesenchymal Stem Cells in gastric cancer |
Q35662257 | Recruitment of Matrix Metalloproteinase-9 (MMP-9) to the Fibroblast Cell Surface by Lysyl Hydroxylase 3 (LH3) Triggers Transforming Growth Factor-β (TGF-β) Activation and Fibroblast Differentiation |
Q53164626 | Recruitment of podoplanin positive cancer-associated fibroblasts in metastatic lymph nodes predicts poor prognosis in pathological N2 stage III lung adenocarcinoma. |
Q26786129 | Redox-fibrosis: Impact of TGFβ1 on ROS generators, mediators and functional consequences |
Q38383375 | Redox-sensitive mechanisms underlying vascular dysfunction in heart failure |
Q37408293 | Reduced CX3CL1 Secretion Contributes to the Susceptibility of Oral Leukoplakia-Associated Fibroblasts to Candida albicans |
Q37293806 | Reduced Contractility and Motility of Prostatic Cancer-Associated Fibroblasts after Inhibition of Heat Shock Protein 90 |
Q28647000 | Registered report: Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis |
Q34268182 | Regulation of ROCK1 via Notch1 during breast cancer cell migration into dense matrices. |
Q37590325 | Regulation of angiogenesis in malignancies associated with Epstein-Barr virus and Kaposi's sarcoma-associated herpes virus |
Q26862059 | Regulation of endothelial cell plasticity by TGF-β |
Q35748219 | Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway |
Q33734780 | Regulation of tumor growth and metastasis: the role of tumor microenvironment |
Q38948512 | Regulatory T Cells and Cancer: A Two-Sided Story |
Q38928127 | Regulatory circuits of T cell function in cancer |
Q33609069 | Relationships of alpha-SMA-positive fibroblasts and SDF-1-positive tumor cells with neoangiogenesis in nasopharyngeal carcinoma |
Q36402018 | Release of TGFβig-h3 by gastric myofibroblasts slows tumor growth and is decreased with cancer progression. |
Q37016995 | Remodeling of tumor stroma and response to therapy |
Q38979314 | Reprogramming adult dermis to a neonatal state through epidermal activation of β-catenin |
Q36107831 | Reprogramming of Normal Fibroblasts into Cancer-Associated Fibroblasts by miRNAs-Mediated CCL2/VEGFA Signaling |
Q35729814 | Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320 |
Q28821190 | Repurposed drug screen identifies cardiac glycosides as inhibitors of TGF-β-induced cancer-associated fibroblast differentiation |
Q38633691 | Repurposing itraconazole as an anticancer agent |
Q44181118 | Resveratrol Regulates Colorectal Cancer Cell Invasion by Modulation of Focal Adhesion Molecules. |
Q99605264 | Resveratrol and Tumor Microenvironment: Mechanistic Basis and Therapeutic Targets |
Q84514067 | Retinoic acid enhances skeletal myogenesis in human embryonic stem cells by expanding the premyogenic progenitor population |
Q26771696 | Reversible Human TGF-β Signal Shifting between Tumor Suppression and Fibro-Carcinogenesis: Implications of Smad Phospho-Isoforms for Hepatic Epithelial-Mesenchymal Transitions |
Q38247899 | Review: Cell Dynamics in Malignant Pleural Effusions |
Q37189305 | Revisiting the biological roles of PAI2 (SERPINB2) in cancer |
Q37463413 | Revisiting the seed and soil in cancer metastasis |
Q34249114 | Rho GTPases RhoA and Rac1 mediate effects of dietary folate on metastatic potential of A549 cancer cells through the control of cofilin phosphorylation |
Q89587304 | Rho-ROCK Signaling in Normal Physiology and as a Key Player in Shaping the Tumor Microenvironment |
Q24631326 | Rho-associated kinases in tumorigenesis: re-considering ROCK inhibition for cancer therapy |
Q37682275 | RhoA knockout fibroblasts lose tumor-inhibitory capacity in vitro and promote tumor growth in vivo |
Q35970782 | Robotic production of cancer cell spheroids with an aqueous two-phase system for drug testing |
Q38970580 | Role of Endothelial Cells and Fibroblasts in Multiple Myeloma Angiogenic Switch |
Q64068152 | Role of Exosomes in Crosstalk Between Cancer-Associated Fibroblasts and Cancer Cells |
Q91674537 | Role of Helicobacter pylori infection in cancer-associated fibroblast-induced epithelial-mesenchymal transition in vitro |
Q52721968 | Role of Stromal Paracrine Signals in Proliferative Diseases of the Aging Human Prostate. |
Q40050341 | Role of a Preorganized Scaffold Presenting Four Residues of a GM-3 Lactone Mimetic on Melanoma Progression. |
Q36284948 | Role of bone marrow-derived cells in angiogenesis: focus on macrophages and pericytes |
Q28239062 | Role of cancer microenvironment in metastasis: focus on colon cancer |
Q92889830 | Role of cancer-associated fibroblasts in tumor structure, composition and the microenvironment in ovarian cancer |
Q36120825 | Role of chemokines in tumor growth |
Q34027977 | Role of constitutive behavior and tumor-host mechanical interactions in the state of stress and growth of solid tumors |
Q42917103 | Role of epithelial mesenchymal transition (EMT) in chronic obstructive pulmonary disease (COPD). |
Q29417845 | Role of epithelial-mesenchymal transition (EMT) and fibroblast function in cerium oxide nanoparticles-induced lung fibrosis |
Q35684545 | Role of estrogen receptor signaling in breast cancer metastasis |
Q47153204 | Role of metastasis-induced protein S100A4 in human non-tumor pathophysiologies. |
Q92366817 | Role of microRNAs in remodeling the tumor microenvironment (Review) |
Q33948361 | Role of non-coding RNAs in pancreatic cancer: the bane of the microworld |
Q26750359 | Role of nuclear receptors in breast cancer stem cells |
Q27003859 | Role of oxidative stress and the microenvironment in breast cancer development and progression |
Q33727318 | Role of soluble guanylyl cyclase-cyclic GMP signaling in tumor cell proliferation |
Q64974995 | Role of the Hippo Pathway in Fibrosis and Cancer. |
Q38083596 | Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease |
Q37769582 | Role of the metastasis-promoting protein osteopontin in the tumour microenvironment |
Q36625697 | Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma |
Q38207013 | Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma |
Q37596178 | Role of the tumor microenvironment in the pathogenesis of gastric carcinoma |
Q39726007 | Role of tumor associated fibroblasts in human liver regeneration, cirrhosis, and cancer |
Q55078149 | Role of tumor microenvironment in ovarian cancer pathobiology. |
Q58724750 | Role of tumor microenvironment in the pathobiology of ovarian cancer: Insights and therapeutic opportunities |
Q39449113 | Role of tumor microenvironment in triple-negative breast cancer and its prognostic significance |
Q37738074 | Role of tumor microenvironment in tumorigenesis |
Q42828684 | Role of vasostatin-1 C-terminal region in fibroblast cell adhesion. |
Q37339711 | Roles of TGFbeta in metastasis |
Q34413441 | Roles of tumor suppressors in regulating tumor-associated inflammation |
Q34839397 | S100A4 expression in xenograft tumors of human carcinoma cell lines is induced by the tumor microenvironment |
Q36293908 | SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer. |
Q52841133 | SOCS1 inhibits migration and invasion of prostate cancer cells, attenuates tumor growth and modulates the tumor stroma. |
Q42831528 | SPARC enhances tumor stroma formation and prevents fibroblast activation |
Q37337322 | SPARCL1 suppresses metastasis in prostate cancer. |
Q30849602 | STAT3 can be activated through paracrine signaling in breast epithelial cells |
Q36169762 | STAT3-mediated IGF-2 secretion in the tumour microenvironment elicits innate resistance to anti-IGF-1R antibody |
Q64987986 | Salivary Glycine Is a Significant Predictor for the Attenuation of Polyp and Tumor Microenvironment Formation by Fucoxanthin in AOM/DSS Mice. |
Q36707153 | Scaffold-Free Coculture Spheroids of Human Colonic Adenocarcinoma Cells and Normal Colonic Fibroblasts Promote Tumorigenicity in Nude Mice. |
Q37583096 | Sclerosing adenosis and risk of breast cancer. |
Q36679133 | Second harmonic generation reveals matrix alterations during breast tumor progression |
Q37651981 | Secreted CLIC3 drives cancer progression through its glutathione-dependent oxidoreductase activity. |
Q82968978 | Secreted growth factors from stromal fibroblasts of the human lung and pancreatic carcinomas |
Q41844791 | Senescent cancer-associated fibroblasts secrete active MMP-2 that promotes keratinocyte dis-cohesion and invasion |
Q38968807 | Senescent stroma promotes prostate cancer progression: the role of miR-210. |
Q38731737 | Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma |
Q39187279 | Separation and cultivation of laryngeal carcinoma-associated fibroblasts and biological influence on a laryngeal carcinoma cell line |
Q41193853 | SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer. |
Q34998455 | Serum biomarkers reflecting specific tumor tissue remodeling processes are valuable diagnostic tools for lung cancer |
Q57463786 | Serum-derived carcinoembryonic antigen (CEA) activates fibroblasts to induce a local re-modeling of the extracellular matrix that favors the engraftment of CEA-expressing tumor cells |
Q38925157 | Signal transducer and activator of transcription 3 as a therapeutic target for cancer and the tumor microenvironment |
Q53530314 | Significance of Vascular Endothelial Growth Factor (VEGF)-C and VEGF-D in the Progression of Cutaneous Melanoma. |
Q36101233 | Significance of heparanase in cancer and inflammation |
Q37845923 | Significance of myofibroblasts in oral squamous cell carcinoma |
Q36357356 | Significance of tumor-associated stroma in promotion of intratumoral lymphangiogenesis: pivotal role of a hyaluronan-rich tumor microenvironment |
Q30412034 | Silencing of miR-148a in cancer-associated fibroblasts results in WNT10B-mediated stimulation of tumor cell motility |
Q41871186 | Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling |
Q33687149 | Simulating tumor microenvironment: changes in protein expression in an in vitro co-culture system |
Q87852511 | Simultaneous analysis of the gene expression profiles of cancer and stromal cells in endometrial cancer |
Q51361969 | Simultaneous blocking of IL-6 and IL-8 is sufficient to fully inhibit CAF-induced human melanoma cell invasiveness. |
Q90179380 | Single Tumor Cells With Epithelial-Like Morphology Are Associated With Breast Cancer Metastasis |
Q42373073 | Single cell dual adherent-suspension co-culture micro-environment for studying tumor-stromal interactions with functionally selected cancer stem-like cells |
Q38886389 | Single cell migration in oral squamous cell carcinoma - possible evidence of epithelial-mesenchymal transition in vivo |
Q40110840 | Single-chain Fv immunoliposomes for the targeting of fibroblast activation protein-expressing tumor stromal cells |
Q50533003 | Sipa1 deficiency unleashes a host-immune mechanism eradicating chronic myelogenous leukemia-initiating cells. |
Q41957111 | Sirtuin 1 suppresses nuclear factor κB induced transactivation and pro-inflammatory cytokine expression in cat fibroblast cells |
Q57385040 | Skin Cell Heterogeneity in Development, Wound Healing, and Cancer |
Q42677551 | Skin transcriptome reveals the intrinsic molecular mechanisms underlying hair follicle cycling in Cashmere goats under natural and shortened photoperiod conditions |
Q52341066 | Small proline-rich protein 2B drives stress-dependent p53 degradation and fibroblast proliferation in heart failure. |
Q37726232 | Small role with big impact: miRNAs as communicators in the cross-talk between cancer-associated fibroblasts and cancer cells |
Q57664399 | Smooth muscle actin-expressing stromal fibroblasts in head and neck squamous cell carcinoma: Increased expression of galectin-1 and induction of poor prognosis factors |
Q42288796 | Snail suppresses cellular senescence and promotes fibroblast-led cancer cell invasion |
Q34503198 | Somatic cell plasticity and Niemann-Pick type C2 protein: fibroblast activation |
Q37575859 | Sox10+ adult stem cells contribute to biomaterial encapsulation and microvascularization |
Q49391559 | Spatial and single-cell transcriptional profiling identifies functionally distinct human dermal fibroblast subpopulations. |
Q26774121 | Special cancer microenvironment in human colonic cancer: Concept of cancer microenvironment formed by peritoneal invasion (CMPI) and implication of subperitoneal fibroblast in cancer progression |
Q37183172 | Specific glycosphingolipids mediate epithelial-to-mesenchymal transition of human and mouse epithelial cell lines |
Q33626567 | Specific protein and miRNA patterns characterise tumour-associated fibroblasts in bladder cancer |
Q38856698 | Specific upregulation of RHOA and RAC1 in cancer-associated fibroblasts found at primary tumor and lymph node metastatic sites in breast cancer |
Q39029861 | Spheroid formation and invasion capacity are differentially influenced by co-cultures of fibroblast and macrophage cells in breast cancer. |
Q36782379 | Sphingosine kinase 1 is required for TGF-β mediated fibroblastto- myofibroblast differentiation in ovarian cancer. |
Q36767279 | Src-mediated morphology transition of lung cancer cells in three-dimensional organotypic culture. |
Q30487084 | Staged stromal extracellular 3D matrices differentially regulate breast cancer cell responses through PI3K and beta1-integrins |
Q84911206 | Starting the scar: a primary role for pericytes? |
Q42328088 | Stiffened Extracellular Matrix and Signaling from Stromal Fibroblasts via Osteoprotegerin Regulate Tumor Cell Invasion in a 3-D Tumor in Situ Model. |
Q44784893 | Stochastic modelling of biased cell migration and collagen matrix modification |
Q41045204 | Stochastic multi-scale models of competition within heterogeneous cellular populations: Simulation methods and mean-field analysis. |
Q38125197 | Strategies to increase drug penetration in solid tumors |
Q35062322 | Stretching fibroblasts remodels fibronectin and alters cancer cell migration |
Q39310184 | Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer |
Q37148199 | Stroma-directed molecular targeted therapy in gastric cancer |
Q37214284 | Stromal Activation by Tumor Cells: An in Vitro Study in Breast Cancer |
Q34581844 | Stromal CD10 and SPARC expression in ductal carcinoma in situ (DCIS) patients predicts disease recurrence |
Q35666119 | Stromal Expression of Fibroblast Activation Protein Alpha (FAP) Predicts Platinum Resistance and Shorter Recurrence in patients with Epithelial Ovarian Cancer |
Q35962304 | Stromal Integrin α11β1 Affects RM11 Prostate and 4T1 Breast Xenograft Tumors Differently |
Q34810329 | Stromal LRP1 in lung adenocarcinoma predicts clinical outcome |
Q47373003 | Stromal Lkb1 deficiency leads to gastrointestinal tumorigenesis involving the IL-11-JAK/STAT3 pathway. |
Q33714718 | Stromal PDGFR-α Activation Enhances Matrix Stiffness, Impedes Mammary Ductal Development, and Accelerates Tumor Growth. |
Q60045514 | Stromal PTEN Regulates Extracellular Matrix Organization in the Mammary Gland |
Q61136284 | Stromal PTEN determines mammary epithelial response to radiotherapy |
Q41767315 | Stromal PTEN inhibits the expansion of mammary epithelial stem cells through Jagged-1 |
Q26774497 | Stromal Targets for Fluorescent-Guided Oncologic Surgery |
Q35068998 | Stromal alterations as quantitative optical biomarkers of epithelial tumor progression |
Q42700193 | Stromal and epithelial networks: Temporal gene expression profiling during invasive neoplasia |
Q38494338 | Stromal biology and therapy in pancreatic cancer: a changing paradigm |
Q38017601 | Stromal biomarkers in breast cancer development and progression |
Q48009734 | Stromal cell cadherin-11 regulates adipose tissue inflammation and diabetes. |
Q55016792 | Stromal cells in breast cancer as a potential therapeutic target. |
Q35609967 | Stromal cells in tumor microenvironment and breast cancer |
Q83770207 | Stromal cells modulate TCL1 expression, interacting AP-1 components and TCL1-targeting micro-RNAs in chronic lymphocytic leukemia |
Q42273036 | Stromal control of oncogenic traits expressed in response to the overexpression of GLI2, a pleiotropic oncogene |
Q84364466 | Stromal expression of CD34, α-smooth muscle actin and CD26/DPPIV in squamous cell carcinoma of the skin: a comparative immunohistochemical study |
Q42316344 | Stromal expression of Fer suppresses tumor progression in renal cell carcinoma and is a predictor of survival |
Q34374236 | Stromal expression of decorin, Semaphorin6D, SPARC, Sprouty1 and Tsukushi in developing prostate and decreased levels of decorin in prostate cancer |
Q35202991 | Stromal expression of heat-shock protein 27 is associated with worse clinical outcome in patients with colorectal cancer lung metastases |
Q83327370 | Stromal expression of vascular endothelial growth factor C is relevant to predict sentinel lymph node status in melanomas |
Q38225334 | Stromal fibroblasts and the immune microenvironment: partners in mammary gland biology and pathology? |
Q34268740 | Stromal fibroblasts in digestive cancer |
Q34627461 | Stromal fibroblasts in the microenvironment of gastric carcinomas promote tumor metastasis via upregulating TAGLN expression |
Q27333747 | Stromal fibroblasts mediate extracellular matrix remodeling and invasion of scirrhous gastric carcinoma cells |
Q37716611 | Stromal fibroblasts present in breast carcinomas promote tumor growth and angiogenesis through adrenomedullin secretion |
Q33719793 | Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers |
Q36796966 | Stromal induction of breast cancer: inflammation and invasion |
Q36641872 | Stromal interactions as regulators of tumor growth and therapeutic response: A potential target for photodynamic therapy? |
Q36751290 | Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling |
Q54198345 | Stromal miR-21 is more important than miR-21 of tumour cells for the progression of gastric cancer. |
Q83381970 | Stromal miR-320 keeps an oncogenic secretome in check |
Q42696083 | Stromal myofibroblasts accompany modifications in the epithelial phenotype of tongue dysplastic and malignant lesions |
Q38402765 | Stromal myofibroblasts in focal reactive overgrowths of the gingiva |
Q33659120 | Stromal optical properties: differentiating normal and cancerous stroma |
Q50138285 | Stromal resistance of fibroblasts against oxidative damage: involvement of tumor cell-secreted platelet-derived growth factor (PDGF) and phosphoinositide 3-kinase (PI3K) activation. |
Q37247542 | Stromal uptake and transmission of acid is a pathway for venting cancer cell-generated acid. |
Q34944820 | Stromal-dependent tumor promotion by MIF family members |
Q48112414 | Stromal-derived IGF2 promotes colon cancer progression via paracrine and autocrine mechanisms |
Q61812058 | Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma |
Q37460975 | Stromal-epithelial crosstalk provides a suitable microenvironment for the progression of ovarian cancer cells in vitro |
Q37295029 | Structural and ultrastructural evidence for telocytes in prostate stroma |
Q38734680 | Structure and Function of a Prostate Cancer Dissemination-Permissive Extracellular Matrix |
Q36559850 | Structure and function of glycosphingolipids and sphingolipids: recollections and future trends |
Q36049145 | Studying primary tumor-associated fibroblast involvement in cancer metastasis in mice |
Q36372792 | Suboptimal cytoreduction in ovarian carcinoma is associated with molecular pathways characteristic of increased stromal activation |
Q47897668 | Substrate stiffness modulates lung cancer cell migration but not epithelial to mesenchymal transition |
Q36596228 | Suicide Gene-Engineered Stromal Cells Reveal a Dynamic Regulation of Cancer Metastasis |
Q91775763 | Suppression of Stromal Interferon Signaling by Human Papillomavirus 16 |
Q54114273 | Suppression of TGFβ-mediated conversion of endothelial cells and fibroblasts into cancer associated (myo)fibroblasts via HDAC inhibition. |
Q57794781 | Suppression of stromal-derived Dickkopf-3 (DKK3) inhibits tumor progression and prolongs survival in pancreatic ductal adenocarcinoma |
Q38676055 | Surviving at a distance: organ specific metastasis |
Q35171136 | Sustained β-catenin activity in dermal fibroblasts promotes fibrosis by up-regulating expression of extracellular matrix protein-coding genes |
Q58861133 | Synchronous collision malignant melanoma and adenocarcinoma of the rectum |
Q34998315 | System-wide analysis reveals a complex network of tumor-fibroblast interactions involved in tumorigenicity |
Q33499686 | Systems-level modeling of cancer-fibroblast interaction |
Q34343664 | T cells and stromal fibroblasts in human tumor microenvironments represent potential therapeutic targets |
Q34105259 | TAGLN expression is upregulated in NF1-associated malignant peripheral nerve sheath tumors by hypomethylation in its promoter and subpromoter regions |
Q37705967 | TGF-β Mediated Crosstalk Between Malignant Hepatocyte and Tumor Microenvironment in Hepatocellular Carcinoma |
Q28547113 | TGF-β Negatively Regulates CXCL1 Chemokine Expression in Mammary Fibroblasts through Enhancement of Smad2/3 and Suppression of HGF/c-Met Signaling Mechanisms |
Q39071510 | TGF-β, Bone Morphogenetic Protein, and Activin Signaling and the Tumor Microenvironment |
Q28075605 | TGFΒ-induced transcription in cancer |
Q39519065 | THBS4, a novel stromal molecule of diffuse-type gastric adenocarcinomas, identified by transcriptome-wide expression profiling |
Q92123390 | TLRs in pulmonary diseases |
Q41485983 | TRAF4 promotes lung cancer aggressiveness by modulating tumor microenvironment in normal fibroblasts |
Q38203918 | TRP channels and STIM/ORAI proteins: sensors and effectors of cancer and stroma cell migration |
Q34832513 | TSPAN12 is a critical factor for cancer-fibroblast cell contact-mediated cancer invasion |
Q33403396 | Tamoxifen induces pleiotrophic changes in mammary stroma resulting in extracellular matrix that suppresses transformed phenotypes |
Q37862154 | Tangled fibroblasts in tumor-stroma interactions |
Q36056206 | Targeted Mesoporous Iron Oxide Nanoparticles-Encapsulated Perfluorohexane and a Hydrophobic Drug for Deep Tumor Penetration and Therapy |
Q52579251 | Targeting Accessories to the Crime: Nanoparticle Nucleic Acid Delivery to the Tumor Microenvironment. |
Q35760031 | Targeting Matrix Metalloproteinases in Cancer: Bringing New Life to Old Ideas |
Q39434606 | Targeting PDGFR-β in Cholangiocarcinoma |
Q26769963 | Targeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer Treatment |
Q33513307 | Targeting TNF-alpha for cancer therapy |
Q89667670 | Targeting cancer stem cell pathways for cancer therapy |
Q36187424 | Targeting chemokine pathways in esophageal adenocarcinoma |
Q36414357 | Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers |
Q36685345 | Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signaling |
Q37452281 | Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice |
Q36730567 | Targeting inhibition of fibroblast activation protein-α and prolyl oligopeptidase activities on cells common to metastatic tumor microenvironments |
Q34547374 | Targeting metastasis-initiating cells through the fatty acid receptor CD36 |
Q28067219 | Targeting microenvironment in cancer therapeutics |
Q50159459 | Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors. |
Q36624058 | Targeting of cancer‑associated fibroblasts enhances the efficacy of cancer chemotherapy by regulating the tumor microenvironment |
Q47961293 | Targeting senescent cholangiocytes and activated fibroblasts with B-cell lymphoma-extra large inhibitors ameliorates fibrosis in multidrug resistance 2 gene knockout (Mdr2-/- ) mice. |
Q38852121 | Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread. |
Q92652651 | Targeting the Interplay Between Cancer Fibroblasts, Mesenchymal Stem Cells, and Cancer Stem Cells in Desmoplastic Cancers |
Q58789499 | Targeting the Microenvironment in High Grade Serous Ovarian Cancer |
Q42145272 | Targeting the adventitial microenvironment in pulmonary hypertension: A potential approach to therapy that considers epigenetic change |
Q37686160 | Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer |
Q36626921 | Targeting the tumour microenvironment in ovarian cancer |
Q37391029 | Targeting the tumour stroma to increase efficacy of chemo- and radiotherapy |
Q37767356 | Targeting the tumour vasculature: insights from physiological angiogenesis |
Q48308048 | Targeting tumor microenvironment to curb chemoresistance via novel drug delivery strategies. |
Q53307716 | Targeting tumor-stroma crosstalk: the example of the NT157 inhibitor. |
Q49887906 | Targeting tumour microenvironment by tyrosine kinase inhibitor. |
Q37008387 | Telomere attrition in cancer cells and telomere length in tumor stroma cells predict chromosome instability in esophageal squamous cell carcinoma: a genome-wide analysis |
Q33694568 | Tenascin-W is a specific marker of glioma-associated blood vessels and stimulates angiogenesis in vitro |
Q35858640 | Texture Analysis of Non-Contrast-Enhanced Computed Tomography for Assessing Angiogenesis and Survival of Soft Tissue Sarcoma |
Q64060659 | The 1ALCTL and 1BLCTL isoforms of Arg/Abl2 induce fibroblast activation and extra cellular matrix remodelling differently |
Q34121796 | The 5-HT(2B) receptor plays a key regulatory role in both neuroendocrine tumor cell proliferation and the modulation of the fibroblast component of the neoplastic microenvironment |
Q37008870 | The Action of Discoidin Domain Receptor 2 in Basal Tumor Cells and Stromal Cancer-Associated Fibroblasts Is Critical for Breast Cancer Metastasis. |
Q38586078 | The Amazing Power of Cancer Cells to Recapitulate Extraembryonic Functions: The Cuckoo's Tricks. |
Q52914635 | The Antiaging Properties of Andrographis paniculata by Activation Epidermal Cell Stemness. |
Q35894249 | The Arp2/3 complex is required for lamellipodia extension and directional fibroblast cell migration |
Q50579985 | The Binding Site Barrier Elicited by Tumor-Associated Fibroblasts Interferes Disposition of Nanoparticles in Stroma-Vessel Type Tumors. |
Q92712560 | The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment |
Q90041289 | The Diagnostic Significance of PDGF, EphA7, CCR5, and CCL5 Levels in Colorectal Cancer |
Q36507002 | The Effect of Stromal Integrin β3-Deficiency on Two Different Tumors in Mice |
Q41775545 | The Effect of Tumor Microenvironment on Autophagy and Sensitivity to Targeted Therapy in EGFR-Mutated Lung Adenocarcinoma. |
Q58093770 | The Emerging Role of the Microenvironment in Endometrial Cancer |
Q38636468 | The Emerging Roles of Extracellular Vesicles As Communication Vehicles within the Tumor Microenvironment and Beyond |
Q92594835 | The Evolving Field of Stereotactic Body Radiation Therapy in Pancreatic Cancer |
Q58784339 | The Expression Levels of IL-4/IL-13/STAT6 Signaling Pathway Genes and SOCS3 Could Help to Differentiate the Histopathological Subtypes of Non-Small Cell Lung Carcinoma |
Q33361929 | The Extracellular Matrix in Epithelial Ovarian Cancer - A Piece of a Puzzle |
Q33838714 | The Functions of MicroRNA-200 Family in Ovarian Cancer: Beyond Epithelial-Mesenchymal Transition |
Q35818450 | The HSP90 Inhibitor Ganetespib Radiosensitizes Human Lung Adenocarcinoma Cells |
Q64927223 | The IL-1/IL-1R axis induces greater fibroblast-derived chemokine release in human papillomavirus-negative compared to positive oropharyngeal cancer. |
Q90133583 | The Immune Microenvironment of Breast Cancer Progression |
Q54942438 | The Impact of Radiation on the Tumor Microenvironment: Effect of Dose and Fractionation Schedules. |
Q36761574 | The Initiator Methionine tRNA Drives Secretion of Type II Collagen from Stromal Fibroblasts to Promote Tumor Growth and Angiogenesis |
Q40444191 | The Interaction Between Human Papillomaviruses and the Stromal Microenvironment |
Q26783022 | The Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal Metastasis |
Q54236409 | The Microenvironment in Epstein-Barr Virus-Associated Malignancies. |
Q38679301 | The Microenvironment of Lung Cancer and Therapeutic Implications |
Q90140513 | The Milk Protein Alpha-Casein Suppresses Triple Negative Breast Cancer Stem Cell Activity Via STAT and HIF-1alpha Signalling Pathways in Breast Cancer Cells and Fibroblasts |
Q97537884 | The Mini-Organo: A rapid high-throughput 3D coculture organotypic assay for oncology screening and drug development |
Q37876782 | The Nyhus-Wantz lectureship: etiology, herniosis, diverticulosis coli, and cancer |
Q37758303 | The Oncogenic Potential of Mesenchymal Stem Cells in the Treatment of Cancer: Directions for Future Research |
Q92230700 | The Role of Autophagy in Cancer |
Q92923287 | The Role of Bone Morphogenetic Protein 7 (BMP-7) in Inflammation in Heart Diseases |
Q28077024 | The Role of CC-Chemokines in the Regulation of Angiogenesis |
Q92027212 | The Role of Cancer Stem Cells and Mechanical Forces in Ovarian Cancer Metastasis |
Q92509065 | The Role of Exosomal MicroRNAs in the Tumor Microenvironment of Breast Cancer |
Q39521033 | The Role of FoxC2 Transcription Factor in Tumor Angiogenesis |
Q28391620 | The Role of PTEN in Tumor Angiogenesis |
Q26801843 | The Role of Stroma in Tumor Development |
Q64923650 | The Roles of YAP/TAZ and the Hippo Pathway in Healthy and Diseased Skin. |
Q92799863 | The Tumor Microenvironment as a Regulator of Endocrine Resistance in Breast Cancer |
Q37970636 | The Tumor-Promoting Flow of Cells Into, Within and Out of the Tumor Site: Regulation by the Inflammatory Axis of TNFα and Chemokines |
Q40127968 | The VEGF angiogenic switch of fibroblasts is regulated by MMP-7 from cancer cells |
Q38112032 | The adventitia: Essential role in pulmonary vascular remodeling |
Q27000503 | The adventitia: essential regulator of vascular wall structure and function |
Q58579097 | The anti-psychotic drug pimozide is a novel chemotherapeutic for breast cancer |
Q38006769 | The bed and the bugs: interactions between the tumor microenvironment and cancer stem cells |
Q38828825 | The biology and function of fibroblasts in cancer |
Q37987661 | The biology of personalized cancer medicine: facing individual complexities underlying hallmark capabilities |
Q38767957 | The brain tissue response to surgical injury and its possible contribution to glioma recurrence. |
Q26824147 | The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? |
Q33410394 | The carboxyl terminal trimer of procollagen I induces pro-metastatic changes and vascularization in breast cancer cells xenografts |
Q57188839 | The contributions of cancer cell metabolism to metastasis |
Q37321944 | The critical role of SDF-1/CXCR4 axis in cancer and cancer stem cells metastasis. |
Q37267037 | The crosstalk: Tumor-infiltrating lymphocytes rich in regulatory T cells suppressed cancer-associated fibroblasts |
Q33642464 | The dominant role of IL-8 as an angiogenic driver in a three-dimensional physiological tumor construct for drug testing |
Q92367121 | The double edge sword of fibrosis in cancer |
Q94563647 | The double-edged sword role of fibroblasts in the interaction with cancer cells; an agent-based modeling approach |
Q38210012 | The double-edged sword: conserved functions of extracellular hsp90 in wound healing and cancer |
Q26830787 | The dynamic role of cardiac fibroblasts in development and disease |
Q36459089 | The effect of matrix density on the regulation of 3-D capillary morphogenesis |
Q46157035 | The effect of sorafenib on hepatic stellate cells: implication of its effect on tumor microenvironment |
Q64097202 | The effects and the mechanisms of autophagy on the cancer-associated fibroblasts in cancer |
Q37418330 | The effects of CA IX catalysis products within tumor microenvironment. |
Q34226670 | The efficacy of a novel, dual PI3K/mTOR inhibitor NVP-BEZ235 to enhance chemotherapy and antiangiogenic response in pancreatic cancer |
Q38129921 | The endothelin axis in head and neck cancer: a promising therapeutic opportunity? |
Q37673528 | The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer |
Q59789307 | The epithelial-to-mesenchymal transition induced by tumor-associated macrophages confers chemoresistance in peritoneally disseminated pancreatic cancer |
Q39987977 | The essential role of fibroblasts in esophageal squamous cell carcinoma-induced angiogenesis |
Q28079015 | The ever-expanding role of HIF in tumour and stromal biology |
Q86940390 | The evolution of the cancer niche during multistage carcinogenesis |
Q59134962 | The evolving relationship of wound healing and tumor stroma |
Q36181412 | The expression pattern of matrix-producing tumor stroma is of prognostic importance in breast cancer |
Q37948581 | The extent of retraction clefts correlates with lymphatic vessel density and VEGF-C expression and predicts nodal metastasis and poor prognosis in early-stage breast carcinoma |
Q39856408 | The extracellular matrix glycoprotein elastin microfibril interface located protein 2: a dual role in the tumor microenvironment |
Q37826353 | The extracellular matrix in digestive cancer |
Q33796058 | The fibroblast integrin alpha11beta1 is induced in a mechanosensitive manner involving activin A and regulates myofibroblast differentiation |
Q36841980 | The fibromatosis signature defines a robust stromal response in breast carcinoma |
Q33864284 | The footprint of the ageing stroma in older patients with breast cancer |
Q29615536 | The functions and regulation of the PTEN tumour suppressor |
Q36391951 | The hallmarks of cancer: a long non-coding RNA point of view. |
Q36545542 | The herbal compound Songyou Yin (SYY) inhibits hepatocellular carcinoma growth and improves survival in models of chronic fibrosis via paracrine inhibition of activated hepatic stellate cells |
Q38896944 | The hypoxic microenvironment: A determinant of cancer stem cell evolution |
Q84127499 | The impact of caveolin protein expression in tumor stroma on prognosis of breast cancer |
Q37933095 | The inflammatory tumor microenvironment, epithelial mesenchymal transition and lung carcinogenesis |
Q27333738 | The influence of electric field and confinement on cell motility |
Q91865980 | The interplay between intrinsic and extrinsic Wnt signaling in controlling intestinal transformation |
Q35868405 | The interplay of extracellular matrix and microbiome in urothelial bladder cancer |
Q47624410 | The involvement of lncRNAs in the development and progression of pancreatic cancer |
Q93013140 | The life cycle of cancer-associated fibroblasts within the tumour stroma and its importance in disease outcome |
Q36251455 | The matrix protein Fibulin-5 is at the interface of tissue stiffness and inflammation in fibrosis |
Q37849666 | The mechanisms of cancer immunoescape and development of overcoming strategies |
Q46304569 | The metabolic cross-talk between epithelial cancer cells and stromal fibroblasts in ovarian cancer progression: Autophagy plays a role. |
Q39911126 | The metalloproteinase ADAM-12 regulates bronchial epithelial cell proliferation and apoptosis. |
Q36928869 | The metastatic niche: adapting the foreign soil |
Q37563816 | The microenvironment in mature B-cell malignancies: a target for new treatment strategies |
Q39426202 | The migration speed of cancer cells influenced by macrophages and myofibroblasts co-cultured in a microfluidic chip |
Q38853674 | The nanomechanical signature of liver cancer tissues and its molecular origin |
Q34291977 | The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer |
Q39366753 | The pancreatic cancer microenvironment: A true double agent. |
Q92242397 | The paracrine effects of fibroblasts on Doxorubicin-treated breast cancer cells |
Q36905454 | The paracrine hormone hypothesis of colorectal cancer. |
Q84975992 | The parallel lives of angiogenesis and immunosuppression: cancer and other tales |
Q35291689 | The polyphenols (-)-epigallocatechin-3-gallate and luteolin synergistically inhibit TGF-β-induced myofibroblast phenotypes through RhoA and ERK inhibition |
Q38204343 | The potential role of HIF on tumour progression and dissemination. |
Q35931795 | The pro-metastatic role of bone marrow-derived cells: a focus on MSCs and regulatory T cells |
Q33779031 | The prognostic significance of cancer-associated fibroblasts in esophageal squamous cell carcinoma |
Q90327752 | The prognostic significance of carcinoma-associated fibroblasts and tumor-associated macrophages in nasopharyngeal carcinoma |
Q35870502 | The prognostic significance of tumour-stroma ratio in endometrial carcinoma |
Q48634875 | The renal (myo-)fibroblast: a heterogeneous group of cells. |
Q34599918 | The reprogramming of tumor stroma by HSF1 is a potent enabler of malignancy |
Q35133043 | The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma |
Q28073714 | The role of cancer-associated fibroblasts in esophageal cancer |
Q38216639 | The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance |
Q38777172 | The role of chemerin and ChemR23 in stimulating the invasion of squamous oesophageal cancer cells |
Q38021441 | The role of endothelial-mesenchymal transition in development and pathological process |
Q37271443 | The role of endothelial-to-mesenchymal transition in cancer progression |
Q34505037 | The role of epithelial plasticity in prostate cancer dissemination and treatment resistance |
Q36640439 | The role of human peritoneal mesothelial cells in the fibrosis and progression of gastric cancer |
Q33942378 | The role of mechanical forces in tumor growth and therapy |
Q30429895 | The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts. |
Q90086637 | The role of myofibroblasts in the progression of oral submucous fibrosis: A systematic review |
Q38075556 | The role of non-hematopoietic stromal cells in the persistence of inflammation |
Q37110541 | The role of palladin in actin organization and cell motility |
Q38055432 | The role of promoter hypermethylation in fibroblast activation and fibrogenesis |
Q47807012 | The role of shear stress and altered tissue properties on endothelial to mesenchymal transformation and tumor-endothelial cell interaction. |
Q38063961 | The role of stromal cells in the persistence of chronic inflammation |
Q33703599 | The role of stromal factors in breast tumorigenicity. |
Q38032281 | The role of stromal myofibroblast and extracellular matrix in tumor angiogenesis |
Q35531372 | The role of the cell-cell interactions in cancer progression |
Q88779993 | The role of the epithelial-to-mesenchymal transition (EMT) in diseases of the salivary glands |
Q26997815 | The role of the myofibroblast in tumor stroma remodeling |
Q99568119 | The role of the tumour microenvironment in the angiogenesis of pituitary tumours |
Q38922999 | The roles of tumor- and metastasis-promoting carcinoma-associated fibroblasts in human carcinomas. |
Q89017919 | The significance of scirrhous gastric cancer cell lines: the molecular characterization using cell lines and mouse models |
Q60915495 | The transcriptome landscape of the carcinogenic treatment response in the blind mole rat: insights into cancer resistance mechanisms |
Q27318697 | The tumor as an organ: comprehensive spatial and temporal modeling of the tumor and its microenvironment |
Q37318832 | The tumor microenvironment and its contribution to tumor evolution toward metastasis |
Q34343645 | The tumor microenvironment in colorectal carcinogenesis |
Q28077074 | The tumor microenvironment in esophageal cancer |
Q37800217 | The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. |
Q37036957 | The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through β1 integrin |
Q38536374 | The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence |
Q53338021 | The tumour microenvironment as a target for chemoprevention. |
Q53629802 | The tumour stromal features are associated with resistance to 5-FU-based chemoradiotherapy and a poor prognosis in patients with oral squamous cell carcinoma. |
Q52581537 | The versatile role of exosomes in cancer progression: diagnostic and therapeutic implications. |
Q30354655 | Theranostic Probes for Targeting Tumor Microenvironment: An Overview. |
Q36721737 | Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer |
Q36545163 | Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma |
Q42360479 | Therapeutic properties of aerobic training after a cancer diagnosis: more than a one-trick pony? |
Q33770035 | Therapeutic strategies for targeting the ovarian tumor stroma |
Q90620377 | Therapeutic targeting of the crosstalk between cancer-associated fibroblasts and cancer stem cells |
Q37851151 | Therapeutic targeting of tumor-stroma interactions. |
Q38756772 | Therapy-induced microenvironmental changes in cancer |
Q47282821 | Thermodynamic Aspects and Reprogramming Cellular Energy Metabolism during the Fibrosis Process |
Q49693689 | Three-Dimensional Hepatocellular Carcinoma/Fibroblast Model on a Nanofibrous Membrane Mimics Tumor Cell Phenotypic Changes and Anticancer Drug Resistance. |
Q38903329 | Three-dimensional Co-culture model for tumor-stromal interaction |
Q47134459 | Three-dimensional organotypic matrices from alternative collagen sources as pre-clinical models for cell biology. |
Q35931790 | Tie1 deficiency induces endothelial-mesenchymal transition |
Q39496546 | Time-dependent micromechanical responses of breast cancer cells and adjacent fibroblasts to electric treatment |
Q50133270 | Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer. |
Q42317488 | Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer |
Q34383988 | Tissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts |
Q37956221 | Tissue transglutaminase, inflammation, and cancer: how intimate is the relationship? |
Q26851658 | Trabectedin and plitidepsin: drugs from the sea that strike the tumor microenvironment |
Q58770422 | Tracing the path of cancer initiation: the AA protein-based model for cancer genesis |
Q36319389 | Tracking miRNAs' footprints in tumor-microenvironment interactions: Insights and implications for targeted cancer therapy |
Q36695058 | Transcription factor networks in invasion-promoting breast carcinoma-associated fibroblasts |
Q42153424 | Transcriptional profile of fibroblasts obtained from the primary site, lymph node and bone marrow of breast cancer patients |
Q36007057 | Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks |
Q37269535 | Transcriptional regulation of tenascin-W by TGF-beta signaling in the bone metastatic niche of breast cancer cells |
Q30664746 | Transfer of mitochondria via tunneling nanotubes rescues apoptotic PC12 cells |
Q36531166 | Transformable Peptide Nanocarriers for Expeditious Drug Release and Effective Cancer Therapy via Cancer-Associated Fibroblast Activation. |
Q51776900 | Transformed epithelial cells and fibroblasts/myofibroblasts interaction in breast tumor: a mathematical model and experiments. |
Q38766773 | Transforming Growth Factor β1 Promotes Migration and Invasion of Human Hepatocellular Carcinoma Cells Via Up-Regulation of Connective Tissue Growth Factor |
Q60620985 | Transforming growth factor-β modulates pancreatic cancer associated fibroblasts cell shape, stiffness and invasion |
Q34982720 | Transgenic expression of polyomavirus middle T antigen in the mouse prostate gives rise to carcinoma |
Q34994693 | Transglutaminase 2 overexpression in tumor stroma identifies invasive ductal carcinomas of breast at high risk of recurrence |
Q37981102 | Transglutaminases: key regulators of cancer metastasis. |
Q30497815 | Translating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX Colon Cancer Assay |
Q89587297 | Translational Landscape of mTOR Signaling in Integrating Cues Between Cancer and Tumor Microenvironment |
Q38858806 | Translational aspects in targeting the stromal tumour microenvironment: from bench to bedside. |
Q35219539 | Translational horizons in the tumor microenvironment: harnessing breakthroughs and targeting cures |
Q37040712 | Transplantation of iPSC-derived TM cells rescues glaucoma phenotypes in vivo. |
Q36241046 | Treatment of breast cancer stem cells with oncolytic herpes simplex virus |
Q37106988 | Triggering the landslide: The tumor-promotional effects of myofibroblasts |
Q90040642 | Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness |
Q35646453 | Tumor Interstitial Fluid Formation, Characterization, and Clinical Implications |
Q39141484 | Tumor Microenvironment and Differential Responses to Therapy |
Q98771756 | Tumor Microenvironment in Ovarian Cancer: Function and Therapeutic Strategy |
Q39143305 | Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy |
Q98291393 | Tumor Microenvironment-Responsive Peptide-Based Supramolecular Drug Delivery System |
Q51846287 | Tumor Restrictions to Oncolytic Virus. |
Q38811204 | Tumor Specific Recruitment and Reprogramming of Mesenchymal Stem Cells in Tumorigenesis |
Q26830901 | Tumor angiogenesis and lymphangiogenesis: tumor/endothelial crosstalk and cellular/microenvironmental signaling mechanisms |
Q33425253 | Tumor associated stromal cells play a critical role on the outcome of the oncolytic efficacy of conditionally replicative adenoviruses |
Q27027489 | Tumor cell migration in complex microenvironments |
Q34606502 | Tumor cell-targeted delivery of nanoconjugated oligonucleotides in composite spheroids |
Q39172441 | Tumor fibroblast-derived epiregulin promotes growth of colitis-associated neoplasms through ERK |
Q37800793 | Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets |
Q35624103 | Tumor intrinsic subtype is reflected in cancer-adjacent tissue. |
Q35838122 | Tumor lymphangiogenesis as a potential therapeutic target |
Q37346644 | Tumor macrophages are pivotal constructors of tumor collagenous matrix. |
Q55518010 | Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers. |
Q38697619 | Tumor matrix stiffness promotes metastatic cancer cell interaction with the endothelium. |
Q38121570 | Tumor microenviroment and hepatocellular carcinoma metastasis |
Q92393764 | Tumor microenvironment and stroma in intestinal adenocarcinomas and associated metastases in Atlantic salmon broodfish (Salmo salar) |
Q50246934 | Tumor microenvironment in invasive lobular carcinoma: possible therapeutic targets. |
Q35141434 | Tumor microenvironment-derived proteins dominate the plasma proteome response during breast cancer induction and progression |
Q37982937 | Tumor microenvironment: a main actor in the metastasis process. |
Q35361431 | Tumor microenvironment: a new treatment target for cancer |
Q30493184 | Tumor necrosis factor-alpha regulates transforming growth factor-beta-dependent epithelial-mesenchymal transition by promoting hyaluronan-CD44-moesin interaction. |
Q42371988 | Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness. |
Q35750139 | Tumor signaling to the bone marrow changes the phenotype of monocytes and pulmonary macrophages during urethane-induced primary lung tumorigenesis in A/J mice |
Q27015980 | Tumor stroma as targets for cancer therapy |
Q35765454 | Tumor stroma derived biomarkers in cancer |
Q36300899 | Tumor stroma with senescence-associated secretory phenotype in steatohepatitic hepatocellular carcinoma. |
Q41789360 | Tumor suppression by stromal TIMPs |
Q91650496 | Tumor suppressor HIC1 is synergistically compromised by cancer-associated fibroblasts and tumor cells through the IL-6/pSTAT3 axis in breast cancer |
Q41061574 | Tumor talk: understanding the conversation between the tumor and its microenvironment |
Q37800110 | Tumor vasculature as target for therapeutic intervention. |
Q35862799 | Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells. |
Q37086710 | Tumor-associated fibroblasts predominantly come from local and not circulating precursors |
Q36903707 | Tumor-associated fibroblasts promote the proliferation and decrease the doxorubicin sensitivity of liposarcoma cells. |
Q39268764 | Tumor-associated fibrosis as a regulator of tumor immunity and response to immunotherapy. |
Q37063911 | Tumor-associated macrophages and stromal TNF-α regulate collagen structure in a breast tumor model as visualized by second harmonic generation. |
Q37148134 | Tumor-associated macrophages as incessant builders and destroyers of the cancer stroma |
Q30372640 | Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination. |
Q92092602 | Tumor-associated macrophages promote ovarian cancer cell migration by secreting transforming growth factor beta induced (TGFBI) and tenascin C |
Q37728674 | Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin pathways. |
Q49509990 | Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer. |
Q90087582 | Tumor-derived exosomes educate fibroblasts to promote salivary adenoid cystic carcinoma metastasis via NGF-NTRK1 pathway |
Q39307587 | Tumor-derived mesenchymal stem cells and orthotopic site increase the tumor initiation potential of putative mouse mammary cancer stem cells derived from MMTV-PyMT mice |
Q41402133 | Tumor-driven Molecular Changes in Human Mesenchymal Stromal Cells |
Q42654111 | Tumor-educated mesenchymal stem cells promote pro-metastatic phenotype. |
Q54764898 | Tumor-induced Stromal STAT1 Accelerates Breast Cancer via Deregulating Tissue Homeostasis. |
Q37197484 | Tumor-induced stromal reprogramming drives lymph node transformation |
Q37213623 | Tumor-microenvironment interactions: dangerous liaisons |
Q89561456 | Tumor-on-a-chip for integrating a 3D tumor microenvironment: chemical and mechanical factors |
Q37324753 | Tumor-secreted LOXL2 activates fibroblasts through FAK signaling |
Q35184789 | Tumor-specific expression and alternative splicing of the COL6A3 gene in pancreatic cancer |
Q39450414 | Tumor-stroma interactions a trademark for metastasis |
Q58799845 | Tumor-stroma interactions differentially alter drug sensitivity based on the origin of stromal cells |
Q36261787 | Tumor-stroma ratio is an independent predictor for survival in NSCLC. |
Q37955892 | Tumor-stroma: In vivo assays and intravital imaging to study cell migration and metastasis |
Q38968257 | Tumor-α9β1 integrin-mediated signaling induces breast cancer growth and lymphatic metastasis via the recruitment of cancer-associated fibroblasts |
Q30495528 | Tumors as organs: complex tissues that interface with the entire organism |
Q26765895 | Tumour Cell Heterogeneity |
Q36527927 | Tumour cell-derived Wnt7a recruits and activates fibroblasts to promote tumour aggressiveness |
Q37363554 | Tumour cells down-regulate CCN2 gene expression in co-cultured fibroblasts in a Smad7- and ERK-dependent manner. |
Q29617359 | Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion |
Q26766468 | Tumour progression and metastasis |
Q33698636 | Tumour stromal cells derived from paediatric malignancies display MSC-like properties and impair NK cell cytotoxicity |
Q38164308 | Tumour suppressor gene function in carcinoma-associated fibroblasts: from tumour cells via EMT and back again? |
Q38998166 | Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets. |
Q52841791 | Tumour-microenvironment interactions: role of tumour stroma and proteins produced by cancer-associated fibroblasts in chemotherapy response. |
Q37507440 | Tumour-site-dependent expression profile of angiogenic factors in tumour-associated stroma of primary colorectal cancer and metastases. |
Q37174369 | Tumour-stroma interactions in colorectal cancer: converging on beta-catenin activation and cancer stemness |
Q93336606 | Turning foes to friends: targeting cancer-associated fibroblasts |
Q33990838 | Twist and snai1 expression in pharyngeal squamous cell carcinoma stroma is related to cancer progression |
Q42685028 | Twist1 contributes to cranial bone initiation and dermal condensation by maintaining Wnt signaling responsiveness |
Q33997938 | Twist1 is up-regulated in gastric cancer-associated fibroblasts with poor clinical outcomes. |
Q36186532 | TβRIII Expression in Human Breast Cancer Stroma and the Role of Soluble TβRIII in Breast Cancer Associated Fibroblasts |
Q26852398 | Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment |
Q27024041 | Understanding the role of stromal fibroblasts in cancer progression |
Q37948053 | Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers |
Q37802195 | Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies |
Q36410426 | Unique cellular interactions between pancreatic cancer cells and the omentum |
Q36226867 | Unlike pancreatic cancer cells pancreatic cancer associated fibroblasts display minimal gene induction after 5-aza-2'-deoxycytidine |
Q28473677 | Unraveling the microenvironmental influences on the normal mammary gland and breast cancer |
Q38786015 | Unravelling the relationship between macroautophagy and mitochondrial ROS in cancer therapy |
Q42272472 | Unveiling the role of tumor reactive stroma in cholangiocarcinoma: an opportunity for new therapeutic strategies |
Q58760425 | Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications |
Q36719083 | Upregulated Neuro-oncological Ventral Antigen 1 (NOVA1) Expression Is Specific to Mature and Immature T- and NK-Cell Lymphomas. |
Q38617601 | Upregulation of cancer-associated myofibroblasts by TGF-β from scirrhous gastric carcinoma cells |
Q42119412 | Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma. |
Q38109107 | Using functional nanomaterials to target and regulate the tumor microenvironment: diagnostic and therapeutic applications |
Q38984111 | Using real-time impedance-based assays to monitor the effects of fibroblast-derived media on the adhesion, proliferation, migration and invasion of colon cancer cells. |
Q37618011 | VEGF blockade enhances the antitumor effect of BRAFV600E inhibition. |
Q34149273 | VEGF-independent angiogenic pathways induced by PDGF-C. |
Q28385088 | Validated prediction of pro-invasive growth factors using a transcriptome-wide invasion signature derived from a complex 3D invasion assay |
Q38247284 | Value of caveolin-1 in cancer progression and prognosis: Emphasis on cancer-associated fibroblasts, human cancer cells and mechanism of caveolin-1 expression (Review). |
Q37527128 | Varying effects of EGF, HGF and TGFβ on formation of invadopodia and invasiveness of melanoma cell lines of different origin |
Q92257481 | Vascularized Microfluidics and the Blood-Endothelium Interface |
Q42011268 | Vasodilator-stimulated phosphoprotein promotes activation of hepatic stellate cells by regulating Rab11-dependent plasma membrane targeting of transforming growth factor beta receptors |
Q39285839 | Vinorelbine inhibits angiogenesis and 95D migration via reducing hypoxic fibroblast stromal cell-derived factor 1 secretion |
Q34253198 | Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy |
Q47139553 | Vulvar squamous cell carcinoma aggressiveness is associated with differential expression of collagen and STAT1. |
Q35884610 | Warburg meets autophagy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis |
Q38922402 | Whole-Organism Cellular Pathology: A Systems Approach to Phenomics. |
Q29614274 | Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression |
Q36555217 | Wnt signaling in skin development, homeostasis, and disease |
Q39053166 | Wnt-expressing cells in the intestines: guides for tissue remodeling |
Q34542869 | Wound healing and blastema formation in regenerating digit tips of adult mice. |
Q26828560 | Wounds that will not heal: pervasive cellular reprogramming in cancer |
Q43643304 | YAP forces fibroblasts to feel the tension |
Q59792731 | YAP/TAZ Signaling as a Molecular Link between Fibrosis and Cancer |
Q40171088 | ZEB1-regulated inflammatory phenotype in breast cancer cells |
Q53680625 | [Carcinoma-associated fibroblasts in cancer: the great escape]. |
Q53536050 | [Tumour-stroma interactions in urothelial cancer]. |
Q37396605 | c-Ski activates cancer-associated fibroblasts to regulate breast cancer cell invasion |
Q36557492 | miR-146b-5p mediates p16-dependent repression of IL-6 and suppresses paracrine procarcinogenic effects of breast stromal fibroblasts |
Q37086079 | miR-155-5p inhibition promotes the transition of bone marrow mesenchymal stem cells to gastric cancer tissue derived MSC-like cells via NF-κB p65 activation |
Q37593531 | miR-205 hinders the malignant interplay between prostate cancer cells and associated fibroblasts |
Q55340090 | miR-221 stimulates breast cancer cells and cancer-associated fibroblasts (CAFs) through selective interference with the A20/c-Rel/CTGF signaling. |
Q53218512 | miR-27 is associated with chemoresistance in esophageal cancer through transformation of normal fibroblasts to cancer-associated fibroblasts. |
Q45137895 | miR-29b moulds the tumour microenvironment to repress metastasis |
Q59793155 | miR-338-3p Is Regulated by Estrogens through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts (CAFs) |
Q64059124 | miR-494 induces EndMT and promotes the development of HCC (Hepatocellular Carcinoma) by targeting SIRT3/TGF-β/SMAD signaling pathway |
Q54975654 | miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers. |
Q27025496 | miRNA Deregulation in Cancer Cells and the Tumor Microenvironment |
Q37452957 | microRNA-mediated regulation of the tumor microenvironment |
Q38213075 | microRNAs in the tumor microenvironment: solving the riddle for a better diagnostics |
Q36921242 | p16(INK4A) represses the paracrine tumor-promoting effects of breast stromal fibroblasts. |
Q84074778 | p21/waf1 and smooth-muscle actin α expression in stromal fibroblasts of oral cancers |
Q34356907 | p38 MAPK inhibits breast cancer metastasis through regulation of stromal expansion. |
Q34393678 | p53 status in stromal fibroblasts modulates tumor growth in an SDF1-dependent manner. |
Q28541398 | uPARAP function in cutaneous wound repair |
Q39210673 | β-adrenoceptors are upregulated in human melanoma and their activation releases pro-tumorigenic cytokines and metalloproteases in melanoma cell lines |
Search more.